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Summary 
The World Health Organization report in 2007, declared that, it will not be possible to 
achieve national and international health goals without greater investments in health 
systems. It is a known fact that today, the advancement in science has led to a better 
understanding of etiologies and risk factors of most diseases burden in the world. 
However, the capacity to deliver these innovations to the population that needs them 
the most is severely handicapped by fragile and poor health systems, particularly in 
developing countries. The differing diseases burden spectrum between and within 
countries, underscores the complexity and the need for context specific measures to 
address disease burdens and major causes of poor ill health in respective societies. 
Today, malaria continues to be a public health problem and important cause of 
morbidity and mortality in countries with ongoing transmission. In Tanzania, malaria is 
among the leading causes of hospital attendance and mortality in prevalent areas. 
Efficacious interventions to combat malaria have advanced such that endemic regions 
are seeing a decline in malaria related deaths and morbidity. These gains however, are 
threatened with the emergency of drugs and insecticide’s resistance, environmental, 
vectors and hosts’ related challenges. Despite these challenges, malaria is a 
preventable disease and historically the disease, once prevalent in the North, was 
successfully eradicated. This provides hope for elimination and possible eradication of 
malaria in endemic regions in future if efficacious interventions are adopted in scale.  
The current malaria control strategies in Tanzania can broadly be categorized as; vector 
control activities which includes use of treated bed nets, indoor residual praying and 
environmental management; chemoprevention to specific vulnerable groups; and 
prompt, effective treatment of cases. Health care provision in the country is facing many 
bottlenecks such as shortage of qualified workforce, lack of appropriate technologies 
and frequent stock-out of essential medicines. In addition, reports of poor providers’ 
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compliance to treatment recommendations undermine the effectiveness of the health 
system.  
Through a phase four platform of effectiveness and safety studies of antimalarials 
(INESS), we assessed the quality of malaria case management in the study areas. The 
goal was to understand factors influencing treatment outcomes in real world settings, 
with focus in diagnostic accuracy and provider’s compliance for malaria treatment. This 
work involved a pair of cross-sectional health facility surveys that interviewed patients, 
providers and inventoried health facilities for availability of products related to malaria 
treatment. Complimentary data were obtained from the IMPACT-Tz project which 
introduced artemisinin based combination therapy (ACT) in similar study areas, before 
the national adoption of ACT for malaria treatment. 
Findings from this work demonstrated that, increased use of malaria rapid tests (RDTs) 
for routine care reduced over-treatment with ACT during high malaria transmission 
period from 45.8% in a pre-RDT area to 20.9% in a post-RDT area. Conversely, correct 
treatment with ACT was higher in the post-RDT area 85.9% as compared to pre-RDT 
area 58.3%. This implies that, having appropriate technology in place improves 
targeting of resources and facilitates providers’ compliance. Further assessment on 
correct dosing revealed that age based dosing were more prone to errors. The 
proportion of patients receiving correct dosing as per national guideline was lower in 
middle aged groups; 42% for 9-12 years old and 50% for 3-9 years old patients. 
Analysis of health facility data from 2002 to 2010 showed that presence of parasitemia 
at health facility was generally declining to children below 5 and increasing to above 5 
years. However, significant intra-group’s differences were observed. While children 
below age of 2 showed a declining trend, those above 2-5 years had an increasing 
trend (p<0.001). This was in contrary to the findings from population based surveys. 
This work also described health workers’ specific factors that influences correct 
treatment of malaria and showed that, work experience does influence quality of care. 
Providers with 3 or more years of work experience had higher of odds of giving a correct 
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treatment than otherwise [aOR: 2.6 (1.2-5.6)]. In the same pattern, lower cadre health 
workers [aOR: 4.2 (1.5-11.7)] and having a confirmatory test [aOR: 2.6 (1.2-5.8)] were 
significant predictors of correct treatment. Furthermore, this work revealed that 
provider’s attitudes towards treatment recommendations have little influence in their 
personal practices; a good proxy indicator of their general practice. Factors like type of 
patients, place of work and level of health care, had more influence in their personal use 
of treatment recommendation. 
Findings from this work underscore the multidisciplinary nature of health problems.  
Concentrating in only certain aspects of the health system than others may lead to 
undesirable consequences. Addressing a common health problem requires looking at 
the problem holistically, with systems thinking approach. Understanding the complexity 
nature of systems is the underlying principle of systems thinking. The problems 
highlighted here in relation to malaria case management may constitute a small part of 
disease burden in Tanzania, but provides important lessons for harmonization of 
technical and organizational challenges that hinders progress to better health outcomes 
with the right pace.  
This work made evident the need to advocate transparency and harmonization of health 
system actors, towards a common goal; empower policy makers and health managers 
to understand and adopt systems thinking approach in their daily endeavours as well, 
provide more scientific evidence for what does or doesn’t work, to guide policy making 
decisions. 
Unless we change the status-quo, health systems performance will remain sub-optimal 
and an impediment for moving the malaria (and other diseases) elimination agenda 
forward.  
Summary / Zusammenfassung_________________________________________ 
 
- xiii - 
 
Zusammenfassung 
Der Bericht der Welt Gesundheits Organisation des Jahres 2007 sagt aus, dass es nicht 
ohne grössere und effizientere Investitionen in Gesundheitssystemen und -
Dienstleistungen möglich ist, nationale und internationale Gesundheitsziele zu 
erreichen. Der Fortschritt in der Wissenschaft führt zu einem besseren Verständnis von 
Ätiologie und der Risikofaktoren von den meisten Krankheiten. Die Fähigkeit, diese 
Innovationen der Bevölkerung in Entwicklungsländern, welche sie am meisten benötigt, 
zur Verfügung zu stellen, wird durch anfällige und schlechte Gesundheitssysteme 
untergraben. Die unterschiedlichen Krankheitsbelastungen in einem Land und im 
Vergleich zu anderen Ländern unterstreichen die Komplexität und das Bedürfnis nach 
gezielten Massnahmen gegen Krankheitsbelastungen und den schlechten 
Gesundheitszustand in den genannten Völkern. 
Heutzutage ist Malaria weiterhin ein bekanntes Gesundheitsproblem und führt in den 99 
betroffenen Ländern zu steigender Morbidität und Letalität durch kontinuierliche 
Übertragung. In Tansania ist Malaria einer der Hauptgründe für Spital-Einweisungen 
und Tod in infizierten Regionen. Getroffene Gegenmassnamen waren insofern wirksam, 
als dass in endemischen Gegenden die Morbidität und Letalität zurück ging. Diese 
positive Entwicklung wird jedoch durch Medikament- und Insektizid Resistenz 
zusammen mit Umwelteinflüssen und deren Vektoren und Überträger, erschwert. Trotz 
diesen bekannten Bedrohungen kann Malaria verhindert werden, historisch belegt 
durch die Ausrottung im Norden. Dadurch entsteht die Hoffnung, dass Malaria auch in 
den endemischen Gebieten in naher Zukunft ausgerottet werden kann, sofern effiziente 
Massnahmen zur Anwendung kommen.  
Die aktuelle Malaria-Strategie kann grob in folgende Kategorien unterteilt werden. 
Erstens: Vektorbezogene Massnahmen, wie der Gebrauch von Behandelten Netzen 
über dem Bett, Spray-Anwendung im Haus und Umweltmanagement. Zweitens: Chemo 
prävention in gefährdeten Bevölkerungsgruppen und drittens: Schnelle und effektive 
behandlung von Malaria. Die gesundheitsvorsorge in Tansania hat einige engpässe wie 
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wenige, qualifizierte Arbeitskräfte, fehlende, angemessene Technologien und zu wenig 
Medizin für Patienten zu bewältigen. Zusätzlich schwächt die Nichteinhaltung von 
Behandlungs-Vorschriften die Effektivität des Systems.  
Im Rahmen eines Phase 4-Trial Programms von Indepth Network Effectiveness and 
Safety Studies of  antimalarials (INESS) untersuchten wir die Qualität von behandlung 
in den Studiengebieten. Das Ziel war es, faktoren zu verstehen, welche in der praxis 
behandlungsergebnisse beeinflussen, wobei der fokus bei der diagnostikgenauigkeit 
und der zustimmung der anbieter für malaria behandlung. Die arbeit enthielt ein paar 
von cross-sectional Gesundheitszentren umfrage in der regen- und der trockenzeit. Im 
rahmen dieser Studien wurden Patienten, Anbieter und involvierte Gesundheitszentren 
über die Verfügbarkeit von Produkten für die Malariabehandlung befragt. Zusätzliche 
Daten erhielten wir vom Interdisciplinary Monitoring Project of Antimalarial Combination 
Therapy in Tanzania (IMPACT-Tz), welches vor der nationalen Einführung von ACT für 
Malariabehandlung artemisinin based combination therapy (ACT) in ähnlichen 
Studiengebieten einführte. 
Zusammenfassend zeigten die Resultate dieser Studien, dass die anwachsende 
Anwendung von malaria schnelltests “rapid tests“ (RDTs) für Routineuntersuchungen 
die Übertherapie mit ACT während Perioden mit hoher Malariaübertragung von 45.8% 
(37.2-54.6) in einem pre-RDT Gebiet zu 20.9% (14.7-28.8) in einem post-RDT gebiet 
reduzierte. Dies impliziert, dass das Vorhandensein von geeigneten Technologien das 
Targeting von Ressourcen und die Zustimmung der Anbieter verbessert. Weitere 
Untersuchungen zur korrekten Dosierung von ACT für das behandlung von 
unkomplizierter Malaria zeigten, das altersabhängige Dosierung fehleranfälliger war. 
Der Anteil von Patienten, welche eine korrekte Dosis nach nationalen Richtlinien 
erhielten, war in der Gruppe der älteren Kinder kleiner; 42% für 9-12 Jahre alte Kinder 
und nur 50% für 3-9 Jahre alte Patienten. Auch in der multivariaten Datenanalyse zeigte 
sich ein signifikanter Zusammenhang mit einem tieferen chancen für korrektes Dosieren 
(p<0.05). Die Analyse von gesundheitszentren-daten aus den Jahren 2002 bis 2010 
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zeigte, dass die präsenz von parasitemia in einem Gesundheitszentrum über die Jahre 
zurückging für Kinder unter fünf Jahren und anstieg für Kinder über fünf Jahre. 
Allerdings wurden signifikante Unterschiede innerhalb der Gruppen festgestellt. 
Während Kinder unter zwei Jahren einen abnehmenden trend für die Präsenz von 
parasitemia in einem Gesundheitszentrum zeigten, hatten diejenigen Kinder zwischen 
zwei und fünf Jahren einen zunehmenden trend (p<0.001). Diese Funde stehen im 
Widerspruch zu Ergebnissen von Bevölkerungsbasierten Untersuchungen. 
Diese Arbeit  beschreibt unter anderem spezifische faktoren von fachkräften im 
gesundheitswesen, welche die richtige Behandlung von malaria beeinflussen. Es war 
interessant  zu sehen, dass die arbeitserfahrung der fachkräfte im gesundheitswesen 
die behandlungsqualität beeinflusst. Dienstleistende, welche schon 3 oder mehr jahre 
arbeitserfahrung vorweisen konnten,  hatten einen höheren odds die richtige 
behandlung durchzuführen, als dienstleistende mit weniger als 3 jahren 
Arbeitserfahrung. Genauso waren lower cadre health workers und der besitz eines 
bestätigungstest signifikante einflusswerte für eine richtige malariabehandlung. Weiter 
zeigt diese arbeit, dass die einstellung der dienstleistenden gegenüber 
behandlungsempfehlungen wenig einfluss auf ihre eigene praxis hat. Dies stellt ein 
guter proxy-indikator der allgemeinen praxis dar. Mehr einfluss auf den persönlichen 
gebrauch von behandlungsempfehlungen hatten faktoren wie patientenkategorien, wie 
zum beispiel kinder vs. erwachsene, schwangere vs. nicht-schwangere, oder wie 
arbeitsplätze, wie zum beispiel öffentliche vs. private arbeitsplätze oder auch level der 
gesundheitsversorgung wie zum beispiel spital vs. krankenhausapotheke.  
Resultate dieser Arbeit betonen den multidisiplinären Charakter der Strategien zur 
Krankheitsbekämpfung. Den Schwerpunkt auf nur einen Gesundheitsaspekt zu legen, 
könnte führen zu unerwünschten folgen. Harmonisierung der verschiedenen Funktionen 
des Systems auf eine gemeinsame Gesundheits-Problems erfordert das Problem 
suchen ganzheitlich, mit Systemen denken Ansatz. Das Verständnis der Komplexität 
der Natur von Systemen ist das zugrunde liegende Prinzip des Systemischen Denkens. 
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Die probleme hier in Bezug auf malaria behandlung hervorgehoben darstellen kann 
einen sehr kleinen teil in der karte der krankheitslast in Tansania, sondern bietet 
wichtige Lehren für die harmonisierung der technischen und organisatorischen 
herausforderungen, die den fortschritt behindert, bessere gesundheitliche ergebnisse 
mit dem richtigen tempo. 
Solange der aktuelle Zustand nicht geändert wird, wird die Leistungsfähigkeit des 
Gesundheitssystems suboptimal bleiben und stellt somit im Vorantreiben der 
Beseitigung von Malaria und anderen Krankheiten ein Hindernis dar. 
 
________________
Abbreviations_________________________________________________ 
 
- xvii - 
 
Abbreviations: 
<5 Children less than 5 years of age 
>5 Children or adults above 5 years of age 
ACT Artemisinin-based combination therapy 
ADDO Accredited Drug Dispensing Outlet 
ADR Adverse Drug Reaction 
AIDS Acquired Immunodeficiency Syndrome 
AL (ALU) Artemether-Lumefantrine 
AMO Assistant Medical officer 
aOR adjusted Odds Ratio 
BS Blood smear 
CDC Centers for Disease Control and Prevention 
CHMT Council health management team 
CMO Chief Medical Officer 
CO Clinical officer 
cOR crude Odds Ratio 
DHA Dihydroartemisinin 
DMO District Medical Officer 
HDSS Health and Demographic Surveillance System 
HF Health facility 
HIS Health information system 
HIV Human Immunodeficiency virus 
HMIS Health management information system 
HRP2  Histidine Rich Protein 2 
HW Health worker 
i.e. that is 
IHI Ifakara Health Institute (formally known as IHRDC) 
IHRDC Ifakara Health research and Development Center 
IMCI Integrated Management of Childhood Illness 
Abbreviations_________________________________________________ 
 
- xviii - 
 
IMPACT-Tz 
Interdisciplinary Monitoring Programme for Antimalarial 
Combination Therapy in Tanzania 
INESS 
Indepth Network for Effectiveness and Safety Studies of 
antimalarials 
IRB Institution ethical Review Board 
K/U Kilombero/ Ulanga 
LGA Local Government Authority 
LSHTM London School of Hygiene and Tropical Medicine 
M&E Monitoring and Evaluation 
MO Medical officer 
MOHSW Ministry of Health and Social Welfare 
mRDT Malaria RDT 
NBS National Bureau of Statistics 
NCDs Non-communicable diseases 
NIMR 
NMAIST 
National Institute for Medical Research 
Nelson Mandela African Institute of Science and 
Technology 
NMCP National malaria control program 
PCR Polymerase Chain Reaction 
PMO Prime Minister's Office 
POPC President's Office Planning Commission 
QA 
RBCs 
Quality Assurance 
Red Blood Cells 
RALG Regional Administrative and Local Government 
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Chapter 1: Introduction 
 1.1 Malaria: 
Malaria has been and still is an important cause of human morbidity and mortality. The 
disease is caused by members of the phylum Apicomplexa, genus Plasmodium. 
Plasmodium species exhibit a heteroxenous life cycle involving a vertebrate host and 
the anthropod vector. Five Plasmodium species are responsible for human infection; P. 
falciparum, P. vivax, P. ovale, P. malariae and P. knowlesi (WHO, 2011; Figtree M 
2010). The species differ in their morphology, details of their life cycles and clinical 
manifestations. Malaria due to P. falciparum is the most deadly and it predominates in 
Africa. 
Pathogenesis and Transmission of malaria: 
Malaria infection in humans is transmitted through the bite of female infected anopheline 
mosquitoes. Sporozoites injected during mosquito feeding, enter the circulatory system, 
and within 30-60 minutes will invade a liver cell (figure 1). In the hepatocyte 
(exoerythrocytic cycle), the parasite undergoes asexual replication, often called pre-
erythrocytic cycle (schizogony) (Kakkilaya, 2011; Vaughan AM et al., 2008) . During this 
replicative process, merozoites are released into the circulation following rupture of 
hepatocytes. In P. vivax and P. Ovale infections, some sporozoites do not undergo 
asexual replication, entering a dormant phase known as hypnozoite. Hypnozoites can 
reactivate on a later stage causing a relapse (Cogswell, 1992). While relapse in malaria 
refers to a reactivation of infection through hypnozoites, recrudescence describes a 
situation where parasites fall below a detectable level and later, increases to a patent 
detectable parasitemia. 
As alternative to schizogony, some parasites undergo a sexual cycle and differentiate 
into gametocytes (Vaughan AM et al., 2008). Gametocytes do not cause pathology in 
the human host, but once taken up by mosquito, they go into a sexual stage in the 
mosquito gut and produce sporozoites (sporogony cycle) that carry on malaria 
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transmission (figure1). Merozoites released from infected liver cells invade erythrocytes 
(erythrocytic cycle). The pathology associated with all malaria species is related to 
rupture of infected red blood cells (RBCs) (Cogswell, 1992; Cowman A.F and Crabb 
B.S, 2006); erythrocytes, releasing parasite materials, metabolites, hemozoin (malaria 
pigment) and cell debris. This corresponds to malaria paroxysm, which is the main 
clinical stage of malaria. During this stage, there are increased activities of the 
reticuloendothelial system, particularly in the liver and spleen, resulting in their 
enlargement. Destruction of RBCs results in anemia. The destroyed RBCs and along 
with toxins, sequestrate into blood vessels causing tissue damage. Of all the species, 
P.falciparum infection is associated with severe clinical manifestation. 
 
Figure 1: Life Cycle of malaria parasite. Source: merckmanuals.com  
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Clinical manifestation of malaria: 
The clinical manifestation of malaria is almost exclusively due to the asexual 
erythrocytic stage. All malaria species present non-specific prodromal symptoms before 
a febrile attack. These symptoms includes; headache, slight fever, muscle pain, 
anorexia, nausea and lassitude (Kakkilaya, 2011). The symptoms tend to correlate with 
increasing parasite counts. The prodromal period is followed by febrile attacks known as 
paroxysm, which shows periodicity of 48 to 72 hours depending with the Plasmodium 
species. In P. falciparum infection, the paroxysms may be irregular, exhibiting periods of 
continuous fever, daily or irregular attacks. Patients may also present with 
splenomegally, hepatomegally with slight jaundice and hemolytic anemia.  
The paroxysm is usually followed with onset of chills (with rigorous shivering) where a 
patient experiences cold despite having elevated temperature. The cold stage is 
immediately followed by the hot stage, where a patient feels intense heat, severe 
headache, fatigue, dizziness, anorexia, myalgia and nausea. The next stage is 
characterized by profuse sweating and the decline of fever. The patient feels weak and 
exhausted but does not exhibit other symptoms until the next paroxysm (Kakkilaya, 
2011). Among the serious disease complications is cerebral malaria. Cerebral malaria is 
commonly characterized by impaired consciousness (Molyneux ME, 1989); severe 
headache, convulsions, drowsiness, confusion and coma. These neurological 
manifestations are believed to be due to manifestation of infected erythrocytes in 
microvasculature. 
The burden of malaria: 
Malaria is a public health problem with ongoing transmission in 99 countries (WHO, 
2011). In 2010, there were estimated 216 million episodes of malaria of which 
approximately 81% were in the African region (WHO, 2011). Estimates in early 21st 
century describe the annual global burden of malaria as deaths, 1.12 million, 300-500 
million clinical cases and disability-adjusted life years (DALYs) 34.0 million (WHO, 
2001). Murray and colleagues in 2012, reported higher malaria mortality burden, 
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especially in the adult population, than previously estimated or reported by the WHO 
(Murray CJL et al., 2012). More than 90% of malaria disease burden falls in sub-
Saharan Africa where P. falciparum infection is most prevalent (WHO, 1999). The most 
vulnerable groups in malaria are children below age of 5, mainly due to their less 
developed compensatory and immune mechanisms as well as pregnant women 
because of their increased circulatory demands and pregnancy induced immune-
suppression. 
Malaria is among the leading causes of hospital attendance and mortality where the 
disease is prevalent. The national malaria medium term strategic plan (NMMTSP 2008-
13) reports that malaria accounts for up to 40% of all out-patient-department (OPD) 
attendances in health facilities (PMI, 2008). The WHO world malaria report, 2012 
describes a significant reduction in malaria burden since 2000, with 52% of cases 
averted and 58% lives saved from the 2000 estimates (WHO, 2012b). The number of 
cases is estimated to have decreased globally from 244 million in 2005 to 225 million in 
2009 to 219 million in 2010. Likewise, deaths due to malaria have decreased from 
985,000 in 2000 to 781,000 in 2009 to 660,000 in 2010 (WHO, 2010b; WHO, 2011; 
WHO, 2012b). Africa continues to bear the biggest burden of malaria with 91% of all 
malaria deaths reported from (WHO, 2011). The disease is also a major cause of school 
absenteeism and loss of productivity, hence a huge impact in the countries’ economy. 
1.2 Malaria epidemiology: 
Malaria is mainly a disease of the tropics, sub-tropics and hot humid regions of Africa, 
Asia, South and Central America. In the past, malaria was also found in temperate 
areas including Europe and North America, but it has been eliminated. Literature shows 
that, the ideal environmental conditions for malaria transmission are rainfall about 
80mm for not less than five months per year and temperature between 22-32°C (Craig 
MH et al., 1999). These conditions are favourable for the existence of Anopheles 
gambiae s.I. mosquito that transmits malaria (Charlwood JD et al., 1995). Anopheles 
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gambiae complex are complimented with Anopheles funestus group that feeds almost 
exclusively indoor at nigh (Killeen et al., 2006). 
The epidemiology of malaria can be described according to its transmission intensity, 
clinical features, etc. In terms of transmission, we have areas with stable malaria which 
implies persistency of high prevalence of malaria infection with minimal seasonal 
fluctuation; where as in areas with unstable malaria, there are variability of malaria 
infection in place and time. In terms of parasitemia we can have hypo-endemic 
(intermittent transmission) with <10% parasite prevalence among 2-9 years old, meso-
endemic (regular/ seasonal transmission) with 11-50% prevalence in 2-9 years old age 
group, hyper-endemic (intense but with periods of no transmission) with >50% parasite 
prevalence and holoendemic (all year long transmission) with >75% parasite prevalence 
in infants (WHO, 1951). 
Figure 2: World Malaria distribution. Source World Health Organization 
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Epidemiology of malaria in Tanzania: 
Malaria in Tanzania remains a major public health problem, and a leading cause of 
morbidity and mortality (NMCP, 2003c). The disease is endemic in all parts of the 
country but with variation in endemicity levels caused by differing rainfall patterns, 
altitude and temperature. In early 2000, a programme of mapping malaria risk in Africa 
(MARA) described Tanzania, to have different malaria transmission patterns (figure 4). 
There were areas with unstable seasonal malaria with transmission, not exceeding 
three months a year which included areas at high altitude above 2000 Meters above 
sea level and semi-arid along the Rift Valley (NMCP, 2003c). Areas with stable, 
seasonal malaria have about 3-6 months of intense transmission; where as stable 
perennial transmission occurs along the coastal areas extending as far as 160-240 Km 
inland. 
Figure 3: Malaria Transmission pattern in Tanzania (2002) 
 
 
 
 
 
 
 
 
 
Data from the country’s statistics indicates that malaria prevalence is on the decline. 
Abstracts from National health management information system in early 2000, 
estimated 14-18 million cases and mortality ranging between 140-165 per 100,000 
population (NMCP, 2003c). The community household surveys of the countrywide 
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representative sample commonly known as Tanzania Demographic and Health survey 
(TDHS) have shown a steady decline of fever prevalence in children below age of five. 
Fever as the commonest malaria indicator averaged 35.1% in 1999, to 24.4% in 2004 to 
22.9% in 2010 (NBS, 1999; NBS, 2004/5; NBS and Macro ICF, 2011). Likewise, the 
Tanzania HIV/AIDS and Malaria Indicator Survey report a decline in malaria positivity 
from 18.1% in mainland Tanzania in year 2007/8 to 9.5% in 2012 by rapid test or 4.5% 
by microscopy, with a wide rural-urban difference, whereby urban has persistently lower 
malaria prevalence than rural areas (THMIS, 2007/8; THMIS, 2012). This rural-urban 
difference is also seen in the TDHS reports. 
Figure 4: Variations in malaria prevalence, Tanzania (2007/8) 
 
 
Malaria and poverty: 
Malaria and poverty has been a topic of interest for many years. The disease is almost 
always referred to as the disease of poverty. While the disease is largely determined by 
environment, host and vector factors; there is a striking correlation between global 
burden of malaria and poverty (figure 2- malaria, figure 5- poverty below). The indirect 
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and direct costs of malaria are related to loss of income and productivity and 
expenditure related to the disease prevention measures and treatment.  
Although the relationship between malaria and poverty has long been recognized, its 
paths and mechanisms are not clear. Studies suggest that causality works both ways; 
trapping communities in cycles of poverty. This underscores the need for malaria control 
efforts to include poverty reduction strategies (Teklehaimanot A and Mejia P, 2008). 
Figure 5: World Poverty map: Percent of population living below poverty line. Source: 
Econosystemics.com 
 
1.3 Malaria control strategies in Tanzania and beyond: 
Malaria is an entirely preventable and treatable disease, provided that recommended 
interventions are properly implemented (WHO, 2011). The major preventive mechanism 
for control of malaria infection relies on avoiding contact with vector that transmits 
malaria, chemoprevention and effective treatment of infected cases. 
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Vector control:  
The goals for malaria vector control are to protect people against infective mosquito 
bites and reduce intensity of local malaria transmission, by reducing longevity, density 
and human-vector contacts. The most common interventions targeting vector control 
includes environmental management (EM), use of insecticide treated bed-nets (ITNs), 
preferably long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS). 
Environmental management (EM) through larva control is advisable in minority of 
settings including urban to complimenting IRS and LLINs. Historically, EM has brought 
important achievements in overall malaria control and improvements in health 
conditions that was evident with the construction of Panama canal and Zambia copper 
belt as good examples (Keiser et al., 2005; Castro et al.). In Tanzania, EM activities 
were done during the colonial period and shortly after independence, but were 
discontinued due to country’s adverse economic conditions (Castro et al.). During 2005-
07, the partnership between Japan International Cooperation Agency (JICA), the 
National Malaria Control Programme (NMCP) and the Urban Malaria Control 
Programme (UMCP) planned and implemented a pilot intervention of community-based 
EM of Anopheles breeding sites in Dar es Salaam (NMCP, JICA 2004). This 
programme reported a significant reduction in malaria infection during the post-cleaning 
period, but as well recommended a need for multidisciplinary coordination of integrated 
vector management for malaria control (Castro et al.). 
Indoor residual spraying, involves application of residual insecticides to the inner 
surface of dwellings where many species of anopheles mosquito rest after taking a 
blood meal. It remains one of the main interventions for reduction and interruption of 
malaria transmission in all epidemiological settings (WHO, 2011). Currently there are 12 
insecticides recommended by WHO pesticide evaluation scheme (WHOPES) for IRS 
(WHO, 09), of which selection of use depends on resistance data, residual efficacy, 
costs, safety and the surface to be sprayed. The Dichloro-Diphenyl-Trichloroethane 
(DDT), has a long residual efficacy (6+ months), and is allowed to use for IRS, as long 
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as appropriate guidelines are followed. IRS activities in Tanzania mainland are carried 
out in epidemic prone areas since 2009 (PMI, 2011). The early IRS implementation in 
Muleba district was associated with a 56% reduction in hospital admissions and a 75% 
reduction of deaths attributable to malaria (PMI, 2011). 
Insecticide-treated nets are among the key malaria control interventions that have 
shown tremendous success in the fight against malaria.  The use of insecticide treated 
bed-nets provides physical and other barriers against mosquito bites. The effectiveness 
of ITNs for malaria prevention has been demonstrated in several African countries such 
as Ghana and Tanzania, in late 20th century (Binka et al., 1998; Abdulla et al., 2005; 
Abdulla et al., 2001). Furthermore, use of ITNs have been reported to provide both 
individual and community protection against infective bites (Abdulla et al., 2005; Killeen 
et al., 2007). The need to extend ITNs benefits to malaria risk groups, led to exploration 
of different delivery strategies through both public and private sectors. There is now 
more evidence to suggest that, delivery of ITNs through different mechanisms including 
social marketing, free distribution, etc, significantly increases coverage of ITNs to the 
communities (Abdulla et al., 2001; Schellenberg et al., 2001; Khatib et al., 2008; Curtis 
C et al., 2003).  
One of the challenges reported in the early use of ITNs was the low level of net re-
treatment. This was a major setback to the fully realization of ITNs impact to sustainable 
malaria control efforts. However, availability of long lasting insecticide nets (LLINs) has 
provided a solution to the re-treatment challenge, at least to the life span of the net. 
Another challenge to vector control for the control of malaria is related to changes in 
behaviour of the vector populations. Russell and colleagues, reported an increase in 
proportion of outdoor feeding among residual malaria vector populations following 
increased use if ITNs in rural Tanzania (Russell TN et al., 2011). 
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Chemoprevention:  
There are other effects of malaria that are not always directly linked to the disease. 
Scientists have long documented that, malaria causes some indirect effects especially 
related to pregnancy outcomes and growth of the fetus. In malaria endemic regions, 
pregnant women are at risk of infection due to the decreased immunity. Malaria in 
pregnancy is associated with abortions, stillbirths, anemia and delivery of low birth 
weight babies. Birth weight has been shown to be a significant predictor of child’s 
survival and growth (Greenwood et al., 1992). In order to reduce the consequences of 
malaria in pregnancy and child survival, the intermittent preventive treatment in 
pregnancy (IPTp) is recommended to women living in endemic areas. In IPTp, a 
therapeutic course of antimalarial is taken, and had shown to reduce placental 
parasitemia (Newman et al., 2003; van Eijk et al., 2011). Despite of the benefits 
reported, uptake of the second IPTp dose has been a major setback (WHO, 2011). 
Another vulnerable group to the hazardous effects of malaria is infants. Many children in 
malaria endemic African countries die due to malaria. The World Health Organization 
reported that about 86% of all malaria deaths in 2010 were in children below the age of 
five (WHO, 2011).  The fact that newborns and younger children have underdeveloped 
immunity plays a huge role in malaria pathogenesis to this group. Randomized clinical 
trials (RCTs) have demonstrated that, providing antimalarial preventive treatments as 
intermittent preventive treatment to infants (IPTi), protects children and significantly 
reduce the negative health consequences of malaria in this age (Schellenberg et al., 
2006). WHO now recommends IPTi with Sulphadoxine Pyrimethamine (SP) in countries 
with moderate to high malaria transmission, where levels of parasite resistance to SP 
are low (WHO, 2011). 
Development of other tools for malaria control is still ongoing. This includes malaria 
vaccines for African children and other malaria endemic countries. A phase 3 trial of 
candidate malaria vaccine RTS,S/A S01 conducted in seven African countries brought 
new hope for an efficacious vaccine of malaria in future. In this trial, RTS, S/A S01 
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provided protection against both clinical and severe malaria in African children (The 
RTS, S Clinical Trial Partnership). Initial results provided by the study team, published in 
the New England Journal of Medicine in October, 2011 shows that, the RTS,S vaccine 
provided protection against clinical and severe malaria in both per- protocol and 
intention-to-treat analysis (RTSS/AS01, 2011). 
Malaria case management: 
Prompt and effective treatment of malaria cases is advocated for control of the disease. 
The emergency and widespread of resistance to insecticides and commonly used 
antimalarials medicines such as Chloroquine and Sulphadoxine-Pyrimethamine (SP), 
makes appropriate treatment very challenging to poor countries. The current global 
efforts to improve malaria treatment are on use of artemisinin based combination 
therapy (ACTs) for malaria treatment. Artemisinins are still effective even against 
Chloroquine resistant parasites and are being used for treatment of both severe and 
uncomplicated forms of malaria. Tanzania changed her malaria treatment guidelines 
twice within a decade. First, in early 2001, Chloroquine was replaced by SP for 
management of uncomplicated malaria and in late 2006, artemether-lumefantrine (ALu) 
which is an artemisinin based combination treatment, replaced SP. Quinine continued to 
be a treatment of choice for severe malaria, newborns below 2 kg of weight and 
pregnant women in their first trimester. In 2012, the country is reviewing malaria 
treatment guidelines to introduce artesunate injection as first line medicine for treatment 
of severe malaria. 
Studies in rural Tanzania have shown that, malaria patients seek care and obtained 
antimalarial medicines from informal retail outlets (Goodman et al., 2004; Kachur et al., 
2006; Hetzel et al., 2008). In the move to increase accessibility of antimalarial 
medicines, the Government of Tanzania (GoT) piloted and started to implement a 
revised pharmaceutical criterion, allowing ACTs to be stocked in private Accredited 
Drug Dispensing Outlets (ADDOs). During the pilot phase, ADDOs demonstrated an 
improvement in availability of malaria treatment in study areas (Quick JD et al., 2005). 
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Tanzania also bans the use of artemisinin based monotherapy, in order to reduce 
development of drug resistance. In addition, GoT introduced malaria rapid diagnostic 
tests (mRDTs) for routine use to all levels of care, to complement microscopy services 
wherever available. Introduction of mRDTs in routine health care system is expected to 
improve quality of care given to malaria suspected patients, limit the use of ACTs to true 
malaria patients and provide accurate estimates of the disease burden in the country. 
Despite good prospects for using mRDTs in routine care, bottlenecks in the health 
system may limit obtaining the full value of this tool in malaria control (Masanja et al., 
2011). 
1.4 Health systems 
The WHO defines health system as all organizations, people and actions whose primary 
intent is to promote, restore or maintain health (WHO, 2007). But, the description of 
health system performance goes beyond assessment of health care services indicators 
such as immunization coverage, number of hospital beds, maternity care etc (Olafsdottir 
AE, 2011). It needs to include wider determinants of health including governance and its 
relation to health and health equity, human resources for health, availability of supplies 
and products, etc. The WHO health system framework describes health system in terms 
of six core interconnecting building blocks; finances, health workforce, information, 
governance, medical products and technologies as well as service delivery (figure 6) 
(WHO, 2008).How this framework depends on substantial inter-linkage and interactions 
among the blocks such that, they all contribute to the strengthening of the health 
systems in different ways, was clarified by de Savigny and Adam in 2009 (De Savigny D 
and Adam T, 2009).  
Health systems building blocks: 
While governance provides a cross-cutting role in health systems performance, 
financing, human resources, information, medicines and technologies for health are 
major inputs for production of health, whereas service delivery reflects the immediate 
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outputs of the health system (WHO, 2008). All of the six blocks have unique strengths to 
influence performance of the entire health care system in respective countries 
(Kaufmann D, 2008). Assessment of governance in health requires ensuring 
appropriate policies and strategies are in place, and effectively implemented or enforced 
(Mikkelsen-Lopez et al., 2011). 
Figure 6: The WHO Health systems framework: The six building blocks  
 
 
Financing in health systems requires raising of sufficient funds to run the system 
through revenue collection and external sources; but also to provide financial risk 
protection to the population, avoiding catastrophic expenditures in health through a 
proper mix of financing policies; weighing between regressive and progressivity as well 
as providing efficiency use of resources, in order to avoid wastes and corruption.  
The information sub-system is the basis for decision making and policy development. 
Information may be of little value if it lacks accuracy, completeness and not be available 
in timely manner and in appropriate formats to meet the needs of multiple users. One 
big challenge related to health information systems is the existence of different methods 
of data collection, multiple data sources and multiple indicators. Many reports have 
highlighted the challenges of fragmentation, untimely availability and incompleteness of 
data from routine health care systems in resource poor countries (Smith M et al., 2008). 
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Now, information technology experts are thinking of ways to simplify the complexity of 
health information system (HIS) through enterprise architecture (EA) (Mwanyika H, 
2011), e-health and the Health Metrics Network framework (WHO, 2012a). 
Human resources for health are known to have a big influence in delivery of quality 
health services. Studies have shown a positive link between number of health workers 
and population health outcomes (Anand S and Barnighausen T, 2007). The critical 
shortages of health workers in sub-Sahara African countries are known to have many 
contributing causes, including inadequate skill mix, mal-distribution (Maestad, 2006; 
Leon BK, 2010; Kurowski C et al., 2003), death, retirement as well as career change 
and out-migration. Brain drain and health workers attrition is an all too common 
phenomenon much reported in literature (Kurowski C et al., 2003; Pang T, 2002).  
Provision of quality service requires available products and technologies in place.  In 
order to ensure availability of medical products, vaccines and technologies, an effective 
and accountable local and national procurement and drug management system is 
needed. This is unfortunately not always practical in resource poor countries and may 
leave way for leakages and corruption. New health system technologies may improve 
the situation. Such programmes as use of short text messages (Barrington et al., 2010) 
to assess stocking levels of products and act accordingly, brings new hope for ensuring 
availability of necessary medical products for improving quality of health care.  
Service delivery block is the most visible component of the health system. Health 
services can be promotive, preventive, curative or rehabilitative services and may be 
delivered at home, community, and workplace or in health facilities. Effective service 
delivery depends on having resources in place; including staff, medicines, supply chain, 
etc, that are timely accessible to people. Any improvement in the provision of health 
care is most likely to improve the livelihood of people in the respective communities. 
With respect to malaria, studies have shown that, improving access to recommended 
treatment also improved malaria treatment and treatment seeking behavior, with an 
impact in the disease morbidity and mortality (Alba, 2010).  
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Health systems strengthening and global health systems: 
The WHO report in 2007 (Everybody’s Business); declares that it will be impossible to 
achieve national and international health goals without greater and more effective 
investments in health systems and services (WHO, 2007). Among the challenges facing 
health systems in developing world has to do with failing health systems, failure of 
scaling-up effective interventions and resources constraints. The facts that the spectrum 
of disease burden differs across communities and countries, and countries differs in 
economic, social-cultural and political contexts; makes it extremely difficult to have 
common measures of action for health systems improvement globally. The WHO 
reports that, threats posed by new epidemics such as the avian or human pandemic 
influenza, demands response from all countries rich and poor (WHO, 2007); which 
further illustrates the severity of challenges faced. 
The recognition of the need to strengthen health systems has resulted a growth in 
country’s domestic budgets and donors support, particularly in low and middle income 
countries (WHO, 2007). The patterns of disease, risk factors and treatments 
recommendations also keep changing, posing differing demands in time and place. In 
many developing countries, the poorest quintile is the hardest to reach by interventions 
that seem to be working well for the majority of people. This brings the issue of inequity 
and inequality of services, and ethical concerns for human rights to access quality 
health care and efficiency of health systems. Despite these challenges and complexity 
of addressing them in context, the WHO now advocates a ‘systems thinking’ approach 
to guiding response to health systems challenges as described in several reports 
including its 2009 publication; Systems Thinking for Health Systems Strengthening (De 
Savigny D and Adam T, 2009). 
The Tanzanian Health System: 
Tanzania is one of the low income countries that have a well defined national health 
strategy and health care delivery structure. As described in the Ministry of Health and 
Social Welfare  government website (www.tanzania.go.tz/health.html), 
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village/community health services are the lowest level of health care delivery in the 
country (www.tanzania.go.tz/health.html). They essentially provide preventive services 
which can be offered at home. Dispensaries are the second stage, and cater for 6,000 
to 10,000 people, as well as supervising all village health posts in its ward. Health 
centers (3rd level) are expected to cater for 50,000 people, which is approximately a 
population of one administrative division. The fourth level is the district hospitals 
followed by regional hospitals. These two levels, offer similar services, but regional 
hospitals may have specialists in some fields, offering additional service. The highest 
level of hospital services in Tanzania is referral/ consultant or specialized hospitals. 
These hospitals are also used for teaching purposes. 
In the past, health services in Tanzania have been largely a prerogative of the state with 
only a limited number of private-for-profit health services available in major towns 
(www.tanzania.go.tz/health.html). The importance of private sector in health care 
delivery was further recognized with the amendment to the Private Hospitals 
(Regulatory) Act, in 1977 (www.tanzania.go.tz/health.html). Administratively, each 
higher level of care has the mandate to supervise services provided at their respective 
lower level categories. In addition, the District Medical Officer (DMO) is the senior health 
manager in the district and the Regional Medical Officer (RMO) served the region. The 
DMO works hand in hand with the Council Health Management Team (CHMT) to plan, 
implement and supervise health related activities in their district. Each health facility in 
turn, have a committee made of members from the Village Government, who, among 
other tasks, have the mandate to monitor daily running of the health facility in their 
respective areas. The distribution of health facilities has a heavy rural emphasis since 
more than 70% of population lives in rural areas (www.tanzania.go.tz/health.html).  
Among the major challenges facing the Tanzania health system are the shortage of 
human resources for health with a small and inequitable distribution (Leon BK, 2010; 
Kurowski C et al., 2003), incomplete and inaccurate data (Smith M et al., 2008) as well 
as frequent stock-outs of medical supplies. This has resulted in low standard of care, 
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particularly in public sector and in-appreciation of the value of user fees in public health 
facilities. The total government expenditure in health is low, hence, running of the 
system is highly dependent on donor funding and driven by disease specific 
programmes. The process of decentralization by devolution, adds a layer of complexity 
on the country’s health system performance by stretching the roles and managerial 
ability of staff at the Ministry of Health and Social Welfare (MOHSW) and the Prime 
Minister’s Office-Regional Administration and Local Government (PMO-RALG) (Musau 
S et al., 2011)  
1.5 Health systems influence in malaria case management 
The 20th century was faced with many challenges in malaria control. Countries that were 
close to moving from control to malaria elimination status were stalled and even 
backsliding. The increased burden of malaria morbidity and mortality was primarily due 
to growing resistance of malaria parasite to anti-malarias medicines and insecticides in 
use, changing in weather patterns (e.g. the El-Nino rains), human migration as well as 
deteriorating health systems. The global consensus to move to the use of ACTs for 
malaria treatment aimed at curbing anti-malarial drug resistance. Most malaria endemic 
countries adopted the use of ACTs for management of uncomplicated malaria; following 
WHO recommendations (WHO, 2010a) and increased use of rapid tests for malaria 
confirmation. The use of long lasting insecticide-treated nets (LLINs) was emphasized, 
as well as IRS and environmental management for vector control. Another important 
step was the recognition of the need to invest greater efforts to health systems 
strengthening. There is now increased donor funding to support malaria control 
activities in endemic countries, both from funders through global coordinated efforts 
such as the Global Fund to fight Malaria, TB and HIV; and from individual developed-
nation’s support, through bilateral agreements with endemic countries.  
These efforts have lead to a significant reduction of malaria prevalence in many areas 
where malaria has been a major public health problem for decades. One good example 
is the achievement of the Zanzibar Island (Tanzania) where prevalence of malaria has 
Chapter 1: Introduction________________________________________________ 
 
- 21 - 
 
stayed consistently low to a point that the government is declaring moving the malaria 
control status to the elimination stage. In Mainland Tanzania, prevalence of fever 
reported through country representative household surveys, has also declined from 
35.1% in 1999 to 22.9% in 2010 (NBS, 1999; NBS and Macro ICF, 2011). Despite these 
gains, there are still striking rural-urban differences as well as persistent of variation in 
transmission intensities in various areas of the country. The global malaria mortality also 
shows a similar trend. Murray et al, reported a decline of mortality due to malaria in the 
past decade, from 1,817,000 in 2004 to 1,238,000 in 2010 ; but surprisingly reported 
more deaths due to malaria in individuals aged 5 years and above, than has been 
previously estimated (Murray CJL et al., 2012). 
Health Systems Effectiveness  
Prompt and effective treatment of malaria can only be achieved through good access to 
health care and presence of appropriate personnel, technology and medicines. 
Inappropriate use of available effective treatment will not provide effective cure and is 
known to foster development of drug resistance. Studies from Tanzania and elsewhere 
found that clinicians continued to prescribe anti-malarials to patients whose test did not 
provide evidence of the presence of malaria parasites, hence no malaria (Makani et al., 
2003; Reyburn et al., 2007; Opoka RO et al., 2008). Ideally, a good provider’s 
compliance to treatment recommendation should be coupled with better patients’ 
adherence to prescribed medicine, for maximum treatment benefits. This means that 
effectiveness of the treatment recommendation is a shared responsibility among 
individuals, families, communities and health care providers.  
Development of medicines follows a defined pipeline from exploration of the possible 
chemical combinations to field trials. The candidate treatment formulation is again 
subjected to a series of clinical trials (phase 1 to 3), before being approved for human 
use. This process may take years to be completed, followed by registration of the 
product for routine use in clinical settings. In countries with well developed health 
systems, the registered medical products continue to be monitored routinely to ascertain 
Chapter 1: Introduction________________________________________________ 
 
- 22 - 
 
any delayed adverse reactions. These are commonly known as phase 4 trials and occur 
in real world settings. The importance of phase 4 platforms relies on a fact that humans 
live in very diverse conditions environmentally, socio-culturally, politically and in very 
different health systems. 
1.6 Rationale of systems effects in health care 
Health systems researchers have hypothesized the links between drug’s efficacy and 
health systems effectiveness. A drug with very high efficacy may not provide desired 
benefits when subjected to real life routine use. This decay in drug’s apparent efficacy 
may be influenced by other system factors which have a role in achieving provision of 
care. These may include poor access to treatment, inappropriate provider’s behavior 
such as poor prescription practices, patients’ non-adherence of prescribed treatment or 
dosing scheme, in-availability of medicines hence use of a substitute or poor quality 
product, etc. This is where the need to understand factors influencing treatment 
outcomes, becomes of paramount importance. In the schematic presentation below, 
treatment effectiveness is shown to be not only a result of efficacy, but also a product of 
access, diagnostic accuracy, provider’s compliance and patient’s adherence which are 
characteristic elements of the health system delivering the service. 
Figure 7 Health systems factor that can lead to a decay of drug efficacy once introduced 
in real world health systems. Source: The malERA Consultation Group (malERA, 2011) 
. 
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The present work was conducted to understand the influence of health system factors in 
malaria control strategies by assessing the quality of malaria case management as 
determined by diagnostic accuracy and provider’s compliance. The assessment 
analyzes health system factors in the framework of the existing Tanzanian health care 
system and currently available resources without much influence in the system 
performance. The work was carried out in a phase 4 platform of effectiveness and 
safety studies of antimalarials in Africa, named INESS: Indepth Network for 
Effectiveness and Safety Studies of antimalarials in Africa (INESS). These studies 
therefore address the following research questions: 
1. What systems factors (e.g. health workers characteristics, availability of products, 
etc) are associated with appropriate management of uncomplicated malaria? 
2. Does availability of malaria diagnosis technology improve providers’ compliance? 
3. What are the predictors of malaria parasitemia in patients seeking care at formal 
health sector (to facilitate diagnostic accuracy)?  
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Chapter 2: Objectives and Methods 
2.1 Goal of the study 
The goal of this work was to determine health systems factors which influence 
appropriate malaria case management in Tanzania. 
2.2 Specific Objectives 
1. To determine the influence of malaria diagnostics to guide appropriate targeting of 
antimalarial treatment for uncomplicated malaria; 
2. To assess determinants of correct dosing for treatment of uncomplicated malaria by 
health workers in rural Tanzania; 
3. To assess health workers factors that predict providers’ compliance with treatment 
recommendations for uncomplicated malaria; 
4. To assess health workers attitudes and personal use of recommended antimalarial 
treatment;  
5. To assess predictors of parasitemia in patients seeking care in the formal health 
sector of rural Tanzania. 
 
2.3 Methods 
Description of project: 
The INDEPTH Effectiveness and Safety Studies of Antimalarials (INESS) project 
undertakes Phase 4 comparative safety and effectiveness studies of new combination 
therapies for malaria in seven INDEPTH Network Demographic Surveillance System 
(DSS) sites in four countries in Africa. In Tanzania, the project is implemented in Rufiji 
District (Pwani Region) and Kilombero/ Ulanga districts (Morogoro Region). These DSS 
sites are managed by the Ifakara Health Institute (IHI). The project creates the missing 
final section of drug development pipeline in Africa. In order to reach its objectives, 
INESS work is organized into separate modules that answer a particular objective 
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(http://indepth-network.org/iness/) (INESS). Additional data to assess trends in some 
outcome measures (objective 4 and 5) were collected from the IMPACT-Tz project 
(Interdisciplinary Monitoring Project for Antimalarial Combination Therapy in Tanzania); 
a multiyear implementation research evaluation project implemented in same study area 
as INESS (Kachur et al., 2004). 
Study design and study period: 
In INESS, we conducted repeated cross-sectional cluster surveys in all health facilities 
within the HDSS area. These were government, private and other non-government 
health facilities. A cluster was defined as all patients consultations performed in a health 
facility on one day during regular working hours, i.e. 8am to 5pm. The surveys were 
conducted during March 2010 (coinciding with the rainy season) and October 2010 
(during dry season) in order to capture the high and low malaria transmission seasons, 
respectively. 
Study area:  
The INESS study (and IMPACT-Tanzania) was implemented in Rufiji and Ifakara Health 
and Demographic Surveillance Systems (HDSS). The Ifakara HDSS extends to include 
part of Kilombero and Ulanga districts (figure 8 below). The Rufiji HDSS has been 
operating since 1998 and has registered about 85,000 people (Mwageni E et al.). The 
Ifakara HDSS started in 1996 with a population of about 99,000 population extending to 
include part of the Kilombero and Ulanga districts (Ifakara HDSS). 
Study participants: 
The health facility module collected information from three areas: 
a) Health facilities: Any public or private health facility serving in the HDSS area that 
provides curative care in the outpatient settings. These were referred to as ACT 
providers. 
b) Health workers: Any health worker who performs consultations with the sick 
patients in outpatient settings of an eligible ACT provider 
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c) Patients: All patients who came for initial consultation, seeking care for any 
illness in outpatient department of an eligible ACT provider, during regular 
working hours, Monday to Friday (except public holidays). 
 
Figure 8: Map of the study sites (adopted from IMPACT Tanzania project 2000-2005): 
 
 
Sampling: 
The final sample size calculated was 1,537 patients for both sites, presenting for initial 
consultation to estimate a 50% +/-10% fever prevalence for targeting accuracy with a 
95% confidence, accounting for clustering with a design effect of two. We worked with 
assumptions that: 50% of patients presenting to health facilities will have fever, and 
20% of them will have malaria parasites. 70% of patients with fever and parasitemia will 
receive any ACT and 10% of patients without fever will get ACT. 
Training of data collectors 
Field workers were trained for two days on the survey procedure and blood slide 
collection procedure in a classroom setting and then practiced in the test health facility 
outside the HDSS area. 
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Data collection and field procedures: 
One team of two to three field workers visited the health facility to collect data. The 
assumption was that, 15 patients were to be enrolled per health facility per day, then the 
survey needed to include 48 health facilities-survey days per round. Procedures at the 
health facility included:  
a) Dates of survey visit were not announced in advance to health facility staff. On a 
survey day, the team arrived before working hours with a letter from the DMO 
specifying the nature and purpose of the assessment. The teams meet with facility 
staff to introduce themselves and introduce the survey purpose. In addition, they 
created a list of health workers who perform outpatient consultation and conduct 
health worker’s interviews to obtain information about their training, supervision and 
knowledge of malaria case management.  
 
The survey team also obtained agreement from the laboratory to obtain an extra 
blood smear for study purposes. 
 
b) As ill patients arrive into the facility, presence of the study team was announced in 
the waiting area to alert patients. Patients were assessed for their eligibility at the 
waiting area. These eligibility criteria required a person to be attending a facility for 
initial illness consultation, not a follow-up visit from a recent illness, ascertained by a 
series of three questions.  All eligible patients who gave their consent were included 
in the study and provided with identification number and card. The laboratory 
personnel used this identification number to label an extra slide.  
 
When the patient was ready to leave the facility, the surveyor interviewed the patient 
and collected a blood smear if this patient was not send to a laboratory as part of 
routine service. The interview was used to determine if the patient understood 
information provided by the provider, as well all prescribed and provided medications 
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were recorded. At the end of the interview, or end of the day, information from 
patient’s record was extracted. 
 
c) The team remained at the facility until regular closing time. After the facility closure, 
one surveyor conducted an inventory of facility equipment and drug stocks. One 
surveyor conducted interviews with the facility staff to obtain information on the 
health workers’ training, supervision and knowledge of malaria case management. 
 
Before leaving the facility, interviewers reviewed all data forms to ensure completeness. 
Laboratory procedures 
If the patient was not sent to a laboratory and an extra slide was not collected, the field 
worker performed a finger prick and took a blood smear after completing patient 
interview, before the patient leave the facility. All blood smears were stained with 
Giemsa stain. Two independent laboratory technicians read all films. A third 
microscopist read discordant results. Parasite density was calculated by counting 
asexual stage parasites per 200 white blood cells (WBCs) assuming 8000 WBCs/ dl of 
blood. Smears were considered negative if no parasites were found after counting 200 
fields. Results were available approximately one week after the survey and were sent to 
the facility, where participants could pick up their results. 
Data management and analysis 
Data was double entered in EPI Data. Entry screens were optimized with data checks 
and skip patterns to ensure consistency. Patient’s results from slide readings were 
merged with data from exit interview. Analysis was done in STATA 11 (STATA 
Corporation, College Station, USA) accounting for clustered nature of the data. 
Pregnant women were excluded in the analysis. Both Univariate and multivariate 
analysis were performed in order to assess relation of outcome variables and various 
predictors.  
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Ethical considerations 
Written informed consent was sought from patients and caretakers of children. Consent 
forms were translated into Swahili and back translated into English to for validation. 
Unaccompanied minors (person <18 years) were not included in the survey since they 
were unable to provide informed consent. Permission to carry out the surveys was 
obtained from the district health authorities. Additional verbal consent was sought for 
health workers interview. In order to maintain confidentiality, participants personal data 
such as names, were not collected, instead code numbers and HDSS permanent 
identity numbers were used. No cost was incurred by study participants. 
 
INESS project was granted national (August 17, 2009) and institutional ethical approval 
number IHI/IRB/No.67-2009, in June 20, 2009. As well, IMPACT-Tz project received 
both institutional and national ethical clearance in year 2000. 
Collaboration with IMPACT project and access to data: 
The INESS project involves international collaborations with technical expertise from 
Swiss TPH, the US Center for Disease Control and Prevention (CDC), University of 
Ghana, etc. In the Swiss TPH, collaboration is with the Health Systems Research and 
Dynamic Modeling (HSRDM) unit, with lead from Professor Don de Savigny and Dr 
Irene Kuepfer. INESS collaboration in CDC, it is within the Malaria branch with Dr Jacek 
Skarbinski and Dr Patrick Kachur as health facility module leaders.  
The IMPACT – Tanzania project was also a collaborative effort between the Ifakara 
Health Institute (Tanzania), the CDC, Malaria branch and other local and international 
collaborators as described at a footnote in Kachur et al, 2004 (Kachur et al., 2004). In 
both INESS and IMPACT-Tanzania programmes I supervised activities under the health 
facility surveys. As a senior researcher, I have publishing access to the modules’ data.  
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Chapter 3: Malaria Diagnostics 
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Abstract:  
Background: The World Health Organization recommends parasitological confirmation 
of all malaria cases. Tanzania is implementing a phased rollout of malaria rapid 
diagnostic tests (RDTs) for routine use in all levels of care as one strategy to increase 
parasitological confirmation of malaria diagnosis. This study was carried out to 
evaluated artemisinin combination therapy (ACT) prescribing patterns in febrile patients 
with and without uncomplicated malaria in one pre-RDT implementation and one post-
RDT implementation area. 
 
Methods: A cross-sectional health facility surveys was conducted during high and low 
malaria transmission seasons in 2010 in both areas. Clinical information and a 
reference blood film on all patients presenting for an initial illness consultation were 
collected. Malaria was defined as a history of fever in the past 48 h and microscopically 
confirmed parasitemia. Routine diagnostic testing was defined as RDT or microscopy 
ordered by the health worker and performed at the health facility as part of the health 
worker-patient consultation. Correct diagnostic testing was defined as febrile patient 
tested with RDT or microscopy. Over-testing was defined as a febrile patient tested with 
RDT or microscopy. Correct treatment was defined as patient with malaria prescribed 
ACT. Over-treatment was defined as patient without malaria prescribed ACT. 
 
Results: A total of 1,247 febrile patients (627 from pre-implementation area and 620 
from post-implementation area) were included in the analysis. In the post-RDT 
implementation area, 80.9% (95% CI, 68.2-89.3) of patients with malaria received 
recommended treatment with ACT compared to 70.3% (95% CI, 54.7-82.2) of patients 
in the pre-RDT implementation area. Correct treatment was significantly higher in the 
post-implementation area during high transmission season (85.9% (95%CI, 72.0-93.6) 
compared to 58.3% (95%CI, 39.4-75.1) in pre-implementation area (p = 0.01). Over-
treatment with ACT of patients without malaria was less common in the post-RDT 
implementation area (20.9%; 95% CI, 14.7-28.8) compared to the pre-RDT 
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implementation area (45.8%; 95% CI, 37.2-54.6) (p < 0.01) in high transmission. The 
odds of overtreatment was significantly lower in post- RDT area (adjusted Odds Ratio 
(OR: 95%CI) 0.57(0.36-0.89); and much higher with clinical diagnosis adjusted 
OR (95%CI) 2.24(1.37-3.67) 
 
Conclusion: Implementation of RDTs increased use of RDTs for parasitological 
confirmation and reduced over-treatment with ACT during high malaria transmission 
season in one area in Tanzania. Continued monitoring of the national RDT rollout will be 
needed to assess whether these changes in case management practices will be 
replicated in other areas and sustained over time. Additional measures (such as 
refresher trainings, closer supervisions, etc.) may be needed to improve ACT targeting 
during low transmission seasons. 
 
Keywords: Malaria rapid diagnostic tests, ACT, HDSS, INDEPTH network, Tanzania 
 
3.1 Background 
The World Health Organization (WHO) recommends that clinically suspected malaria be 
confirmed parasitologically prior to treatment (WHO, 2010a). Diagnosis based on signs 
and symptoms has varied sensitivity and specificity depending on clinical features 
present, age, and transmission-associated acquired immunity (O’Dempsey TJ et al., 
1993). Microscopic analysis of blood films for malaria parasites has been the most 
commonly used method for parasitological confirmation of malaria infection. However, 
due to reports of poor quality malaria microscopy (Payne, 1988; Bell et al., 2006) and 
the logistical, personnel and financial resources required to increase coverage of quality 
microscopy services, many endemic countries in sub-Saharan Africa have opted to use 
malaria rapid diagnostic tests (RDTs) to expand the use of parasitological-based 
malaria diagnosis (Zurovac et al., 2008a; Harvey SA et al., 2008).  
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Tanzania mainland introduced the use of artemether-lumefantrine (AL), an artemisinin-
based combination therapy (ACT), as a first line treatment for uncomplicated malaria in 
2006 (NMCP, 2006). In early 2009, a phased rollout of RDTs was initiated in all levels of 
care to complement microscopy services for parasitological confirmation of malaria prior 
to treatment (National guideline for the use of rapid malaria diagnostic tests in Tanzania, 
2007, National Malaria Control Programme, Dar es Salaam, Tanzania: unpublished). 
This roll-out is expected to cover the entire country before end of year 2012. Since the 
adoption of RDT policy and increased rollout of this strategy in sub-Saharan Africa, 
there has been limited evidence of the performance of RDTs in routine use and their 
impact on case management practices, on a wider scale, outside research settings. 
 
Using a pair of cross-sectional health facility surveys conducted in two areas of 
Tanzania in 2010, this study assessed the impact of RDTs by comparing malaria case 
management practices in a post-RDT implementation area with a pre-RDT 
implementation area. The assessment aimed on determining ACT targeting accuracy, 
i.e. the proportion of patients presenting to ACT provider for initial illness consultation 
with fever or history of fever in the last 48 h who were prescribed AL; and provider 
compliance, i.e. the proportion of patients presenting to an ACT provider for initial illness 
consultation with fever or history of fever in the last 48 h and blood slide confirmed 
malaria parasitaemia, who were prescribed AL.  
 
In the post-RDT implementation area, Rufiji Health and Demographic Surveillance 
System (HDSS) located in Rufiji District, RDTs were introduced for routine use in 
November 2009 as part of the national rollout. In the pre-RDT implementation area, 
Ifakara HDSS located in Kilombero and Ulanga Districts, RDT were not introduced as 
part of the national roll-out, but were available in seven health facilities (out of 79 health 
facilities in Kilombero and Ulanga districts) as part of small scale research study; the 
ACCESS programme, since 2008 (ACCESS Project). 
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3.2 Methods 
INDEPTH Network Effectiveness and Safety Studies of Antimalarial Drugs in Africa 
platform (INESS) operates in HDSSs in Rufiji District, Coast Region, and in Kilombero 
and Ulanga Districts, around the town of Ifakara, Morogoro Region, Tanzania (INESS). 
The platform assesses safety and community effectiveness of anti-malarial drugs in real 
life health systems. As part of this effort, INESS conducts assessments of the quality of 
malaria case management using a series of health facility surveys to evaluate ACT 
prescribing patterns among febrile patients with and without parasitological confirmed 
uncomplicated malaria. 
 
Study area 
The study was conducted in health facilities located in the Rufiji and Ifakara HDSS 
areas, in March and October 2010 corresponding to high and low malaria transmission 
seasons respectively at those sites. The Rufiji HDSS has been operational since 1998 
and contains a population of approximately 85,000 people (Rufiji DSS). Malaria rapid 
tests were available on a limited scale as part of demonstration project in 12 health 
facilities in the Rufiji HDSS since 2007 (Masanja et al., 2010) and in all facilities after the 
national RDT rollout in 2009. Ifakara HDSS has been operational since 1996 and 
contains a population of approximately 99,000 people (Ifakara HDSS). Early in 2008, 
the ACCESS project introduced RDT in seven (out of 79) health facilities in Kilombero 
and Ulanga districts; four out of these seven facilities are within the HDSS area 
(ACCESS Project). Although use of RDTs under ACCESS project was under research 
settings, health workers received training and guidelines similar to those provided in the 
rollout areas for routine case management. These were modified versions of the generic 
guides provided by the WHO. The two areas differ in terms of support supervision and 
stock supply for RDTs. In Rufiji, supervision and acquisition of supplies was to follow 
routine practices in existing health system; those under ACCESS project were assessed 
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by project investigators who were also responsible for replenishing facility supplies of 
RDTs. 
 
Health facility surveys 
Cross-sectional health facility cluster surveys were conducted in March and October 
2010. A cluster was defined as all outpatient consultations in a health facility conducted 
in one day during regular working hours. All government and non-government health 
facilities that provide outpatient care to the HDSS population were included (16 in Rufiji 
HDSS and 14 in Ifakara HDSS). Each facility was visited for two to three days with the 
goal to collect data on 720 patients per HDSS per year in order to estimate the 
proportion of patients with uncomplicated malaria correctly treated with ACT with 10% 
confidence, assuming 20% of all patients present with uncomplicated malaria, 75% of 
patients with uncomplicated malaria are treated with ACT, and a design effect of 2 for 
cluster sampling 
 
All outpatients presenting for initial illness consultation on a day of a survey, and who 
consented to participate in the survey, were interviewed prior to leaving the health 
facility. Using standardized questionnaires developed in English and translated into 
Kiswahili, information on history of fever, health worker’s diagnoses, laboratory tests, 
medications prescribed and counselling messages were collected. In addition, a 
reference blood film for malaria microscopy was collected on every patient. Patients 
with severe malaria were excluded from the survey. Moreover, interviews were carried 
out with health workers providing outpatient consultations and collected information on 
pre-service training, work experience, in-service training and receipt of supervision. 
Assessment of the level of staffing, availability of diagnostics, medications and other 
medical supplies was done at the health facility. 
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Laboratory procedure 
Blood films were stained with 10% Giemsa and thick and thin films were examined by 
study microscopists at centralized locations in Rufiji and Ifakara HDSS sites. A second 
reading was conducted by a reference laboratory technician at the Ifakara Health 
Institute Bagamoyo Research and Training Unit. Parasite densities were calculated by 
counting the number of asexual stage parasites per 200 white blood cells (WBCs) and 
assuming an average of 8,000 WBC per micro-litre of blood. A blood film was 
considered negative if no parasites were found after counting 100x high power fields. 
Blood film results were made available to the respective health facilities between five to 
seven days after the day of survey. 
Definitions 
National malaria treatment guidelines and clinical information from the exit interview 
were used to determine when diagnostic testing was indicated, and the same plus study 
blood film results to determine when prescription of ACT was indicated. In the treatment 
guidelines, malaria diagnostic testing was indicated for patients with febrile illness 
(history of fever in the last 48 h), and this was assessed through exit interviews. Malaria 
was defined as a patient with febrile illness as determined by exit interview, and 
reference blood film positive for malaria parasites. Routine diagnostic testing was 
defined as RDT or microscopy ordered by the health worker and performed at the 
health facility as part of the health worker-patient consultation. Correct diagnostic testing 
was defined as febrile patient tested with RDT or microscopy. Over-testing was defined 
as a febrile patient tested with RDT or microscopy. Correct treatment was defined as 
patient with malaria prescribed ACT. Over-treatment was defined as patient without 
malaria prescribed ACT. ACT stock out referred to absence of all types of AL blister 
packs. 
 
Data management and analysis 
Data were double entered in EPIDATA (version 3.1, EPIDATA Association, Odense, 
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Denmark) and analysed using STATA (version 11.0, STATA Corporation, College 
Station, USA) using survey procedures that account for clustering. An alpha level of 
0.05 was used for all significance tests. Pregnant women (N = 60) were excluded from 
the analysis as quinine rather than ACT is the recommended treatment of malaria in the 
first trimester. Descriptive analysis was performed to derive proportions for different 
outcome measures. Logistic regression was done to identify the impact of diagnostics 
on prescription of AL and overtreatment to patients receiving AL. 
Ethical clearance 
All components of the INESS platform were reviewed by the Tanzanian National 
Institutes of Medical Research and IHI’s Ethical Review Boards (IHI/IRB/No.A67-2009), 
Dar es Salaam, Tanzania. 
 
3.3 Results 
A total of 1,531 patients were interviewed (742 in Rufiji HDSS and 789 in Ifakara HDSS) 
and 1,471 non-pregnant patients with complete data were included in the analysis. 
Almost half of all patients in both areas were children age <5 years (Table 1). Use of 
insecticide treated bed nets, availability of ACT and diagnostic testing (RDT and 
microscopy) differed significantly between the two areas. In particular, more patients in 
Rufiji HDSS (post-RDT implementation area) were seen in a health facility with ACT in 
stock (93.8%) or with any diagnostic capacity (RDT or microscopy) (74.2%) compared 
to the Ifakara HDSS (pre-RDT implementation area) where, 42.8% were seen in a 
health facility with ACT in stock and 32.6% seen in a health facility with diagnostic 
capacity. Moreover, the prevalence of uncomplicated malaria varied significantly 
between Rufiji HDSS (high season 19.2% and low season 7.2%) and Ifakara HDSS 
(high season 9.4% and low season 4.2%), respectively. 
 
Results in Table 2 describe the use of RDTs between the two areas. More patients in 
the post- RDT area received a diagnostic test 62.1% (95%CI: 50.3- 72.6) as compared 
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to a pre-RDT area 46.5% (95%CI: 36.3- 57.1) (p=0.05). Use of RDTs was significantly 
higher in post-RDT area whereas microscopy use was more common in the pre-RDT 
area. Overall correct testing and over-testing did not differ significantly between two 
areas.    
 
Table 1: Characteristics of patients in health facility surveys conducted in pre- and post-
RDT implementation HDSS areas  
 
 Ifakara HDSS (pre-RDT 
implementation) (N=761) 
Rufiji HDSS (post-RDT 
implementation) (N=710) 
P-value  
Characteristic n/N % (95%CI) n/N %(95%CI)  
Female 441/761 58.0 (54.7-61.1) 347/710 48.9 (44.9-52.9) <0.01 
Child aged <5 years 352/761 46.3 (41.8-50.8) 349/710 49.2 (44.4-53.9)  0.56 
Used insecticide-treated bed net 
previous night 
575/761 75.6 (71.3-79.4) 344/710 48.5 (40.9-56.1) < 0.01 
Used anti-malarial prior to health 
facility visit 
37/761 4.9 (3.2-7.3) 20/710 2.8 (1.5-5.3) 0.14 
Seen in high transmission season 
(March 2010) 
384/761 50.5 (40.2-60.7) 375/710 52.8 (39.7-65.5)  
0.78 
Seen in low transmission season 
(October 2010) 
377/761 49.5 (39.3-59.8) 335/710 47.2 (34.5-60.3) 
Seen in HF with ACT in stock 326/761 42.8 (30.9-55.7) 666/710 93.8 (86.9-97.2) 0.01 
Seen in HF with RDT or BS in stock 248/761 32.6 (21.4-46.1) 527/710 74.2 (61.1-84.1) <0.01 
Seen in HF with a RDT in stock 132/761 17.4 (10.6-27.6) 343/710 48.3 (35.2-61.7) <0.01 
Seen in a HF with BS in stock 242/761 31.8 (22.0-43.5) 397/710 55.9 (41.9-69.1) 0.28 
Fever prevalence 627/761 82.4 (78.3-85.8) 620/710 87.3 (83.3-90.5) 0.06 
Uncomplicated malaria prevalence 54/761 7.1 (5.1-9.8) 96/710 13.5 (10.3-17.6) <0.01 
High transmission season 36/384 9.4 (6.2-13.9) 72/375 19.2 (14.3-25.3) <0.01 
Low transmission season 16/377 4.2 (2.5-7.2) 24/335 7.2 (4.2-12.0) 0.21 
 
Table 3 shows ACT prescriptions to malaria patients as categorized by use of 
diagnostic tests (RDT and microscopy) or clinically. In both areas, most RDT-positive 
patients received ACT, but only about half microscopy-positive patients received ACT. 
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RDT-negative patients were significantly less likely to be treated with ACT in the post-
RDT implementation area than the pre-RDT implementation area. The proportion of 
patients receiving ACT based on clinical diagnosis alone did not differ between the two 
sites. In the multivariate analysis (table 4), the odds of febrile patients receiving ACT 
were highest with clinical diagnosis (adjusted OR 95%CI: 2.24(1.37-3.67). 
 
Table 2: Use of diagnostics to patients with and without fever in pre- and post-RDT 
implementation HDSS areas 
 
 
Ifakara HDSS (pre-RDT 
implementation area) 
Rufiji HDSS (post-RDT 
implementation area) 
P-value 
(site) 
Characteristic n/N %(95%CI) n/N %(95%CI)  
All patients tested by either RDT or 
microscopy 
354/761 46.5 (36.3-57.1) 441/710 62.1 (50.3-72.6) 0.05 
RDT 132/761 17.4 (11.0-26.2) 309/710 43.5 (32.4-55.4) < 0.01 
Microscopy 242/761 31.8 (28.5-35.2) 132/710 18.6 (15.8-21.7) 0.05 
Correct testing: Patients with fever 
tested  either RDT or microscopy 
314/627 50.1 (38.9-61.2) 400/620 64.5 (51.8-75.5) 0.09 
RDT 123/627 19.6 (12.4-29.6) 282/620 45.5 (33.3-58.2) < 0.01 
Microscopy 210/627 33.5 (29.8-37.3) 118/620 19.0 (16.0-22.3) 0.04 
Over-testing: Patients without fever 
tested with either RDT or microscopy 
40/134 29.9 (16.5-47.9) 41/90 45.6 (32.9-58.8) 0.15 
High season 5/60 8.3 (3.6-18.0) 26/56 46.4 (33.2-60.2) <0.01 
Low season 35/74 47.3 (24.0-71.9) 15/34 44.1 (22.0-68.9) 0.86 
 
 
Overall ACT use and correct treatment of malaria were about similar in the two areas, 
except during high transmission season (Table 5) but over-treatment of non-malaria 
patients with ACT was significantly higher in the pre-RDT area (39.1%; 95%CI 31.0-
47.8) compared to the post-RDT area (24.7%; 95%CI 18.4-32.2), adjusted OR(95%CI) 
0.57 (0.36-0.89); Table 6. Seasonal differences were noted in malaria prevalence 
(Table 1), testing rate (Table 2), correct treatment and over-treatment (Table 5) 
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Table 3: ACT† prescription according to tests results, and clinical malaria* in pre- and 
post-RDT implementation areas  
 
 
Ifakara HDSS (pre- RDT 
implementation) 
Rufiji HDSS (post- RDT 
implementation) 
P-value 
 n/N %(95% CI) n/N %(95% CI)  
RDT positive 22/30 73.3 (53.1-87.0) 79/95 83.2 (69.2-91.6) 0.32 
RDT negative 28/104 26.9 (16.4-40.9) 17/217 7.8 (4.7-12.7) <0.01 
Microscopy positive 62/110 56.4 (41.5-70.1) 15/36 41.7 (22.1-64.3) 0.28 
Microscopy negative 7/135 5.2 (2.1-12.1) 5/96 5.2 (2.3-11.6) 0.99 
Clinical diagnosis of malaria 
and no diagnostic test 
performed 
 
165/313 52.7 (42.9-62.4) 99/220 45.0 (34.3-56.2) 0.33 
No clinical diagnosis of 
malaria and no diagnostic test 
performed 
 
7/94 7.5 (2.9-15.8) 2/49 4.1 (1.1-14.4) 0.45 
* Clinical diagnosis of malaria based on presence of fever in patients who did not receive a 
malaria diagnostic test †= Artemether lumefantrine 
 
 
Table 4: Multivariate analysis of ACT† prescription according to tests results, and 
clinical malaria* for all febrile patients in pre- and post-RDT implementation areas  
 
Variable Crude 
Odd 
ratio 
95%CI p-
value 
Adjusted 
Odd 
ratio 
95%CI p-value 
Type of diagnosis  
mRDT Ref      
Microscopy 0.59 0.37-0.93 0.02 0.61¥ 0.38-1.01 0.054 
Clinical diagnosis 1.29 0.87-1.91 0.21 1.30¥ 0.87-1.95 0.201 
Season  
High season Ref      
Low season 0.64 0.43-0.97 0.036 0.67Ɨ 0.45-1.00 0.048 
Site  
Ifakara HDSS (pre-mRDT) Ref      
Rufiji HDSS (post-mRDT) 0.74 0.49-1.12 0.15 0.72‡ 0.48-1.10 0.127 
¥: adjusted for season and site 
Ɨ: adjusted for type of diagnosis and site 
‡: adjusted for type of diagnosis and season
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Table 5: Prescription of ACT for all patients in post- and pre-RDT implementation areas 
with ACT in stock at health facility 
 
 
Ifakara HDSS (pre-
mRDT implementation) 
Rufiji HDSS (post-mRDT 
implementation) 
P-value 
(site) 
Characteristic n/N %(95% CI) n/N %(95% CI) 
 
All patients treated with ACT (overall) 241/587 41.1 (33.4-49.2) 217/666 32.6 (26.5-39.4) 0.10 
High transmission season (March 2010) 155/332 46.7 (38.9-54.6) 119/349 34.1 (27.9-40.9) 0.02 
Low transmission season (October 2010) 86/255 33.7 (22.6-47.0)  98/317 30.9 (20.7-43.4) 0.74 
Correct treatment: Patients with 
uncomplicated malaria treated with ACT 
(overall) 
26/37 70.3 (54.7-82.2) 76/94 80.9 (68.2-89.3) 0.22 
High transmission season (March 2010) 14/24 58.3 (39.4-75.1) 61/71 85.9 (72.0-93.6) 0.01 
Low transmission season (October 2010) 12/13 92.3 (54.2-99.2) 15/23 65.2 (36.2-86.1) 0.11 
Over treatment: Patients without 
uncomplicated malaria treated with ACT 
(overall) 
215/550 39.1 (31.0-47.8) 141/572 24.7 (18.4-32.2) 0.01 
High transmission season (March 2010) 141/308 45.8 (37.2-54.6) 58/278 20.9 (14.7-28.8) <0.01 
Low transmission season (October 2010) 74/242 30.6 (19.6-44.3) 83/294 28.2 (18.2-41.1) 0.78 
 
Table 6: Multivariate description of ACT over-treatment for all patients in post- and pre-
RDT implementation areas 
 
Variable Crude 
Odd ratio 
95%CI p-
value 
Adjusted 
Odd 
ratio 
95%CI p-value 
Type of diagnosis  
mRDT Ref      
Microscopy 1.20 0.72-
1.98 
0.48 1.05¥ 0.60-1.84 0.856 
Clinical diagnosis 2.54 1.56-
4.12 
0.00 2.24¥ 1.37-3.67 0.001 
Season  
High season Ref      
Low season 0.89 0.57-
1.38 
0.587 0.82 Ɨ 0.54-1.23 0.328 
Site  
Ifakara HDSS(pre-mRDT) Ref      
Rufiji HDSS(post-mRDT) 0.50 0.32-0.8 0.004 0.57‡ 0.36-0.89 0.014 
¥: adjusted for season and site  Ɨ: adjusted for type of diagnosis and site 
‡: adjusted for type of diagnosis and season 
Chapter 3: Malaria diagnostics_______________________________________ 
 
- 47 - 
 
3.4 Discussion 
Parasitological confirmation of all malaria diagnoses is recommended by WHO and 
there is increasing evidence supporting the use of RDTs for clinical management of 
fever and malaria cases (D’Acremont V et al., 2011; Ishengoma DS et al., 2011; 
Faucher J et al., 201). Many of these findings are based on operational research that 
assessed performance and accuracy of RDT use in clinical care as part of a pilot or 
research projects. This study evaluated the implementation of RDTs for routine use in 
the Tanzanian health system, under “real world” conditions. Most importantly, in the 
post-RDT implementation area correct treatment of malaria remained high (80.9%) and 
over-treatment of non-malaria patients was low (24.7%). This suggests that the routine 
use of RDTs might improve malaria case management.  
 
Tanzania began and phased introduction of RDTs for routine malaria case management 
in 2008 and plans to achieve nationwide coverage by 2011 [National guideline for the 
use of rapid malaria diagnostic tests in Tanzania, 2007, National Malaria Control 
Programme, Dar es Salaam, Tanzania: unpublished]. The scaling up of health 
interventions is a complex undertaking and simply increasing coverage might not 
translate into an impact on the larger population (Manham LJ and Hanson K, 2010; 
Gilson L and Schneider H, 2010). By comparing the post-RDT implementation area to 
the pre-RDT implementation area, the impact of RDT roll-out in malaria case 
management can be assessed. First, the post-RDT implementation area had much 
higher availability of malaria diagnostic testing capacity; 74% of patients were seen in a 
health facility that had either RDTs or microscopy available compared to 32.6% of 
patients seen on the pre-RDT implementation area. However, availability of diagnostics 
alone does not improve malaria case management. In particular, more patients were 
tested for malaria in the post-RDT implementation area (62.1%) than the pre-RDT 
implementation area (46.5%), and more patients were correctly tested.  
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Despite the improvement seen in proportion of febrile patients receiving a test, this 
achievement is far from optimal. The reason could be associated with the much too 
frequent stock out of medical products affecting the Tanzania health system, including 
timely in-availability of testing materials/ devices. However, results show that over-
testing in post implementation area is also high. Over-testing may be associated with 
wasted resources as patients who do not meet clinical criteria for malaria diagnostic 
testing are tested. Although we did not assess reasons for over-testing, one may think 
that the problem may be contributed by lower understanding of case selection for the 
test, probably resulting from lack of experience in using the tests, unclear guideline, 
supportive supervision not focusing on the topic or even patient pressure to get tested. 
Post-implementation care quality improvement efforts should focus on ensuring that 
only persons who have clinical signs and symptoms of malaria such as a history of fever 
are tested. 
 
Another important consideration for RDT implementation is assuring the diagnostic test 
performance. In this study, sensitivity and specificity of RDTs in the post-implementation 
area was adequate (>85%). The continued monitoring of RDT performance post-
implementation is critical as poor malaria microscopy performance has been 
documented throughout sub-Saharan Africa. For the time being, RDTs appear to have 
better sensitivity and specificity than routine microscopy and might be critical in 
improving the overall quality of malaria diagnostic capacity in routine settings.  
 
In addition, this study suggests that adherence to RDT results is reasonably high with 
83.2% of RDT-positive patients receiving ACT and only 7.8% of RDT-negative patients 
receiving ACT. Adherence to diagnostic test results is critical if the implementation of 
RDTs is expected to reduce over-treatment. Unlike previous studies, this study 
suggests that health workers do adhere to RDT results, even after routine 
implementation of RDTs. In addition, findings from this study also confirm reports from 
previous studies in Tanzania, that RDT introduction can lower anti-malarial drug 
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consumption (D’Acremont V et al., 2011) and may help reduce the problem of anti-
malarial drug stock-outs. This may imply that once a policy of malaria diagnostic 
confirmation expands to the entire country, the availability of ACT in the Tanzanian 
health sector might be significantly improved.  
 
This study showed that only about a third of fever patients actually received ACT in the 
post RDT implementation area, despite the fact that most of the patients (94%) were 
seen in a facility with ACT in stock. As the use of the rapid tests increase once 
introduced, health workers’ performance is likely to improve since there will be an added 
tool in the line of care that provides more job and client satisfaction (Williams et al., 
2008). Some community studies in Tanzania and elsewhere indicate that community 
members are willing to receive and pay for a laboratory test prior to malaria treatment 
(Rennie W et al., 2009). Moreover, some studies reported that clients’ demand for a 
malaria confirmatory test before treatment (Chandler CIR et al., 2008) and having a 
malaria test increased patient satisfaction with clinical care provided (Williams et al., 
2008; Rennie W et al., 2009). 
 
Rapid tests seemed to be performing better than microscopy. It is important to become 
conscious of the possibility for over-estimation of positivity rate that might result from 
use of RDTs. In particular, this is likely to be a problem with the use of Histidine rich 
protein-2 based RDT devices for detecting Plasmodium falciparum infection, as they 
may continue to test positive weeks after parasite clearance. In this case, training on 
RDTs should stress the need for assessing other disease conditions despite a positive 
test for malaria, and referral to higher level of care for a microscopic examination of 
malaria. This is particularly important for providing quality care of malaria patient in the 
changing malaria transmission patterns, with a downward trend observed in many 
malaria endemic countries. It as well, supports present efforts to obtain accurate 
information about the disease burden in the population. 
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There are several limitations to this evaluation. First, this survey was carried out in 
established health facilities where both the providers and patients were aware of the 
presence of the study team. This may have inadvertently influenced prescription 
behaviour of the providers. Care was taken to use field interviewers who were local 
residents of the survey area. Response bias was minimized by using survey tools that 
recorded what was done on the survey day without longer recall periods, except for 
provider’s experience and training. Secondly, the survey was limited to health facilities 
within the HDSS areas and since the HDSS conducts many health interventions and 
research studies, this may render the population more health conscious than the 
general population. Third, the presence of RDTs in the pre-RDT implementation area 
and some RDT stock-outs in the post-RDT implementation area, may have 
underestimated the true impact of rolling out RDTs. Methodologically, a ‘before and 
after’ design would have provided a better measure of RDT impact in case 
management, but the purpose of this evaluation was to assess performance of health 
care system with all the bottlenecks associated with it such as stock outs of medicines, 
diagnostics and other medical products. In addition, prescription practices may differ 
from one area of practice to another due to common experiences and governing 
principles. This may affect the true measure of impact of RDT implementation between 
the study areas. Lastly, ACT stock out was another limitation that might have affected 
the true impact of the programme. 
3.5 Conclusion: 
In conclusion, the implementation of RDTs increased use of RDTs for parasitological 
confirmation and reduced over-treatment with ACT during high malaria transmission 
season in one area in Tanzania. Continued monitoring of the national RDT rollout will be 
needed to assess whether these changes in case management practices will be 
replicated in other areas and sustained over time. Additional measure such as refresher 
trainings, closer supportive supervisions, etc, may be needed to improve ACT targeting 
during low transmission seasons. The need to extend parasitological confirmation of 
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malaria in the context of integrated community case management is becoming apparent 
and needs to be addressed. 
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Additional file 1: Performance of facility malaria diagnostic tests in pre- and post-RDT 
implementation HDSS areas (table 7 below). 
 
Table 7: Performance of facility malaria diagnostic tests in pre- and post-RDT 
implementation HDSS areas 
 
 
Malaria rapid diagnostic tests (RDT) 
Ifakara HDSS (pre- RDT 
implementation) 
Rufiji HDSS (post- RDT 
implementation) 
P-value 
n/N % (95%CI) n/N 
 
% (95%CI)  
Sensitivity 4/14 28.6 (10.2– 
58.4) 
58/65 89.2 (79.3 - 
94.7) 
<0.01 
Specificity 94/120 78.3 (70.0- 85.0) 210/247 85 (79.6 - 89.2) 0.51 
Predictive value 
positive 
4/30 13.3 (4.4- 34.0) 58/95 61.1 (48.7-72.1) 0.01 
Predictive value 
negative 
94/104 90.4 (83.0- 94.8) 210/217 96.8 (94.1-98.3) 0.05 
 Microscopy  
Ifakara HDSS (pre- RDT 
implementation) 
Rufiji HDSS (post- RDT 
implementation) 
P- value 
n/N 
 
% (95%CI) n/N % (95%CI)  
Sensitivity 7/10 70(19.1 - 
95.8) 
10/13 76.9 (47.9 - 
92.4) 
0.18 
Specificity 132/235 56.2(39.6- 
71.4) 
93/119 78.2 (68.7 - 
85.3) 
0.05 
Predictive value 
positive 
7/110 6.4 (2.6-14.8) 10/36 27.8 (12.4- 51.2) 0.49 
Predictive value 
negative 
132/135 96.9 (90.8-
99.0) 
93/96 96.9 (90.8-99) 0.32 
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Abstract:  
Introduction: Poor adherence and inappropriate use of recommended treatment may 
contribute to drug resistance. Use of artemisinin-based combination therapy (ACT) such 
as artemether-lumefantrine (AL) requires a strict dosing schedule that follows the drugs’ 
pharmacokinetics properties. The quality of malaria case management was assessed in 
two areas with health and demographic surveillance systems to ascertain patients’ 
characteristics and facility-specific factors that influence correct dosing of AL for 
management of uncomplicated malaria in rural Tanzania. 
Methods: Exit interviews were conducted with all patients attending for initial illness 
consultation at health facilities at each site. Information about health workers’ training 
and supervision visits was collected. As well, health facilities were inventoried for 
capacity and availability of medical products related to care of malaria patients. The 
outcome was correct dosing of AL based on age and weight. Logistic regression was 
used to assess health facility factors and patient characteristics association with correct 
dosing of AL by weight. 
Results: A total of 1471 patients were interviewed but only 503 (34.2%) patients who 
received AL were assessed for correct dosing. Most patients 430 (85.5%) were seen in 
public health facilities, 383 (76.1%) in a dispensary and 458 (91.1%) in a facility that had 
AL in stock on the survey day. Overall, 395 (78.5%) patients received correct dosing by 
age and 430 (85.5%) by weight. The proportion of patients receiving correct dose of AL 
as per national guideline was lower for middle aged groups; 42.4% for 9-12 years and 
50.0% for 3-9 years age group. As well only 50.0% of patients weighing 25-35 and 
60.9% of patients weighing 15-25kg received appropriate AL dosing (p<0.001). In 
multivariate analysis, weighing between 15-35 kg was significantly associated with 
incorrect dosing of AL (p<0.05) compared to those above 35kg. 
Conclusion: Although malaria treatment guidelines indicates AL dosing can be 
prescribed based on age or weight of the patient; findings from this study shows that 
age based dosing is more prone to errors. Patients’ age groups predispose them to 
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varying odds of incorrect dosing of AL. The use of weight-based prescriptions is 
emphasized.  
(Key words: AL dosing, uncomplicated malaria, Tanzania) 
 
 
AL dosing instruction chart provided to guide AL prescriptions 
 
 
WEIGHT 
5 - 15 kg 
*Strictly after 8 hours 
 
Start 
Dose 
After 
8 hrs* 
Day 1 Day 2 Day 3 
Morning Night Morning Night AGE 
0 up to 3 
years 
3 years up to 
8 years 
8 years up to 
12 years 
12 years and 
above 
15 - 25 kg 
25 - 35 kg 
35 kg and 
above 
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4.1 Introduction 
The World Health Organization (WHO) declares that much of the ill health, disease, 
premature death and suffering we see are needless, since efficacious and affordable 
interventions for prevention and treatment are available. It is further noted that, these 
effective interventions are not matched with the power of the health systems to deliver 
them to those in greatest need, in a comprehensive way and on an adequate scale 
(WHO, 2007). This well appreciated fact raises the significance of assessing and 
addressing health systems bottlenecks, in order to improve health outcomes and the 
quality of health care services.  
Following wide spread resistance of malaria parasites to commonly used antimalarials 
such as chloroquine and sulphadoxine-pyrimethamine (SP); there was a global to move 
to use artemisinin-based combination therapy (ACT) for malaria treatment (Bosman A et 
al., 2001). This requires the artemisinin derivatives with shorter half-life be combined 
with a longer half-life partner drug, to enhance therapeutic efficacy and reduce 
treatment durations (Bosman A et al., 2001). Currently, the artemisinin derivatives used 
for malaria combination treatment include; artesunate, artemether and 
dihydroartemisinin (DHA). ACTs such as artemether-lumefantrine (AL) have become a 
first-line medicine for management of uncomplicated malaria in many malaria endemic 
countries including Tanzania (NMCP, 2006). 
Poor adherence and inappropriate use of recommended treatments have long been 
linked to development and spread of drug resistance. Use of ACTs for malaria treatment 
requires a strict dosing schedule that follows the drugs pharmacokinetics (Morris CA et 
al., 2011). AL dosing is based on four pre-defined weight bands or age groups. 
According to manufacturers, an 8-hour interval between the first and the second doses 
of AL is critical for appropriate parasite clearance and clinical cure. In addition, 
manufacturers recommend completing the doses at defined time intervals and taking AL 
with a fatty meal for better absorption of the drug to enhance its bioavailability. These 
recommendations, if followed thoroughly, will optimize therapeutic response. 
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Unfortunately many studies have reported that clinical guidelines are not always 
adhered to for various reasons (Zurovac et al., 2004; Dodoo ANO, 2009; Zurovac et al., 
2008c), and especially when they are ambiguous (Rowe et al., 2009). 
Packaging of AL medicines for public sector use in Tanzania is customized for each 
dosing band and incorporates illustrated instructions for low-literate patients and 
caretakers. However, appropriate patient counseling is mandatory for optimal 
adherence. This study was carried to assess the quality of malaria case management 
under real world settings. It included, among other things, assessment of ACT dosing 
schedule and health facility factors related to care of malaria patients. Understanding of 
the factors influencing correct dosing will help disease control programme and local 
health management teams to plan effective malaria related supportive supervision, 
knowing specific areas that requires emphasis. 
4.2 Methods 
Study design and study area: Data was collected through pair of cross-sectional 
health facility surveys in the Rufiji and Ifakara Health and Demographic Surveillance 
Systems (HDSS) area, in March and October, 2010. This work was completed as part 
of the large phase four platform of the INDEPTH Network to assess effectiveness and 
safety of antimalarial drugs called INESS- Indepth Network Effectiveness and Safety 
Studies of antimalarial drugs (INESS). 
Data collection: All out-patients presenting for initial illness consultation on the day of a 
survey, were approached for inclusion in the study. Information was collected by means 
of questionnaires through interviews with patients or caretakers. Information on the 
patients’ complaints, provider’s diagnosis, dosing instructions and counselling 
messages were recorded. As well, patient’s clinical notes were later reviewed and 
recorded, and patients were measured weight and asked for a blood smear for 
independent assessment of presence of malaria parasites. Information of providers 
training, work experience and supervision visits were also recorded. The facility was 
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inventoried for availability of medicines, diagnostics and reference materials related to 
malaria treatment.  
Data entry and analysis: Data was entered in EPIDATA Entry version 3.1 (EpiData 
Association, Odense, Denmark) by two independent entry clerks. Analysis was 
performed in STATA 11 (StataCorp, College Station, Texas). Descriptive analysis was 
undertaken after merging health facility, health worker and patient datasets, clustered 
by health facility consultation days. Analysis was performed at patient level, in order to 
assess effect of care to patients seen. Pearson Chi-squared test was used to draw 
proportions of patients who received correct AL dose based on age or weight by 
different patients’ characteristics and facility factors. Logistic regression was carried out 
to assess association of health facility factors and patients’ characteristics with correct 
dosing of AL, clustered by facility consultation days. An alpha level of 0.05 was used for 
all significance tests. 
Definition of correct dosing of AL: Correct dosing of AL was assessed based on four 
criteria: a patient is prescribed AL; an appropriate number of AL tablets per dose given 
either based on patient’s age or body weight; the appropriate number of doses per day 
and appropriate total number of days, which were always 2 and 3, respectively. Any 
dosing instruction below these criteria was considered inappropriate. 
Additional information on the study area and study population are presented by Masanja 
and colleagues (Masanja  et al., 2012).  
4.3 Results 
A total of 1471 patients were interviewed, but only 503 (34.2%) who received AL will be 
included in the analysis (figure 1).  
Results in Table 1 shows that, majority of patients were seen in dispensaries 383 
(76.1%) and public health facilities 430 (85.5%). Most patients who received AL were 
seen in a facility that had AL in stock of the day of a survey 458 (91.1%) but only 280 
Chapter 4: Correct dosing of artemether-lumefantrine (AL)________________ 
 
- 59 - 
 
(55.7%) were seen in a facility with malaria testing capacity on the survey day. Although 
366 (73%) of patients were seen in a facility that had a functioning weighing scale, less 
than half, 167 (33.2%) had their weigh assessed and recorded during a provider- patient 
interaction, compared to 95.6% (481) who had their age assessed and recorded during 
clinical consultation. Very few patients were seen by a health worker who had received 
a supervision visit in the past 6 months (21.7%) and who had training on the use of ACT 
(44.1%).  Most patients reported fever or history of fever 489 (97.2%).  
Figure 1: Distribution of study participants  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total patients seen in Health 
Facilities = 1531 
Total patients included in the general 
analysis = 1471 (100%) 
Pregnant 
women 
excluded = 60 
Patients with clinical malaria and/ or 
other diagnoses = 681 (46.3%) 
Patients with uncomplicated malaria at health 
facility; included in analysis = 790 (53.7%) 
Patients who received AL at health 
facility= 433 (433/790: 54.8%) 
Patients who received AL at health 
facility = 70 (70/681:10.3%) 
All AL prescription at health facility; included 
for assessment of correct dosing= 503 
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Table1: Characteristics of patients who received AL during the survey (N=503) 
Category Health facility and patients characteristic n (%) 
Type of health facility: 
Patients seen in Dispensary  383   (76.1) 
Patients seen in Health Centers 113   (22.5) 
Patients seen in Hospitals 7       (1.4) 
 
Facility ownership: 
Patients seen in Public HFs 430  (85.5) 
Patients seen in Non-public HFs 73    (14.5) 
 
Availability: 
Seen in HF with ALu in stock 458   (91.1) 
Seen in HF with RDT &/or functional microscopy 280  (55.7) 
Seen in HF with any scale 366  (72.7) 
Patients who had their weight assessed / recorded 167  (33.2) 
Patients who had their age assessed/ recorded 481 (95.6) 
 
Other characteristics for 
malaria case management: 
Seen HW who had supervision in last 6 months 109  (21.7) 
Seen by HW who had training on ACT 222  (44.1) 
Seen in HF with ACT guideline/reference 412   (84.7) 
 
Patients characteristics: 
Children <3 years 178  (35.4) 
3-12 years 177  (35.2) 
Above 12 years 148  (29.4) 
 
Had fever/ history of fever in past 48 hours 489  (97.2) 
Had fever and a malaria test performed at HF 175  (34.8) 
 
Patients who slept under net the previous night 312  (62.0) 
 
The proportion of patients who had correct AL dosing by age was 78.5% (395), lower 
than those who had correct dosing by weight 85.7% (431), table 2.  Correct dosing by 
age was low in age group 3-9 years (50.0%) and much lower in age group 9-12 years 
(42.4%; p<0.00). As well, patients weighing between 15-25 kg and 25-35 kg, had low 
proportions of correct dosing than marginal groups (p<0.001) - table 2.  
A multivariate analysis was taken to assess predictors of correct AL dosing by weight 
and age. The middle weighing patients between 15-35 kg had significantly lower odds of 
correct dosing than those above 35 kg, in the unadjusted analysis, table 3. When AL 
dosing was based on age, these middle aged patients groups (3-9 and 9-12 years) has 
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lower odds of correct dosing compared to children below age of 3, in both crude and 
adjusted analysis (p<0.005). Having diagnostics seem to decrease the odds of correct 
dosing by weight in unadjusted analysis. Supervision, and training on ACT also showed 
lower odds of correct dosing in the adjusted model- table 3. 
Table 2: Proportion of patients who received correct dosing of AL according to age and 
weight as per national treatment guideline [N(age)=395; N(weight)=430; N(overall)=503] 
Category 
Health facility and patients 
characteristic 
Correct 
dose by 
age: 
 n (%) 
P-value 
(age) 
Correct 
dose by 
weight:  
n (%) 
P-value 
(weight) 
Overall  Correct dosing: n/N (%) 395/503 (78.5) 431/503 (85.7) 
 
Type of health 
facility: 
Patients seen in Dispensary  296 (74.9) 
0.244 
332 (77.0) 
0.505 Patients seen in Health Centers 92   (23.3) 93  (21.6) 
Patients seen in Hospitals 7     (1.8) 6    (1.4) 
 
Facility 
ownership: 
Patients seen in Public HFs 336 (85.0) 
0.606 
368 (85.6) 
0.871 
Patients seen in Non-public HFs 59 (15.0) 63  (14.6) 
 
Availability: 
Seen in HF with ALu in stock 37 (9.4) 0.527 391 (90.7) 0.520 
Seen in HF with either RDT or 
functional microscopy 
217 (55.0) 0.529 235 (54.5) 0.207 
Seen in HF with any scale 297 (75.2) 0.019 314 (73.0) 0.911 
 
Patients age 
categories  
<3  years                    (N=178) 172 (96.6) 
<0.001 NA 
3- <9  years                (N=144) 72  (50.0) 
9- <12 years               (N=33) 14  (42.4) 
12 years and above    (N=148) 137 (92.6) 
 
Patients weight 
categories 
5 -15 kg             (N= 242) 
NA 
215 (89.6) 
<0.001 
>15 -25 kg         (N=87) 64  (73.6) 
>25- 35 kg         (N= 24) 15  (62.5) 
>35 kg               (N= 150) 137 (91.3) 
 
Other 
characteristics: 
HW who had reference 
materials 
161 (40.8) 0.606 176 (40.9) 0.565 
HW who had supervision in last 
6 months 
85 (21.5) 0.875 90 (20.9) 0.294 
HW trained on AL 174 (44.0) 0.942 186 (43.3) 0.279 
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Table 3: Multivariate analysis of health facility factors and patients characteristics 
associated with correct dosing of AL by weight (and age): N=501 
  Correct dosing by weight 
Health Facility Factors Crude OR 
(95%CI) 
p-value Adjusted OR 
(95%CI) 
p-value 
Type of health facility:   
Hospitals Ref  Ref  
Health Centers  0.92 (0.21-4.17) 0.923 0.85 (0.17-4.22) 0.850 
Dispensaries 1.30 (0.32- 5.20) 0.706 0.68 (0.15-3.21) 0.633 
Type of ownership:  
Public HFs Ref  Ref  
Non-public HFs 0.94 (0.48- 1.84) 0.860 0.58 (0.20-1.68) 0.316 
Products availability:  
HF with functioning scale for all age 1.34 (0.67-2.67) 0.399 1.21 (0.57-2.52) 0.614 
HF with AL in stock 0.64 (0.36- 1.14) 0.128 0.75 (0.23-2.39) 0.626 
HF with RDT or functional microscopy 0.51 (0.29- 0.92) 0.026 0.66 (0.33-1.33) 0.244 
Supporting materials/supervision:  
HF with supervision visit past 6 months 0.71 (0.38-1.33) 0.286 0.39 (0.20-0.74) 0.005 
HW who had training on ACT 0.65 (0.37- 1.16) 0.145 0.50 (0.25-1.02) 0.058 
HW who had reference materials 0.96 (0.53- 1.73) 0.895 0.63 (0.33- 1.21) 0.166 
Patients weight: Correct dosing by weight 
5 -15 kg              1.39 (0.92- 2.11) 0.116 3.39 (0.71-16.1) 0.124 
>15 -25 kg          0.47 (0.26-0.84) 0.012 1.76 (0.32- 9.80) 0.512 
>25- 35 kg          0.30 (0.13- 0.72) 0.007 0.69 (0.15- 3.03) 0.623 
>35 kg               Ref  Ref  
Patients age: Correct dosing by age 
<3  years                     Ref    
3- <9  years                 0.08 (0.05-0.15) <0.001 0.05 (0.02- 0.11) <0.001 
9- <12 years                0.05 (0.02- 0.15) <0.001 0.02 (0.00- 0.06) <0.001 
12 years and above    0.44 (0.25- 0.76) 0.004 0.09 (0.02- 0.41) 0.002 
     
 
Table 4 describes the direction of inappropriate dosing. Most incorrect dosing was 
towards less pill counts than recommended, especially for age based prescriptions. 
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Table 4: Description of inappropriate dosing by pill count according to patients’ age and weight 
(N=501) 
Age categories 
Less 
number of 
tablets 
Appropriate 
number of 
tablets 
More 
number of 
tablets 
Missing/ in-
determinate 
count 
Total 
patients  
 
<3 years 1 164 6 7 178  
3 to 9 years 58 68 10 8 144  
9 to 12 years 15 15 1 3 33  
Above 12 years 7 138 0 1 146  
Total (%) 81 (16) 385 (76.8) 18 (3.5) 19(3.7) 501(100%)  
Weight categories 
 <15 kg 1 206 24 10 241  
15 to 25 kg 16 59 7 5 87  
25 to 35 kg 5 15 2 2 24  
Above 35 kg 9 134 3 2 148  
Total (%) 31 (6.2) 414 (82.8) 36 (7.2) 19(3.8) 500(100%)  
 
4.4 Discussion 
This study gives a snapshot of facility and patient characteristics associated with correct 
dosing of artemether-lumefantrine for management of uncomplicated malaria in rural 
Tanzania, 4 years after AL introduction as a first line treatment. As expected, most 
patients were seen in dispensaries, which are the lowest level of formal health care 
provision in the country. It was of interest to record that, some patient characteristics are 
significantly association with lower odds of correct dosing of AL. In particular, older 
children and young adults, i.e. 3-12 years; are more likely to be subjected to 
inappropriate dosing of AL especially, if dosing is based on age, than younger children 
or adults. Malaria treatment guidelines in Tanzania allow for both age and weight based 
AL dosing, following manufacturers’ recommendations (NMCP, 2006). 
This is not a first study to report inappropriate dosing of malaria treatment for children. A 
study from Kenya showed more similar findings, where infants were more likely to 
receive appropriate treatment than older children (Zurovac et al., 2004). The authors in 
the Kenya study thought that health workers were being more careful with the younger 
Chapter 4: Correct dosing of artemether-lumefantrine (AL)________________ 
 
- 64 - 
 
age group, which seems like a logical explanation for the observation. As well, concerns 
of incorrect dosing of malaria drugs have been reported in other settings (Zurovac et al., 
2008c; Zurovac and Rowe, 2006; Rowe et al., 2009). Correct dosing with AL in our 
study was better with weight than age based categories. This may reflect a problem of 
poor correlation for the age-weight profiles used. Probably the local age-weight profile 
differs with the available nutrition profiles, due to poor nutrition or living conditions in the 
studied population.  
Basically two very similar conclusions can be drawn following these findings. First, AL 
dosing by weight was frequently more correct than dosing by age or AL doses 
prescribed to patients on the basis of their weight is more often correct than given 
based on age. Judging from results presented in table 1, it more reasonable to suggest 
that, AL prescriptions in this survey was more often based on age than weight; because 
of the low proportion of patients who had their weight assessed as compared to age 
(33.2% versus 95.6%). Whichever way one looks at, it signifies the importance of 
stressing the use of weight based prescription to ensuring appropriate amount of 
medicine is delivered in the system. Where age-weight profiles differ, it may practically 
be difficult to have guidelines that comply with age-weight indices for every given 
population. This fact should be emphasized during trainings. 
The fact that some patients received inappropriate dosing levels of ACT in the study 
areas, if dosing is based on age; implies that adequate parasite clearance may not be 
achieved. As a consequence, this provides opportunities for drugs’ selection pressure 
and continued disease transmission in the community. Results have shown that, 
inappropriate dosing  was more likely to happen to older children and young adults who 
are physically active and moves from place to place e.g. school or outdoor activities; 
increasing the likelihood of contact with malaria vectors and other infected or 
susceptible individuals. Understanding predictors of appropriate care for malaria 
patients will assist health managers to plan for resources and supportive supervision 
aiming at quality improvement and disease control.  
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During treatment policy change, it is customary to train health workers on the new 
guideline and provide reference materials for in-depth referencing after training. In this 
assessment, health workers training on ACT, possession of reference materials and 
supervision did not seem to improve the odds of correct dosing of AL. The most logical 
explanation for these findings could be related to a fact that, few patients were seen by 
providers who had training on ACT (44%) and fewer by a provider who had supervision 
visit in the past few months (21.7%). Moreover, we neither had information on the 
contents of the training provided on ACT nor did we have details of the supervision 
visits happening in relation to malaria case management. The role of supervision visits 
in improving quality of case management (in malaria) has provided inconsistent 
conclusions (Zurovac et al., 2004; Trap B et al., 2001; Osterholt et al., 2006) in other 
settings. This finding is alarming and requires further understanding of the role, 
schedule and contents of supervision visits for case management and its impact in 
clinical practices.  
Limitations: 
We did not collect information on total number of patients attended by a provider to 
assess the caseload but, we included all patients and provider’s on the day of survey, 
hence patient’s sample is self weighing on the basis of utilization for the days surveyed, 
assuming survey days were typical for the rest of the year.  The importance of caseload 
assessment has been described (Zurovac et al., 2004; Rowe et al., 2009; Nyandigisi et 
al.).  
4.5 Conclusions: 
A good clinical practice should stress the use of weigh based dosing and support 
infrastructure for having weighing scales available at health facilities. The correct dosing 
of AL in health facilities in the study areas was better when based on weight than age. 
Patients’ characteristics, such as age and weight seem to be associated with the odds 
of correct dosing of AL. This needs to be addressed in order to improve treatment 
outcomes for management of uncomplicated malaria in rural Tanzania.   
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Abstract: 
Background: The relationship between age, severity and patterns of malaria 
transmission has long been reported in literature. Most of these works were done in 
relation to severely ill patients and young children below age of 10. In this report, data 
collected through health facility surveys from 2002-2010, was analysed to assess 
relationship between age and presence of malaria parasitemia at out-patient clinical 
settings. 
Methods: Cross sectional health facility surveys were conducted in Rufiji (2002-2010), 
Kilombero/ Ulanga (2002, 2004 and 2010) and Morogoro rural districts in 2002. 
Information was collected during exit interviews and blood smears were taken to assess 
presence of malaria parasitemia. Data was entered in fox-Pro for 2002-2006 and 
EPIDATA for 2010, but analysis was performed in STATA 11. Graphs showing trends 
were computed using Microsoft excel and multivariate linear regression was used to 
quantify the relation between presence of parasitemia and age. 
Results: Higher proportion of parasitemic patients were seen at dispensaries (48.5%) 
compared to other levels of care. About 4% of positive blood smears had gametocytes. 
Children aged 1-5 had higher prevalence of parasitemia. Overall, parasitemia was 
declining in children below 5 years, showing similar trends as population based surveys; 
but, significant differences were observed within this age group. While children below 2 
years showed a decreasing trend (p<0.001), those aged 2-5 years had an increasing 
trend for malaria parasitemia (p<0.001), contrary to population based findings. Adults 
generally showed a declining trend for presence of parasitemia. Presence of 
parasitemia at health facility declined with a 5 years increase in patient’s age; in both 
crude and adjusted linear regression models (p<0.001).  
Conclusion: Age of parasitemic patients significantly increased with decrease in 
malaria transmission intensity. The disease burden shifted to 2-5 years and older 
children up to 15 years of age. Broad age categorization to below and above 5 years; 
masks important intra-groups’ effects. Older children should also be among the priority 
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target groups for malaria control interventions in the wake of decreasing malaria 
transmission. 
5.1 Background 
Assessing the impact of malaria control strategies requires more robust and reliable 
measures. Rowe and colleagues suggested the use of experimental designs for 
assessing changes in malaria morbidity and mortality, but acknowledges that such 
evaluations would be less feasible in evaluating real- world programmes (Rowe AK et 
al., 2009). Other studies have reported changes in transmission patterns, transmission 
intensity, decreased malaria parasite prevalence in population surveys and a decrease 
of malaria specific mortality, as indicators of changing malaria burden in respective 
areas (Smith T et al., 2004; Okiro EA et al., 2007; Hay SI et al., 2008; Ceesay SJ et al., 
2008; Otten M et al., 2009; Khatib RA et al., 2012). To provide accurate estimates of 
changing malaria transmission in the community, other scientists have used serological 
markers (Stewart L et al., 2009) and age (Marsh K and Snow RW, 1999; Smith T et al., 
2004; Carneiro I et al., 2010).  
The relationship between age and severity of malaria infection has long been reported 
(Marsh K and Snow RW, 1999; O’Meara WP et al., 2008; Carneiro I et al., 2010). It is 
now understood that, as malaria transmission declines, the age of clinical malaria 
attacks also shifts to older children (Aponte JJ et al., 2007). This has mainly been 
documented with relation to severe malaria using inpatients data and, or, blood smear 
results in population bases surveys (O’Meara WP et al., 2008; Ceesay SJ et al., 2008; 
Okiro EA et al., 2007; Schellenberg D et al., 2004; Bodker et al., 2006). In a typical 
clinical setting in rural Tanzania, severe cases of malaria are normally first seen at 
outpatient department (OPD) before admission. It is now widely agreed that 
understanding of disease trends in the respective communities, helps appropriate 
resources allocations for its control. The same can be concluded in relation to patients’ 
management. Knowledge of the local patterns of the disease is useful to guide clinical 
judgment during patient’s care. 
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Efforts to combat malaria in endemic countries have resulted in a steady decline of 
malaria prevalence. The World Health Organization (WHO) world malaria reports a 
reduction of malaria cases globally from 244 million in 2005 to 216 million in 2010 
(WHO, 2010b). Likewise, the Tanzania HIV/ AIDS and malaria indicator survey reports 
a decline in malaria positivity from 18.1% in 2007/8 to 4.5% (by microscopy) or 9.5% (by 
rapid tests) in 2012 (THMIS, 2007/8; THMIS, 2012). This decline however, is not very 
apparent at the health facility level. Patients with malaria like signs and symptoms 
constitute majority of patient seen in Tanzanian hospitals (NMCP, 2003b). The situation 
is particularly challenging in areas where malaria parasitological confirmation is not 
readily available. As a result, clinicians attending these patients may continue to 
consider malaria diagnosis where the likelihood of the disease is minimal, missing 
opportunities to treat other similar life-threatening conditions. In this situation, a 
description of patient demographic characteristics as a possible indicator of the 
increased likelihood to have the disease will be well appreciated to facilitate initial 
screening for a confirmatory test. 
Here, findings from the retrospective analysis of data collected from health facility 
surveys between year 2002 and 2010, is presented to assess the relationship between 
age and presence of parasitemia in out-patients during clinical consultation in endemic 
areas, sub-Saharan Africa. During this study period, some of these areas witnessed the 
introduction of artemisinin based combination therapy (ACTs) for malaria treatment, first 
under pragmatic evaluation (Kachur et al., 2001) and later as a country policy (NMCP, 
2006). 
5.2 Methods 
This work analyzed data from two major projects conducted in south- east of Tanzania. 
First was the Interdisciplinary Monitoring Programme for Antimalarial Combination 
Therapy in Tanzania (IMPACT-Tz) as described in (Kachur et al., 2001; Njau et al., 
2008; Khatib RA et al., 2012) and second, the Indepth Network Effectiveness and 
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Safety Studies (INESS) of antimalarial drugs in Africa (INESS), as reported in (Masanja 
et al., 2012b).  
Study area  
Both IMPACT-Tz and INESS were operating in the Rufiji district in Pwani region, 
Kilombero and Ulanga districts in Morogoro region and the latter also collected data 
from Morogoro rural district, Morogoro region in its early years (Masanja et al., 2012a). 
Kilombero and Ulanga were treated as a single unit (K/U) in both studies, because of 
the high population interactions between the two districts. Morogoro rural was included 
in the IMPACT-Tz baseline assessments, but was dropped from the evaluation after it 
was divided into two districts; Morogoro rural and Mvomero in 2003. Likewise, the 
INESS programme also operated in K/U and Rufiji districts, but its work is mainly 
focused within the Health and Demographic Surveillance System (HDSS) areas 
(Masanja et al., 2012b). 
Health facilities selection and procedures 
During the IMPACT-Tz programme, OPD surveys were conducted in 1 hospital, 1 
health center and 3 dispensaries from each district (most of them within the HDSS 
area); for several days until the required sample size was reached. In INESS surveys, 
all health facilities serving within the HDSS areas were visited for 2-3 days to achieve 
the required sample size. In both studies, sampled patients at the health facility were 
requested for their consent to participate. Upon acceptance, an exit interview was 
conducted, their clinical notes reviewed and few drops of blood were collected for 
assessing the presence of malaria parasites. IMPACT-Tz also assessed haemoglobin 
levels of all patients enrolled in the survey.  
Patients included in the survey during IMPACT-Tz study were of all ages (above and 
below 5 years), excluding trauma patients and severe cases; where as in INESS 
surveys, patients recruited for the study were all patients who came for initial illness 
consultation on the survey day, excluding severe cases. During IMPACT-Tz, data was 
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collected in K/U, Rufiji and Morogoro rural in February- March, year 2002 (as baseline 
survey), then in Rufiji and K/U only in March, year 2004 after Rufiji had started using 
ACT- artesunate plus Sulphadoxine-pyrimethamine (AS+SP), as part of the programme 
implementation. In year 2006- March, health facility survey was conducted only in Rufiji. 
INESS facility surveys were done in March and October, 2010 only. 
Laboratory procedure 
In both IMPACT-Tz and INESS studies, thick and thin blood smears were stained with 
10% Giemsa stain and asexual parasites were counted per 200 white blood cells 
(WBCs) assuming average of 8,000 WBC per blood microlitre. Gametocytes were 
quantified in reference to 500 WBCs. In IMPACT-Tz, 5% of all slides that were read by 
each microscopist were read again by a senior laboratory technician, for quality control. 
Discordant readings were consistently less than 14%; where as in INESS all slides were 
sent for a second reading and discordant results harmonized by a third reader.  
Data management and analysis 
IMPACT-Tz data was entered in FoxPro software (Redmond Washington, USA), and 
INESS data were entered in EPIDATA (version 3.1, EPIDATA Association, Odense, 
Denmark) programme. All data were converted to, and analyzed in STATA version 11 
(STATA Corporation, College Station, USA). The four datasets (2002, 2004, 2006 and 
2010) were combined (appended) for this analysis. Because of differences in variables 
collected throughout the years with slightly different protocols, this analysis only dealt 
with age (in years and months), type of health facility, district, year and month of survey, 
gender, parasite counts, gametocyte counts and type of Plasmodium species. 
Analysis started with frequency distribution of different characteristic variables. Pearson 
chi squared was used to assess relation between presence of parasitemia by different 
patients or facility characteristics. Multivariable linear regression was run to assess 
relationship between parasitemia and age, district or year of study. Graphs were 
constructed using Microsoft Excel (Microsoft Office Excel 2000) to show trends in level 
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of parasitemia with age over the years. Results were considered statistically significant 
at a p-value of <0.05. In order to better describe the distribution of study participants in 
the univariate and bivariate analysis, and in trend graphs, age was grouped into 
categories; first, only two categories were invented (below and above 5 years); second, 
6 categories were created; below 1 year of age, 1-2 years of age, >2-5 years, >5-15 
years, >15 to 25 years and above 25 years. This grouping was considered important for 
discussing public health implications of the findings. Likewise, parasite count was also 
presented into 4 groups (less than or equals to 50parasites/200 WBCs, 51-500, 501-
5000 and >5000/200WBCs). 
The Tanzania HIV/AIDS and Malaria Indicator surveys (THMIS) collects population 
based data related to HIV and Malaria control activities in the country. As well the 
Tanzania Demographic and Health Surveys (TDHS), collect health related indicators in 
the population. Both THMIS and TDHS draw nationally representative samples in their 
surveys. Malaria in TDHS is estimated by the proportion of children below age of 5, who 
had fever two weeks preceding the survey, but since 2007/8 the THMIS performs 
parasitological tests to children below 5 in order to estimate prevalence of malaria 
parasitemia. Data from TDHS 2004/5, THMIS 2007/8 and THMIS 2011 (collectively 
referred to as THMIS in this paper), were plotted against graphs of patients below age 
of 5, i.e. against 2004, 2006 and 2010, respectively; in order to compare trends between 
health facilities and population based surveys (NBS, 2004/5; THMIS, 2007/8; THMIS, 
2012). 
Morogoro rural had only one data point, therefore excluded in the multivariate analysis. 
Ethical review  
Both IMPACT- Tz and INESS programme received ethical approval from national and 
institutional ethical review boards. 
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5.3 Results 
A total of 9,740 patients’ records were included in the analysis. Results in table 1 show 
a similar distribution of age in the five of the six groups; except adults of above 25 
years. Female constituted about 58% of study population. As expected, there were 
more participants in the first survey (2002) due to inclusion of Morogoro rural. Parasite 
counts showed comparable proportions in the first three groups, with fewer patients 
recording very high levels of parasitemia (4.1%) 
Table 1: Characteristics of patients seen during survey(s) period 
Main category (N) Sub-category n (%) 
Age categories 
(9,514) 
Less than 1 year 1,354 14.2 
1 to 2 years 1,546 16.3 
2 to 5 years 1,457 15.3 
5 to 15 years 1,464 15.4 
15 to 25 years 1,319 13.9 
More than 25 years 2,374 24.9 
Prevalence of 
parasitemia 
(1,876) 
Less than 1 year 224 12.0 
1 to 2 years 428 22.9 
2 to 5 years 491 26.3 
5 to 15 years 353 18.9 
15 to 25 years 178 9.5 
More than 25 years 194 10.4 
Gender (9,723) 
Male 4,102 42.2 
Female 5,621 57.8 
District (9,740) 
K/U 3,177 32.6 
Rufiji 5,211 53.5 
Morogoro 1,352 13.9 
Facility type 
(9,728) 
Hospital 2,409 24.8 
HC 2,829 29.1 
Dispensary 4,490 46.1 
Year of interview  
(9,740) 
2002 4,206 43.2 
2004 2,715 27.9 
2006 1,348 13.8 
2010 1,471 15.1 
Parasite 
counts/200 WBCs  
(1,892) 
</= 50 591 31.2 
51 to 500 594 31.4 
501 to 5000 630 33.3 
>5000 77 4.1 
Other clinical 
characteristics 
BS checked 8,237/9,721 84.7 
P. falciparum 1,628/ 1,715 95.0 
Gametocytes 96/1,892 5.1 
Parasite positive 1,876/9,721 19.3 
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Assessment of the characteristics and distribution of parasitemic patients (n=1,892) in 
table 2 showed that, higher parasite count was most common to children below 5 years 
(p<0.001). Dispensaries recorded highest proportion of patients with malaria 
parasitemia (48.5%; p<0.001). Malaria prevalence was higher in 2002 with a decline in 
the following 2 surveys, but indicating a slight increase in 2010. P. falciparum species 
accounted for about 95% of all infections and gametocytes was recorded in 4% of all 
parasitemic individuals, especially in n low parasite densities. 
Table 2: Characteristics and distribution of parasitemic patients (Parasitemia count/ 200 WBCs) 
Parameter (N) 
Sub-group  
</ = 50  
(n; %) 
51-500 
(n;%) 
500-5000 
(n;%) 
>5000 
(n;%) 
Total  
(n; %) 
p 
value 
Gender 
(1,885) 
Male  261 (44.3) 287 (48.4) 291 (46.5) 43 (55.8) 882 (46.8) 
0.201 
Female 328 (55.7) 306 (51.6) 335 (53.5) 34 (44.2) 1,003(53.2) 
  
Age (1,868) 
<5 years 259 (44.7) 364 (62.2) 457 (73.0) 63 (81.8) 1143 (61.2) 
<0.001 
<5 years 321 (55.3) 221 (37.8) 169 (27.0) 14 (18.2) 725 (38.8) 
  
Age in 
categories 
(1,868) 
<1 years 70 (12.1) 69 (11.8) 80 (12.8) 5 (6.4) 224 (12.0) 
<0.001 
1-2 years 86 (14.8) 151 (25.8) 162 (25.9) 29 (37.7) 428 (22.9) 
2-5 years 103 (17.8) 144 (24.6) 215 (34.3) 29 (37.7) 491 (26.3) 
5-15 years 127 (21.9) 109 (18.6) 108 (17.2) 9 (11.7) 353 (18.9) 
15-25 years 87 (15.0) 54 (9.1) 36 (5.7) 1 (1.3) 178 (9.5) 
>25 years 107 (18.4)  58 (9.9) 25 (4.1) 4 (5.2) 194 (10.4) 
  
Type of health 
facility (1,891) 
Hospital 142 (24.0) 94 (15.8) 147 (23.4) 10 (13.0) 393 (20.8) 
0.001 
Health 
centers 184 (31.1) 187 (31.5) 189 (30.0) 20 (26.0) 580 (30.7) 
Dispensaries 265 (44.9) 313 (52.7) 293 (46.6) 47 (61.0) 918 (48.5) 
  
Year of survey 
(1,892) 
2002 330 (55.8) 354 (59.6) 337 (53.5) 13 (16.9) 1034 (54.7) 
<0.001 
2004 158 (26.7) 187 (31.5) 229 (36.3) 39 (50.6) 613 (32.4) 
2006 69 (11.7) 13 (2.2) 10 (1.6) 0 92 (4.9) 
2010 34 (5.8) 40 (6.7) 54 (8.6) 25 (32.5) 153 (8.0) 
  
Plasmodium 
species 
(1,694) 
Pf 528 (96.5) 503 (93.9) 527 (94.4) 50 (98.0) 1608 (94.9) 
0.09 
Non Pf 19 (3.5) 35 (6.5) 31 (5.6) 1 (2) 86 (5.1) 
  
Gametocytes 
carriage 
(1,648) 
Yes 28 (5.3) 24 (4.6) 15 (2.7) 0 67 (4.0) 
0.073 
No 502 (94.7) 498 (95.4) 530 (97.3) 51 (100) 1,581 (96) 
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Assessment of trends of parasitemia by age groups over the survey years shows that, 
overall presence of parasites in children below 5 years was declining, but that of older 
children and adults were on the rise (figure 1). This decline was also evident in 
population based surveys (THMIS). Further analysis with smaller age groups revealed 
intra-group variations with differing patterns; where babies below 1 year and 1-2 years 
generally had a decreasing trend (figures 2a, 2b), those aged 2-5 years old showed an 
increase in proportion parasitemic (figure 2c), contrary to the population based picture 
(THMIS). Similarly, the group of age above five years, showed an increasing trend in 
parasitemia (figure 1) but, intra-group analysis revealed that the increase was only in 
the older children group (5-15 years; figure 2d), but the adults generally showed a 
declining trend (figures 2e, 2f). 
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Figure 2d: Parasitemic patients 5-15 years old: 2002-10
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Figure 2e: Parasitemic patients 15-25 yrs old: 2002-10
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Figure 2f: Parasitemic >25 years old: 2002-10
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In the multivariate analysis, presence of parasitemia was negatively related to age in 
both crude and adjusted analysis. On average, parasitemia decreases with 5 to 6 years 
increase in age (table 3). Parasitemia was mostly concentrated at lower age (right 
skewed) with the arithmetic mean parasite count higher than the median parasite count 
(table 3).  A strong negative relation was seen between Rufiji and K/U where Rufiji 
seem to have lower parasitemia with increasing patient’s age. However, no significant 
relation was observed between the two districts over the years, table 3. 
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Table 3: Relationship between parasitemia, age and district 
 
Parasitemia in relation to: Regression coefficient (95%CI) p value 
Age of patients: 
Age (unadjusted) - 5.59 (-6.51 to -4.68) <0.001 
Age (adjusted by year) - 5.72 (-6.63 to -4.80) <0.001 
Age (adjusted by district) - 5.56 (-6.48 to -4.65) <0.001 
Age (adjusted by year & district) - 5.74 (-6.66 to -4.82) <0.001 
District (Rufiji/ KU only with K/U as reference):  
District (unadjusted) - 59.04 (-97.91 to -20.17) 0.003 
District (adjusted by age) - 49.01 (-88.44 to  -9.58) 0.015 
District (adjusted by year) - 8.78 (-50.07 to 32.50) 0.677 
District (adjusted by age & year)  3.32 (-19.69 to 35.52) 0.877 
  
Arithmetic mean parasite count = 916/ 200 WBC;  Median = 234/ 200 WBCs and 
Geometric mean= 172.7/ 200WBCs 
5.4 Discussion 
Findings from this analysis show a negative relation between presence of parasitemia 
and patients age in an area where malaria prevalence is declining. These results aligns 
with what is already known in literature; that decline in malaria transmission leads to 
changes in the age group most affected with malaria (Marsh K and Snow RW, 1999; 
O’Meara WP et al., 2008). In the studies that assesses effects to children under five; it 
is customary to group the affected age as below 5 and above 5, mainly because malaria 
is known to affect the former more severely than the latter. Likewise, this work 
demonstrates that parasitemia decreases with a 5-6 years age intervals. Despite this 
broader categorization, this work described the specific age most affected within these 
two broad categories and what happens in the light of changing malaria prevalence.  
The decline in malaria burden in the study areas; K/U and Rufiji has been reported 
previously. Schellenberg and colleagues reported the changes in malaria epidemiology 
in Ifakara town (in K/U) between years 1995 to 2000. The mean age of malaria 
admissions changed from1.55 years in 1995 to 2.33 years in 2000, p<0.001 
(Schellenberg D et al., 2004). Recently, Khatib et al published the measured and 
modelled decline in asexual parasitemia prevalence within HDSS areas in Rufiji and 
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K/U (Khatib RA et al., 2012). These findings are supported by country-wide 
representative surveys that reports fever prevalence to children below age of five, in the 
past two weeks preceding the survey during the national demographic and health 
surveys (TDHS) and parasite prevalence through the HIV/AIDS and malaria indicators 
surveys. Fever prevalence was 35.1% in 1999 and 22.9% in 2010 (NBS, 1999; NBS 
and Macro ICF, 2011), where as malaria prevalence declined from 18.1% in 2007/8 to 
<10% in 2011 (THMIS, 2012). 
These achievements can be credited to the malaria control strategies already in place 
including use of ACTs for case management (AS+SP during IMPACT-Tz and 
artemether-lumefantrine (AL) country wide, from late 2006), increased use of treated 
nets (especially in K/U site) as shown by Khatib et al (Khatib RA et al., 2012) and 
community based or health facility based interventions to address malaria. However, the 
proportion of patients who were found to have malaria parasite in this analysis was still 
higher than population based estimates. This is not surprising, as study participants 
were people who attended facilities seeking for care. This is among the limitations of 
using facility based data to assess disease trends (Rowe AK et al., 2009). To a large 
extent, health facility malaria prevalence can be influenced by treatment seeking 
practices in the respective communities, such that frequencies reported, may not reflect 
a true picture of trends in the population. Despite this fact, findings in this work did show 
significantly appreciable trends in age of parasitemic patients managed at health 
facilities within the study areas. 
Focusing on the children below age of five who are most vulnerable to effects of 
malaria; this work shows that, as malaria burden decrease, the burden shift to children 
between 2-5 years and older children up to 15 years of age. It wouldn’t come as a 
surprise because the two to five years olds are at the critical growth stage learning to 
walk, run and play with peers. On the other hand, the group of 5-15 years old are older 
children, most likely, school going, thereby most likely to be active, e.g. playing out late 
evening. These activities would render them susceptible to outdoor biters of malaria 
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transmission (Russell TN et al., 2011). In addition, sleeping arrangements in a typical 
African family may replace an older baby in one sleeping space when a new born 
arrives, or considered “old enough” to sleep separately from the parents (Alaii JA et al., 
2003). This implies that, probably newborns and breastfeeding mothers will almost 
always get a net if one is available. Following the success of pregnant and infants’ 
treated-net provision schemes; these age groups (2-5 and 5-15) should also be 
additional target groups of the current catch-up and keep-up strategies for increasing 
net ownership and use. 
It is anticipated that, as the decline in malaria transmission continues in the same or 
accelerated pace, a shift of parasitemia prevalence to older age group will become 
more obvious. The older children will be burdened with other malaria associated 
morbidities as well, such as anemia as previously reported (Schellenberg D et al., 
2003), bringing public health concerns in respective communities. The time to 
strengthen the use of routinely health facilities surveillance data to monitor trends and 
act is now. At a point of care, clinicians should be made aware of these shifts in age 
patterns to understand local disease profile and enhance appropriate identification of 
patients in need of effective treatment. It is especially important during malaria 
elimination phase as the decrease in natural acquired immunity will render the 
population more susceptible to malaria infection. In fact, as malaria endemic countries 
are heading towards elimination and eradication phases, and population loose natural 
immunity against malaria, even lower parasite densities may become fatal. This work, 
only assessed presence of parasitemia, and did not attempt to relate parasite density 
and other factors. 
Limitations: 
In these surveys, it is possible that some patients found to have malaria parasitemia did 
not have any malaria related signs and symptoms, resulting to overestimation of the 
reported facility based malaria prevalence. However, a fact that they were attending 
facilities for clinical management of illnesses increase our suspicion that, majority of 
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parasitemic patients were true malaria cases. Second, we are aware that microscopic or 
blood smear analysis of malaria parasites may miss sub-microscopic infections of 
malaria in endemic areas as compared to Polymerase Chain Reaction (PCR) (Okell LC 
et al., 2009); which may lower the reported parasite positivity counts. The relevance of 
these sub-microscopic parasitemia levels into development of a clinically relevant 
infection is known to be very low, except for vulnerable groups such as pregnant 
women.  
5.5 Conclusion 
Following the decline in malaria transmission in K/U and Rufiji districts, there was a 
significant age shift of parasitemic patients presenting at health facilities. Presence of 
malaria parasites declined in children less than 2 years old, but increased in those 
above 2 years of age, contrary to population based surveys. Adults (above 15 years) 
generally showed a decline in presence of malaria parasites at health facilities. These 
findings underscore the need to include older children as another priority group in 
malaria control activities, such as the catch-up and keep-up campaigns for increasing 
treated net ownership and usage. 
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Abstract: 
Background: Improving malaria case management is partially dependent on health 
worker compliance with clinical guidelines. We assessed health worker factors 
associated with correct antimalarial prescribing practices at two sites in rural Tanzania. 
 
Methods: We conducted repeated cross-sectional health facility surveys and collected 
information on patient consultations and health worker characteristics.  Using logistic 
regression, we assessed health worker factors associated with correct prescription for 
uncomplicated malaria defined as prescription of artemisinin based combination therapy 
(ACT) for patients with fever and P. falciparum asexual parasitemia based on  blood 
slide according to official policy guideline.  
 
Results: In this analysis, we included 685 patients with uncomplicated malaria who 
were seen in a health facility with ACT in stock and 71 health workers practicing in 30 
health facilities. Overall, 58% of malaria patients were correctly treated with an ACT.  
Health workers with 3 or more years of work experience were significantly more likely 
than others to prescribe correctly (adjusted odds ratio (aOR) 2.6; 95% confidence 
interval (CI) 1.2-5.6; p=0.021). Clinical officers (aOR 3.1; 95% CI 1.2-8.0; p=0.019), 
health workers of the nurse aide or lower cadre (aOR 4.2; 95% CI 1.5-11.7; p=0.007) 
were more likely to correctly prescribe ACT than medical officers; diagnosed by mRDT 
(aOR 2.6; 1.2-5.8) were more likely to correctly prescribe ACT than microscopy. 
Training on ACT use, supervision visits, and availability of job aids were not significantly 
associated with correct prescription.   
 
Conclusion: In this analysis, 58% of malaria patients were correctly treated. Years of 
working experience, health worker cadre and use of mRDT diagnosis were associated 
with correct ACT prescription for uncomplicated malaria.  Targeted interventions to 
improve health worker performance are needed to improve overall malaria case 
management. 
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Keywords: Uncomplicated malaria, correct prescription and Artemisinin Combination 
Therapy 
6.1 Background 
Effective treatment of patients with malaria illness is a cornerstone of global control 
efforts to reduce malaria morbidity and mortality. However, effective malaria case 
management depends on early recognition of symptoms and signs as requiring malaria 
diagnosis and treatment, as well as the clinical skills of the health worker. In most 
malaria endemic areas, management of malaria patients is determined by the clinical 
presentation and where possible, diagnostic confirmation (NMCP, 2006). Many 
countries use evidence-based clinical practice guidelines to help health workers assess, 
diagnose and treat patients with malaria. To implement guidelines, a common strategy 
is to provide health workers with in-service training, printed copies of the malaria 
treatment guidelines, and wall charts and other job aids. Despite these trainings and 
aids, health workers have often been reported not to follow recommended guidelines 
(Nicholas DD et al., 1991; Kelly JM, 2001; Naimoli J et al., 2006).  
 
Improving health worker’s compliance to treatment guidelines remains critical to the 
success of any new drug policy. However, results from health facility surveys conducted 
elsewhere, have shown that health workers (HW) frequently do not comply with 
treatment guidelines (Rowe AK et al., 2001). Different types of treatment error have 
been reported, each with different assumed clinical consequences (Rowe AK et al., 
2003). For example, treatment with an antimalarial drug that is effective but not 
recommended by the guideline has been used as an error (Rowe AK et al., 2003). 
Other scholars have documented that clinical practices can be influenced by factors 
other than treatment recommendations, such as age of the patient and suspected 
concurrent conditions (Dodoo ANO, 2009).  
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In Tanzania, as in many sub-Saharan countries, effective implementation of clinical 
guidelines is a critical challenge– especially for malaria, which is a leading cause of 
child morbidity and mortality (RBM:). This challenge is particularly relevant today 
because new policies are being implemented that recommend artemisinin-based 
combination therapies (ACTs), parasitological confirmation with mRDTs and blood slide. 
Artemisinin based combination therapies are more expensive and have more complex 
dosing regimens than previously used antimalarials. However, there are relatively few 
reports on the quality of clinical practice following implementation of ACT policy in Africa 
(Zurovac et al., 2007; Zurovac et al., 2008b), particularly those focusing on factors 
specific to health workers.  
 
In recognition of the fact that new drug policies will need better implementation 
strategies in the health facility setting, the need for improving health workers 
performance cannot be overly emphasized (Rowe AK et al., 2005). Yet little is known 
about the health worker factors associated with correct prescribing of ACTs for 
uncomplicated malaria. This study therefore, present findings from an assessment of 
health worker factors associated with correct prescription of ACT for management of 
uncomplicated malaria patients in rural health facilities in Tanzania.  
 6.2 Methodology 
Study area:  
The study was conducted in Rufiji and Ifakara Health and Demographic Surveillance 
System (HDSS) sites. Rufiji HDSS situated in Coast Region, the eastern part of 
Tanzania with a catchment population of approximately 85,000 people living in 16,000 
household (Rufiji DSS). Ifakara HDSS is situated in, and covers parts of Kilombero and 
Ulanga Districts in Morogoro Region. Ifakara HDSS site constitutes more than 99,000 
people, living in 28,000 scattered rural households (Ifakara HDSS). The two HDSS sites 
have high malaria transmission during the high rainfall season, between March and 
June annually.  
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Study design and data collection 
This was a cross-sectional cluster survey conducted in March and November 2010, 
where a cluster was defined as all patient consultations performed in a health facility on 
the one day of survey during regular working hours. The survey was conducted in all 
health facilities licensed to prescribe the ACT of interest, Artemether-Lumefantrine 
(ALU) within the Rufiji and Ifakara HDSS.   
 
Twenty interviewers and two supervisors were trained together on survey procedures 
and blood slide collection in a classroom setting and then practiced these activities in 
test health facilities. At health facilities, all health workers performing patient 
consultation on the day of survey were given an identification number. All outpatients 
presenting for initial illness consultation on a day of a survey, and who consented to 
participate in the survey, were interviewed prior to leaving the health facility.  Patients 
eligible to participate in the survey were asked to provide informed consent.  All patients 
who consented were included in the survey and given a study identification card with 
their study identification number.  The health workers seeing a consented patient noted 
their initials and health worker identification number on the patient’s study identification 
card as well the patient’s medical record (file) number.  In the laboratory, the patient 
identification number on the study identification card was used to label any extra blood 
slides they made for patient.  
  
When the patient was ready to leave the health facility after visiting the laboratory and 
pharmacy as needed, the surveyor interviewed the patient and collected a blood slide (if 
not already done in the laboratory). The interview was used to determine if patients had 
understood the information provided by the health worker regarding diagnosis, referral, 
treatment, follow-up, and home care. All information and prescribed medications were 
recorded on a standardized questionnaire.  
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At the end of the survey day all health workers who had performed patient consultations 
were interviewed to collect information on their demographics, cadre, pre-service and 
in-service training, work experience, access to national guidelines and wall charts, and 
exposure to supervision in the preceding six months.  Finally, a health facility 
assessment was undertaken to record the availability of ALU and other antimalarials on 
the survey day and in the past three months, the presence of functional weighing 
scales, thermometers, malaria diagnostics, and any displayed case-management wall 
charts.   
Definitions 
Uncomplicated malaria used in this analysis was defined as either presence of fever 
and blood slide positive for malaria parasitemia or clinical diagnosis of malaria 
according to IMCI classification.  
 
Correct prescription of ACT defined as prescription of artemisinin based combination 
therapy (ACT) for patients with fever and P. falciparum asexual parasitemia based on 
blood slide positive at health facility or clinical confirmed according to IMCI 
classification. 
Data Processing:  
Data were double entered into EPIDATA version 3.1 (Odense, Denmark, 2004) and 
validations were conducted for checking completeness and consistency. All analyses 
were performed using STATA Version 11.0 (StataCorp: 2009, College station, TX) 
procedures that account for survey design by identifying different probabilities of 
selection (sampling weights), clustering and stratification. Thus, all percentages and 
odds ratios reported are population-average estimates which have been adjusted to 
take into account the clustering and sampling weights of the study design. Descriptive 
analysis was done after merging health facilities, health worker and patient datasets and 
clustered by patient consultation days.  
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Logistic regression was used to assess health worker factors associated with correct 
prescribing of ACT for uncomplicated malaria. The outcome variable in this analysis 
was patients with uncomplicated malaria correctly prescribed an ACT and the 
determinant/ explanatory variables were health worker’s factors: health worker cadre; 
in-service training; having 3 or more years of working experience; supervision visit in 
past six months; type of malaria diagnostic and availability of job aids. In-service training 
was classified into two groups: first; health worker trained on either, malaria case 
management, Integrated Management of Childhood Illness (IMCI), or use of new anti-
malarials, and second; health workers’ who are not trained on either of the above 3 
categories. Availability of job aids includes possession of the national malaria treatment 
guideline and wall chart that described the current treatment recommendations.  
 
To identify health worker factors associated with correct prescribing practices, treatment 
practices were analyzed at all health facilities with  the availability of ALU during the 
survey,  a binary response outcome 1 indicates that a patient with uncomplicated 
malaria was correctly prescribed an ACT and 0 indicates that, the patient with 
uncomplicated malaria has not been prescribed an ACT. Health worker factors 
suspected to be associated with correct prescription of ACT for uncomplicated malaria 
were identified in the multivariate model. Pregnant women, patients without 
uncomplicated malaria and patients with uncomplicated malaria seen in a health facility 
without ACT in stock were excluded from the analysis. An alpha level of 0.05 was used 
for all tests of significance. 
Ethical Approval 
Ethical approval for this study was received from the Ifakara Health Institute ethical 
review board (IHI/IRB/No.A67-2009) and National ethical clearance after having met the 
criteria for ethical considerations. 
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6.3 Results 
Patient Characteristics 
Data were collected from 31 health facilities and analysis is based on 685 patients with 
uncomplicated malaria seen in 30 health facilities with ACT in stock (figure 1) by 71 
health workers (table 2).  A total of 846 patients were excluded from analysis (figure 1). 
More than half (54%) of the patients seen at the health facilities were children under five 
and 55 % were females (table 1). 34% were diagnosed by either microscopy or mRDT 
while 66% were clinically diagnosed.  
 
Malaria treatment received by patients 
Overall, only more than half (58%) of patients with uncomplicated malaria seen in health 
facilities with ACT in stock received an ACT (table 1).  Quinine a second line treatment 
for uncomplicated malaria was given to 10% of all patients. Only 1% received SP as the 
first line treatment and 31% of malaria patients did not receive any anti-malarial drug. 
Parasitological diagnosis was available in 82% health facilities and 34% of patient with 
uncomplicated malaria were diagnosed by microscopy or mRDT (table 2). The national 
malaria treatment guidelines recommend presumptive treatment of a fever with ACT 
when malaria tests are not available, but only half (51%) of patients who were clinically 
diagnosed were prescribed ACT (table1).  
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Figure 1: Inclusion of patients in the analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health facility and Health worker characteristics 
Few health facilities had both malaria diagnostic microscopy and mRDT (20%) and 60% 
of the health facilities surveyed had only mRDT diagnostic in stock (table 2). At the time 
of the survey, most of the health facilities reported that they had anti-malarial drugs in 
stock and field staff verified that ACT was in stock in 94% of health facilities surveyed. 
71% of the patients with uncomplicated malaria seen in health facility with ACT in stock 
were seen by Medical Assistant/Clinical Officer/ Clinical Assistant, and only 5% of 
patients were seen by medical officer; 67% were seen by health workers (HW) who had 
All patients enrolled in health 
facility survey (N=1531) 
Excluded from analysis 
(N=846) 
Patient with uncomplicated malaria seen in 
health facility with ACT in stock included in 
analysis (N=685) 
Patients without uncomplicated 
malaria (N=681) 
Patients with uncomplicated malaria 
seen in a health facility without ACT in 
stock (N=105) 
Pregnant women (N=60)  
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received in-service training (which includes either training in malaria case management 
and/or integrated management for child illness, or use of new anti-malaria). 77% of 
patients were seen by health worker having three or more years of working experience.  
Few patients (22%) were seen by health workers who had received at least one 
supervision visit in the last six months and 42% of patients were seen by health workers 
who had job aids in possession (table 2).  
 
Table 1: Patient Characteristics included in analysis 
 N=685 
Patient Demographic n/N % 95%CI 
Patient age    
Mean age (range) 11  (0-80) 
Children under 5 370/685 54.0 50.3-57.8 
5 and above  315/685 46.0 42.3-49.7 
Patient  gender    
Female 373/685 54.5 51.0-57.9 
Male 312/685 45.5 42.2-49.0 
Type of malaria diagnostic    
Patient diagnosed by microscopy 115/685 16.8 10.8-25.2 
Patient diagnosed by MRDT 114/685 16.6 11.1-24.3 
Patient diagnosed by clinical  456/685 66.6 56.6-75.2 
Patient treatment    
Patient prescribed ACT 398/685 58.1 51.9-64.1 
Under 5 219/370 59.2 51.9-66.1 
5 and above 179/315 56.8 49.6-63.8 
Patient prescribed ACT by type of 
diagnostic 
   
Diagnosed by microscopy 70/115 60.9 48.5-72.0 
Diagnosed by mRDT 95/114 83.3 72.9-90.3 
Clinical diagnosed 233/456 51.1 42.8-59.4 
Patient prescribed with Non-ACT 287/687 41.9 35.9-48.2 
SP 5/685 0.7 0.3-2.1 
Quinine 71/685 10.4 7.4-14.3 
Other anti-malaria 1/685 0.1 0.02-1.1 
Not prescribed with any anti-malaria 210/685 30.7 27.2-34.3 
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Table 2: Health facility and health worker characteristics 
 
Distribution of facility and health workers factor n/N % 95%CI 
Availability of malaria diagnostic and ACT    
HF with microscopy 6/30 20.0 7.7-38.6 
HF with mRDT 18/30 60.0 40.6-77.3 
Bothe microscopy and mRDT 6/30 20.0 7.7-38.6 
Health workers    
Medical officer 6/71 8.4 3.2-27.5 
Clinical officer 40/71 56.3 44.0-68.1 
Nurse aide and lower cadre 25/71 35.2 24.2-47.5 
Patient seen by health worker (cadre, experience, training and 
job-aides)  
   
Patient seen by a medical officer 32/685 4.7 2.4-9.0 
Patient seen by a clinical officer 488/685 71.2 60.5-80.0 
Patient seen by nurse aide or lower cadre 165/685 24.1 15.9-34.8 
Patient seen by HW with 3 or more years of experience 525/685 76.6 68.0-83.5 
Patient seen by HW who had supervision visit in the last 6 
month 
153/685 22.3 15.0-32.0 
Patient seen by HW who received in-service training in malaria 
case management* 
458/685 66.9 55.4-76.6 
Patient seen by HW who owns a malaria case management job 
aid** 
289/685 42.2 30.7-54.5 
*In-service training includes malaria case management, Integrated Management of Childhood Illness 
(IMCI), or use of new antimalarials **Job aids include possession of the national malaria guideline and 
wall chart 
 
Health worker factors associated with correct prescription of ACT 
In the univariate analysis, patients seen by nurse aide or lower cadre, patients 
diagnosed by mRDT, and a health worker with three or more years of work experience 
had higher odds ratio of receiving ACTs (OR=2.8, 95%CI: 1.4-5.7, p=0.008,OR=3.2, 
95%CI: 1.5-7.1, p=0.004, and OR 2.7, 95%CI: 1.3-5.6 p=0.008) respectively (table 3). 
These   variables remained statistically significant in multivariate model with odds ratios 
of 4.2, 2.6 and 2.6 respectively (table 4). 
 
Patients seen by a clinical officer and nurse or lower cadre health worker had 
significantly higher odds of getting an ACT than patients seen by medical officer (table 
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4). Health workers with three or more years of work experience had significantly higher 
odds of correctly prescribing ACT (adjusted OR=2.6, 95%CI: 1.2-5.6). Indicating that a 
health worker with more working experience had about three times higher the odds of 
prescribing ACTs compared to one with less work experience. In-service training, 
supervision visit, type of malaria diagnosis used and availability of job aids for health 
workers were not associated with prescribing ACT at 5% significance level. The 
analysis shows that the patients who were diagnosed by mRDT rather than microscopy 
were more likely to be prescribed ACT (adjusted OR=2.6, 95%CI: 1.2-5.8) (see table 4).  
 
Table 3: Univariate analysis for health worker factors associated with correct prescription 
of ACT (N=685) 
 
Variable Odds ratio 95%CI P-value 
Health worker cadre    
    Seen by medical officer Ref   
    Seen by a clinical officer 1.9 0.99-3.63 0.051 
      Seen by a nurse aide or lower cadre 2.8 1.41-5.73 0.004 
Working experience, supervision visit, in-service 
and job aids 
   
Seen by HW with 3 or more years of work experience 2.7 1.30-5.65 0.008 
Seen by HW who had  supervision visit in the last 6 
month 
0.8 0.42-1.48 0.460 
Seen by HW who received in-service training in case 
management  
1.3 0.77-2.09 0.343 
Seen by HW who owns a malaria case management 
job aids 
1.3 0.79-2.09 0.313 
Type of malaria diagnostic    
Diagnosed by microscopy Ref   
Diagnosed by mRDT 3.2 1.46-7.07 0.004 
Clinical diagnosed  0.7 0.36-1.25 0.206 
Age of patients    
Less than 5 Ref   
5 and above 0.9 0.67-1.22 0.520 
Site    
Rufiji Ref   
Kilombero/Ulanga 0.97 0.58-1.61 0.906 
Season    
High transmission season  Ref   
Low transmission season 0.46 0.29-0.72 0.001 
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Table 4: Multivariate analysis for health worker factors associated with correct 
prescription of ACT (N=685) 
Variable Odds ratio 95%CI P-
value 
Health worker cadre    
Seen by medical officer Ref   
Seen by a clinical officer 3.1 1.21-8.00 0.019 
Seen by a nurse aide or lower cadre 4.2 1.49-11.65 0.007 
Working experience, supervision visit, in-service and job 
aids 
   
Seen by HW with 3 or more years of work experience 2.6 1.16-5.63 0.021 
Seen by HW who had  supervision visit in the last 6 month 1.2 0.57-2.70 0.580 
Seen by HW who received in-service training in case 
management  
1.0 0.58-1.87 0.892 
Seen by HW who owns a malaria case management job aids 1.1 0.60-1.82 0.873 
Type of malaria diagnostic    
Diagnosed by microscopy Ref   
Diagnosed by mRDT 2.6 1.22-5.76 0.014 
Clinical diagnosed  0.6 0.30-1.10 0.095 
 
 
6.4 Discussion 
This study aimed to assess a limited range of health workers’ factors that seemed 
possibly associated with correct ACT prescribing practices at health facilities. Our 
findings provide some explanations that help understanding correct prescription of ACT 
for uncomplicated malaria. ACT was more commonly prescribed by clinical officers and 
nurse aides or lower cadres than medical officers. This finding was similar to what was 
observed during the era of SP policy in Kenya (Zurovac et al., 2004) and Chloroquine 
policy in Benin (Rowe AK et al., 2003). Several reasons may explain these results. First, 
there are always more lower level cadres health workers (clinical officers, nursing aide 
and lower cadre) in rural health facilities who interface with most patients with minor 
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illnesses compared to doctors or medical officers. Medical officers are always involved 
in administrative work and when the conditions are severe. Second, clinical officers and 
nursing aides or lower cadres may not know how to prescribe second-line drugs or 
other anti-malarials and therefore avoid using them. Third, clinical officers and nursing 
aides or lower cadres may be better at following clinical algorithms because they have 
less of a ‘medical vocabulary’ of alternative diagnoses and treatments that might 
interfere with the simple ‘fever = malaria’ concept upon which the guideline is based. 
Fourth, medical officers and, to a lesser extent, clinical officers, may have been taught 
that their clinical judgment can and ought to override guidelines. Indeed, they may view 
guidelines as suggestions, rather than rules that should be followed systematically. 
Furthermore, our findings reveal that health workers with lower cadre commonly 
perform consultations and follow recommended guidelines than higher cadres (Zurovac 
et al., 2004) in rural areas of formal health system, although they are not allowed to do 
so. This is because the health sector is facing a serious human resource (HR) crisis that 
is negatively affecting the ability of the sector to deliver quality health services. There is 
a severe shortage of HR at all levels which is more severe in rural districts (Musau S et 
al., 2011). 
 
There is great need to improve the quality of malaria case management for 
uncomplicated malaria in rural Tanzania, with a greater emphasis on health worker to 
comply with clinical guidelines. ACT prescribing for uncomplicated malaria was 
considerably below the RBM target of 80% of uncomplicated malaria treated with ACT. 
In Kenya and Zambia poor quality treatment practices were observed at public and 
mission facilities soon after ACT was introduced as first-line, though subsequent studies 
up to five years later show improvements in the proportion of patients that are 
prescribed and receive ACT (Zurovac et al., 2007; Zurovac et al., 2008b; Juma and 
Zurovac, 2010). As found elsewhere, the proportion of patients that were prescribed or 
received an ACT seems low given the availability of ACT at health facilities (Zurovac et 
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al., 2004; Zurovac et al., 2008b; Juma and Zurovac, 2010; Wasunna et al., 2008; 
Zurovac et al., 2008c; Uzochukwu BSC et al., 2010).  
 
Improved access to mRDT malaria diagnosis was statistically more likely to correctly 
prescribe ACT in the health facilities with ACT in stock. This is due to accuracy of 
malaria rapid diagnosis test is high, parasitological confirmation of all malaria diagnoses 
is recommended by WHO and increased evidence supporting the use of mRDTs reduce 
overtreatment with anti-malarials (Trap B et al., 2001; Uzochukwu BSC et al., 2010; 
Naimoli J et al., 2006; Zurovac and Rowe, 2006; Loevinsohn BP et al., 1995; Zurovac et 
al., 2011; Ishengoma DS et al., 2011). 
 
Health workers who had three or more years of working experience were statistically 
more likely to correctly prescribe ACT in health facilities with ACT in stock. Several 
reasons may explain why having more working experience for caring patients was 
associated with correct prescribing of ACTs. First, the relationship may have been 
confounded by a factor that was studied. For example, the health worker experienced in 
caring for patients has been more involved in training on malaria case management 
which included the use of new antimalarials and more likely for health workers to 
provide correct prescribing of ACTs of interest during the survey. Indeed, theoretically, 
the working experience might improve health worker performance, but still might have 
had enough impact to overcome differences between well-performing health workers 
who were not having three or more years of caring patients and poorly performing 
health workers with less three years of working experience. Second, it is possible that 
health workers who have been more experienced in caring for patients comply with the 
national malaria treatment guidelines. And third, perhaps through years of experience 
they came to trust the recommended medicine for management of uncomplicated 
malaria after having seen other patients getting good clinical response following its use. 
Finally they have had several supervision visits in the course of their practice, and 
hence more confidence with prescribing drugs. 
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Common interventions such as in-service training, regular supervision visits, and 
availability of job aids were not associated with correct prescribing of ACTs for 
uncomplicated malaria at health facility where ACT was in stock (table 4). This result 
has been observed in other settings; not all routine in-service initiatives to improve 
clinical management practices have had positive effects on treatment   practices 
(Zurovac et al., 2004; Naimoli J et al., 2006; Zurovac and Rowe, 2006). In this study 
perhaps the most important observation was that workers having supervision visits in 
the previous six months were more likely to prescribe ACT to patients with 
uncomplicated malaria compared to health workers who do not receive any supervision 
visit. Although few studies have examined the independent effect of supervision on 
health care worker performance, small studies in Africa and the Philippines have 
suggested an association between supervision and improved knowledge, planning, the 
clinical skills and improve health workers’ case management practices (Loevinsohn BP 
et al., 1995; Zurovac et al., 2011; Trap B et al., 2001).  
 
 The lack of association of in-service training and correct prescribing ACTs is consistent 
with other studies (Rowe AK et al., 2003; Reyburn et al., 2007; Paredes P et al., 1996) 
and there are several possible explanations. First, the quality of training may have been 
poor. Although we have no evaluation of the courses, we know they used adult teaching 
methods and were mostly of an adequate duration. Perhaps the short time dedicated to 
clinical practice diminished the training's effectiveness. Secondly, the health workers 
who were trained in-service training may have been too few to detect an important 
difference; however, this explanation is unlikely because the estimated odds ratio was 
substantially higher than one. A third possible explanation for the lack of association 
between in-service training and correct prescribing ACTs treatment is that training 
improves knowledge, but knowledge is not sufficient to improve clinical performance. 
Our failure to find an association between in-service training and correct prescribing 
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ACTs is consistent with other studies showing that correct knowledge does not translate 
into correct behavior (Paredes P et al., 1996; Rowe et al., 2000). 
 
Finally, better prescribing of ACTs practices could not be attributed to any routine ACT 
implementation activities (in-service training, guidelines, wall charts). The reviews of 
previous studies with similar design, as well as systematic reviews of other 
interventional trials on the use of medicines in developing countries, commonly reported 
a mixed association between in-service training and health worker performance, and 
sometimes, as in this study, no association was found with in-service training (Rowe AK 
et al., 2005).  
 
Limitations 
This study had several important limitations. First, not all potential factors were included 
in analysis, such as the complexity of the guideline for health workers. Second, the 
method of directly observing health workers may have influenced their performance 
either making them anxious or motivating them to perform better than usual.  As one 
study found that most health workers reported the presence of observers either had a 
small positive effect or had no effect on their performance (Rowe AK et al., 2002), we 
were less concerned that observation had introduced a large bias. Third, we had only 
limited details on evaluation of training that had no baseline performance measurement, 
and our evaluation of the quality of supervision was not very detailed. Finally, we did not 
assess over-prescription of ACTs to patients without malaria in this analysis. 
 
 6.5 Conclusions  
Health worker’s having three or more years on caring malaria patients; health worker 
cadre and use of mRDT diagnosis were associated with correct prescribing ACTs 
treatment. While in-service training, supervision visit, and availability of job aids were 
not associated with correct prescribing ACTs. We do not mean to imply that training, 
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supervision visit and job aids are useless components of the health worker 
performance; we are concerned by the scarcity of evidence from well-designed study 
that supports these commonly used interventions. Targeted interventions to improve 
health worker performance are needed to improve overall malaria case management. 
Interventions above and beyond in-service training, supervision, job aids, etc will need 
to be tailored to the specific needs of newly qualified providers(less than three years 
working experience) and medical doctors. Improving malaria case management will be 
required to reach Roll Back Malaria goal of “near zero” malaria deaths by 2015. 
Recommendation on further intervention research to explore new approach to improve 
health worker performance such as use of text messaging to health workers is needed.  
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Abstract:  
Background: Due to growing antimalarial drug resistance, Tanzania changed malaria 
treatment policies twice within a decade. First in 2001 chloroquine (CQ) was replaced 
by sulfadoxine-pyrimethamine (SP) for management of uncomplicated malaria and by 
late 2006, SP was replaced by artemether-lumefantrine (AL). We assessed health 
workers’ attitudes and personal practices following the first treatment policy change, at 
six months post-change and two years later.  
Methods:  Two cross-sectional surveys were conducted in 2002 and 2004 among 
healthcare workers in three districts in South-East Tanzania using semi-structured 
questionnaires. Attitudes were assessed by enquiring which antimalarial was 
considered most suitable for the management of uncomplicated malaria for the three 
patient categories: i) children below 5; ii) older children and adults; and iii) pregnant 
women. Practice was ascertained by asking which antimalarial was used in the last 
malaria episode by the health worker him/herself and/or dependants. Univariate and 
multivariate logistic regression was used to identify factors associated with reported 
attitudes and practices towards the new treatment recommendations. 
Results: A total of 400 health workers were interviewed; 254 and 146 in the first and 
second surveys, respectively. SP was less preferred antimalarial in hospitals and 
private health facilities (p<0.01) in the first round, and the preference worsened in the 
second round. In the first round, clinicians did not prefer SP for children below age of 5 
and pregnant women (p<0.01), but two years later, they did not prefer it for all patient 
scenarios. SP was the most commonly used antimalarial for management of the last 
malaria episode for health workers and their dependants in both rounds, in the public 
sector (p<0.01). Health workers in the dispensaries had the highest odds of using SP for 
their own treatment [adjusted OR- first round: 6.7 (95%CI: 1.9-23.4); crude OR- second 
round: 4.5 (1.5-13.3)]   
Conclusion: Following changes in malaria treatment recommendations, most health 
workers did not prefer the new antimalarial drug, and their preferences worsened over 
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time. However, many of them still used the newly recommended drug for management 
of their own or family members’ malaria episode. This indicates that, other factors than 
providers’ attitude may have more influence in their personal treatment practices. 
Key words: health workers, attitude, practices, new treatment guidelines, malaria 
7.1 Background: 
In early 2000, malaria was a leading cause of death (NMCP, 2003c) and hospital 
attendances in Tanzania, particularly among children under the age of five and pregnant 
women (NMCP, 2000). During that time, Tanzania recorded a range of 14-18 million 
clinical malaria cases yearly, with a mortality rate of 140-165 per 100,000 people and 
approximately 70,000 to 100,000 deaths among children under-five (NMCP, 2000; 
NMCP, 2003c). Malaria was endemic in almost all parts of the country but with varying 
endemicity levels (NMCP, 2003a). Current malaria control activities in the country 
involve prompt diagnosis and treatment of cases, intermittent preventive treatment for 
pregnant women (IPTp), promoting the use of insecticide treated bed-nets (ITNs), 
indoor residual spraying (IRS), monitoring and managing epidemics as well as 
environmental management for vector control. However, the emergence and spread of 
insecticide and antimalarial drugs resistance may undermine the disease control 
strategies already in place.  
The pace at which malaria parasites develop resistance to antimalarial drugs is 
alarming and necessitates investigating ways to prolong the lifespan of efficacious 
antimalarials (WHO, 1996; Snow RW et al., 1999). The fact that drug resistance is a 
natural and expected process, stresses the need for cost-effective strategies to delay 
development of resistance, while continuing to provide effective treatment to those in 
need. Fear that resistance will develop to drugs in use, is justifiable and may provide a 
significant challenge to policymaking decisions, initiating endless cycles of drug 
replacement. 
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Towards the end of 2006, mainland Tanzania introduced Artemisinin-based combination 
therapy (ACTs) for routine management of uncomplicated malaria (NMCP, 2005). This 
was a second change of malaria treatment policy within a decade. The first change 
occurred in August 2001 when chloroquine (CQ) was replaced by sulfadoxine-
pyrimethamine (SP) as the first line treatment of uncomplicated malaria (NMCP, 2000). 
The changes were necessary due to growing resistance of malaria parasites to CQ 
(Mubyazi and Gonzalez-Block, 2005). At the time of change, SP was a second line drug 
for treatment of malaria while quinine (QN) was reserved for severe malaria. SP was 
one of the few inexpensive and relatively safe antimalarial drugs that was still effective 
against chloroquine-resistant malaria (Mugittu et al., 2004). SP was introduced on 
interim basis due to the fact that resistance to SP had already been recorded in some 
parts of the country (Gorissen E et al., 2000; Ronn A.M et al., 1996; Schellenberg D et 
al., 2002). Moreover, SP is known to be susceptible to resistance if used on a wide 
scale. 
During the SP era, treatment guidelines indicated that uncomplicated malaria should be 
treated with SP (sulfadoxine 500mg with pyrimethamine 25mg) as a single dose based 
on age (above two months) and weight (above 5 kg) (NMCP, 2003a). Furthermore, the 
policy document explained how to recognize and manage non-response to SP, 
contraindications, administration and adverse effects of SP. In addition, the guideline 
explained that SP should not be used in late pregnancy (36 weeks and above) and for 
lactating mothers whose children are below two months of age. Contraindications for 
use of SP as stated in the guideline included history of sulfadoxine hypersensitivity, 
premature babies and children below two months who were to receive QN. The policy 
also explained when and how to use the second line antimalarial drug, amodiaquine 
(AQ), for management of uncomplicated malaria, including indications, 
contraindications, adverse reactions and dosage regimen (NMCP, 2003a). At all levels 
of care, severe malaria was to be managed with QN and where possible referred to a 
higher level of care after a pre-referral quinine shot (intra-muscular). Non responses to 
QN were to receive Artemisinin derivative along with QN (Gorissen E et al., 2000). 
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The introduction of SP for management of uncomplicated malaria in Tanzania was 
received with fear and negative perceptions from both community and health care 
workers (Nsimba SE, 2006). Fear of side effects related to sulphur content of the SP, 
was exacerbated by newspaper reports of suspected victims of adverse drug reactions 
(ADR) following use of SP. There was a chance that these fears may have affected 
health provider’s acceptance of the new treatment recommendations and behave 
inappropriately, since it is well understood that health workers’ performance can 
influence effectiveness of treatment policies.  Their actions may be a result of their own 
perceptions of treatment efficacy. If a recommended treatment is perceived to be 
effective, it is more likely to be used as stipulated in the guideline whereas treatment 
recommendations that do not measure up to their expectations may be less utilized.  
Contrary to expectations that health providers with more training will more likely abide 
by evidence based guidelines, Zurovac and colleagues reported that more qualified 
health workers such as clinical officers and nurses made more errors as compared to 
nurse aides by using non-recommended antimalarials in treating uncomplicated malaria 
at government health facilities in Kenya (OR 25.4; 95% CI 2.9-217.3 and OR=7.1 95% 
CI 1.1-44.5 respectively) (Zurovac et al., 2004). In Ghana, Dodoo et al. concluded that 
although first line treatment recommendations may change, clinical practice can still be 
influenced by factors other than the decision or ability to diagnose malaria (Dodoo ANO, 
2009). Based on a longitudinal non-intervention study to monitor adverse events, they 
found that age of the patient, diagnostic confirmation and suspected concurrent 
conditions all had significant influence in clinical practice.  
Human beings tend to demand and use what perceive to be the best available option at 
a given time. Clinicians and health workers would want to use the best available 
treatment when managing their own illnesses and their loved ones. Accurate 
information on this practice may shed a light on how health providers’ preferences 
influence their practices. The need to assess if providers’ attitude does influence their 
practices was particularly high following introduction of SP since; first, the change was 
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not well received by providers and the general population, and second, the change was 
on an interim basis whilst evaluating other efficacious treatment options. Understanding 
of this behavior would assist policy making decisions for future treatment changes in 
Tanzania and beyond. 
7.2 Materials and methods: 
Study design: This study was completed as part of the Interdisciplinary Monitoring 
Project for Antimalarial Combination Treatment in Tanzania (IMPACT-TZ). Data 
presented here were collected in two cross sectional surveys aimed at evaluating health 
workers’ understanding and utilization of new treatment recommendations for use of SP 
as first line treatment for management of uncomplicated malaria. The evaluation was 
conducted in two steps: i) First survey in February 2002 (approximately 6 months post-
change to SP) and ii) second survey in March 2004, two years after the first survey. In 
both phases, semi-structured questionnaires were used to assess health workers’ 
attitudes and practices related to the new recommendations. 
Site description: The districts involved in the evaluation were Rufiji, Morogoro Rural, 
Kilombero and Ulanga. For the purpose of this evaluation, Kilombero and Ulanga (K/U) 
were treated as a single unit because population movement between these two districts 
is high. Rufiji and Morogoro rural are isolated from each other and movement between 
them is limited by the Selous game reserve and the long distances required to by-pass 
the game reserve (additional file 1). The three districts are similar in terms of urban, 
peri-urban and rural population proportions and predicted intensity and duration of 
malaria transmission. Based on data modeled by the Mapping Malaria Risk in Africa 
(MARA) project, the three districts have a range of 7-12 months of malaria transmission 
season (additional file 2). 
The Health and Demographic Surveillance Systems (HDSS) were in place since 1998 in 
Rufiji and since 1996 for Ifakara DSS (which covers the districts of Kilombero and 
Ulanga). In the first survey, data were collected from three districts Morogoro Rural, 
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Rufiji and K/U. Two years later Rufiji district had started using ACT, as part of the 
IMPACT-TZ project evaluation and was hence excluded in the comparison between 
rounds. 
Sample selection: In each district, one hospital, one or two health centers and three to 
four dispensaries that record a high number of malaria cases were selected to 
participate. The health facilities were purposively chosen based on type, ownership, 
utilization rates and geographical location. Selection of these facilities was done by the 
research team in collaboration with the District Medical Officer (DMO) using district 
health statistics and maps.  
Eligibility criteria: Health workers from each selected facility were included in this 
study if they were involved in prescribing and caring for malaria patients. Interviews 
were conducted to eligible health workers who were present and could spare time for an 
interview (even after working hours), on a day of visit. In both survey rounds, the same 
health facilities were included, but no attempt was made to match respondents between 
the two surveys. 
Data collection: Information was collected through face-to-face interviews using 
questionnaires. Questionnaires were originally developed in English and translated into 
Swahili, then back translated to ensure accuracy. Trained local field workers performed 
interviews in Swahili and later that day, transcribed the responses into English. The field 
guides had two parts: first were semi-structured and open-ended questions while the 
second section had case scenarios. The section with semi-structured questions asked 
about health workers’ understanding, attitudes and practices relating to the new 
treatment guidelines and needed a mention of antimalarial drug from the interviewee as 
a response. The open-ended questions enquired about challenges and problems faced 
during the implementation of the new treatment policy while the case scenarios were 
knowledge-based questions where a patient scenario was described and required the 
health worker to narrate how that case would be managed. Data analyzed in this report 
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were from the semi- structured part of the tool. Responses from the open-ended and 
case scenario parts will be presented elsewhere. 
Attitudes: Questions to assess attitudes asked which antimalarial drug was thought to 
be most suitable for management of uncomplicated malaria for: i) children below 5, ii) 
children above 5 years/adults and iii) pregnant women.  Practices: Health workers’ 
practices were assessed by asking what antimalarial they or their dependants used the 
last time they suffered malaria.  
Data entry and analysis: Data were entered into EPI Info 2000 (CDC, Atlanta) by a 
project statistician and verified by the project supervisor through range and consistency 
checks for all variables within each dataset separately. Original questionnaires were 
referred to whenever inconsistency, outliers or errors were encountered. Data from the 
two surveys were stored in separate databases. Analysis was done using STATA 10 
(Stata Corporation, Texas). The outcome variables for this paper were attitude and 
practice and risk factors were type of health worker, type of health facility, facility 
ownership and district.  
Definitions: Health workers were grouped into 5 categories; first were physicians with a 
minimum of a medical degree or advanced diploma in medicine, second were clinical 
officers (CO’s) with a diploma in medicine, third were trained nurses (TN) which 
included all nurses with more than two years of training i.e. registered and enrolled 
nurses such as nurse midwives and nurse officers. All other nurses, particularly with 
training of less than two years (nurse assistants and nurse auxiliaries) were grouped as 
“other nurses”. Other health workers e.g. laboratory assistant, who sees malaria 
patients only when it is necessary, were termed as “other cadres”. 
Attitudes towards the national malaria treatment guidelines were assessed by 
comparing what health workers considered the most appropriate antimalarial for the 
three patient scenarios. If the response corresponded to the recommendation in the 
guidelines it was scored as “1” and “0” if not. Practice was assessed from the reported 
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antimalarial used by health workers themselves or their family members in their last 
malaria episode. Again, if the response corresponded to the recommendation on the 
guideline it was scored as “1” and “0” if not. Percentages were drawn and stratified by 
district, type of health facility and type of health worker.  
Percentages were used to describe the variables and characteristics of study 
participants. For each of the three scenarios, crude analyses of the associations 
between the various risk factors and the outcomes (attitude and practice) were 
performed. In the univariate analysis, cross tabulations and chi square tests were 
conducted to identify possible confounders. Logistic regression was used to build 
multivariate models to identify factors independently associated with each outcome. The 
group with the higher number of respondents was regarded as a reference in the 
multivariate analysis. Both crude and adjusted odds ratios are presented.  
Ethical approval: Ethical clearance for the IMPACT- Tanzania project was granted by 
the Ifakara Health Institute Review Board and Tanzanian National Institute of Medical 
Research (NIMR), in 2000. 
7.3 Results: 
Characteristics of study participants: 
In the first survey, 23 health facilities were visited in the 3 districts and 254 health 
workers were interviewed, whereas in the second survey 16 health facilities within 2 
districts were visited and 146 health workers were interviewed (table 1). There were 
fewer respondents during the second survey, due to the exclusion of Rufiji district. As 
shown in table 1, K/U generally had the highest percentage of participants in both 
phases. In the first survey, a higher percentage of participants were from non-public 
facilities (59%). In both rounds, hospitals had the majority of study participants 
compared to dispensaries and health centers (table 1). The proportion of physicians and 
‘other’ cadres was small in both surveys.  
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Attitudes towards recommended treatment 
Results in table 2 shows that, in the first round, 44.1% of providers reported to prefer SP 
for management of uncomplicated malaria in children below five, 68% preferred SP for 
older children and adults and 51.6% preferred SP for pregnant women. Health workers 
in health centers and dispensaries were more likely to report preferring SP than in 
hospitals (p<0.05) and more providers from public facilities were in favor of SP than 
from non-public health facilities; particularly for children and pregnant women; p<0.001 
(table 2).  
Table 1: Characteristics of study participants for survey rounds 1 and 2 
Characteristic 
variable 
Category 
Round 1 Round 2 
n % n % 
Total 254 100 146 100 
District 
Morogoro 73 28.7 59 40.4 
Rufiji 85 33.5 - - 
K/Ulanga 96 37.8 87 59.6 
Health facility 
ownership 
Public 105 41.3 79 54.1 
Non-public 149 58.7 67 45.9 
Health facility 
type 
Hospital 171 67.3 90 61.6 
Health center 45 17.7 22 15.1 
Dispensary 38 15 34 23.3 
Cadre of 
health worker 
Physicians 6 2.4 8 5.4 
Clinical 
Officers 
51 20.1 26 17.8 
Trained 
nurses 
70 27.5 55 37.7 
Other nurses 118 46.5 55 37.7 
Others 9 3.5 2 1.4 
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During the second round, preference for SP treatments was very low in all categories; 
with only 6.2% reporting to prefer SP for management of uncomplicated malaria in 
children below five, 5.5% preferred SP for older children and adults, and only 4.1% 
preferred SP for pregnant women (table 3). There were no statistically significant 
differences in reported preferences in almost all patients’ scenarios and by different 
providers’ characteristics (table 3). 
Table 2: Proportion of health workers who thought SP was appropriate treatment for uncomplicated malaria, year 2002 
Charact
er 
variable 
Category  Children<5 n (%) 
p-value 
Older children/ adults n (%) 
p-
value 
Pregnant women n (%) 
p-
value 
(N=254) SP: 
n=112 
(44.1) 
*Other 
drug: 
n=139 
(54.7) 
DK/ 
Missing: 
n=3 
(1.2) 
SP: 
n=173 
(68) 
*Other 
drug: 
n=79 
(31.1) 
DK/ 
Missing: 
n=2 
(0.8) 
SP: 
n=131 
(51.6) 
*Other 
drug: 
n=116 
(45.7) 
DK/ 
Missin
g: n=7 
(2.7) 
District 
Morogoro 
(73) 
33 
(45.2) 
39 
(53.4) 1 (1.3) 
0.662 
48 
(65.8) 
25 
(34.2) - 
0.085 
27 
(36.9) 
44 
(60.3) 2 (2.7) 
0.032 
Rufiji (85) 
38 
(44.7) 
45 
(52.9) 2 (2.3) 
64 
(75.3) 
19 
(22.4) 2 (2.3) 
53 
(62.4) 
30 
(35.3) 2 (2.3) 
K/Ulanga 
(96) 
41 
(42.7) 
55 
(57.3) - 
61 
(63.5) 
35 
(36.5) - 
51 
(53.1) 
42 
(43.7) 3 (3.1) 
Health 
facility 
type 
Hospitals 
(93) 
39 
(34.5) 
53 
(64.3) 1 (1.2) 
<0.001 
103 
(60.2) 
66 
(38.6) 2 (1.2) 
0.049 
72 
(42.1) 
92 
(53.8) 7 (4.1) 
<0.00
1 
Health 
Centers 
(45) 
27 
(60.0) 
17 
(37.8) 1 (2.2) 
37 
(82.2) 8 (17.8) - 
31 
(68.9) 
14 
(31.1) - 
Dispensari
es (38) 
26 
(68.4) 
12 
(31.6) - 
33 
(86.8) 5 (13.2) - 
28 
(73.7) 
10 
(26.3) - 
HF 
owners
hip 
Public 
(176) 
92 
(52.3) 
82 
(46.6) 2 (1.1) 
<0.001 
126 
(71.6) 
49 
(27.8) 1 (0.6) 
0.189 
113 
(64.2) 
59 
(33.5) 4 (2.3) 
<0.00
1 
Non-public 
(78) 
20 
(25.6) 
57 
(73.1) 1 (1.3) 
47 
(60.3) 
30 
(38.5) 1 (1.3) 
18 
(23.1) 
57 
(73.1) 3 (3.8) 
Cadre 
of 
health 
worker 
Physicians 
(6) 0 6 (100) - 
<0.001 
5 (83.3) 1(16.7) - 
0.01 
- 6 (100) - 
0.007 
Clinical 
Officers 
(51) 
22 
(43.1) 
29 
(56.9) - 
38 
(74.5) 
13 
(25.5) - 
24 
(47.1) 
27 
(52.9) - 
Trained 
nurses 
(70) 
25 
(35.7) 
45 
(64.3) - 
43 
(61.4) 
27 
(38.6) - 
30 
(42.9) 
38 
(54.3) 2 (2.8) 
Other 
nurses 
(118) 
63 
(53.4) 
54 
(45.8) 1 (0.8) 
84 
(71.2) 
33 
(27.9) 1 (0.9) 
74 
(62.7) 
40 
(33.9) 4 (3.4) 
Other 
cadres (9) 
2 
(22.2) 5 (55.6) 2 (22.2) 3 (33.3) 5 (55.6) 1 (1.1) 
3 
(33.3) 5 (55.6) 
1 
(11.1) 
*Other drugs includes: Chloroquine, Amodiaquine, Artemisinins, Quinine or any combination of these       P-value: Chi squared test 
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Practices related to new recommended malaria treatment: 
Most health workers who had malaria episodes in the recent past had used SP for 
treatment in both rounds; 55% in round one and 60% in round two; indicating that, the 
proportion of health workers who had used SP for managing their own illnesses were 
higher in second survey than the first; but fewer in absolute numbers. The exception 
was to health workers in non-public facilities (table 4). However, SP use for health 
workers dependants declined in the second round. Only providers working in 
dispensaries, public facilities and clinical officers recorded higher proportions of SP 
usage among family members (table 4).  
Table 3: Health workers who thought SP was appropriate treatment for uncomplicated malaria year 2004 
Characteri
stic 
variable 
Category  
Children<5 n (%) 
p-
value 
Older children/ 
adults n (%) 
p-
value 
Pregnant women n (%) 
p-
value 
 (N =146) SP; 
n=9 
(6.2) 
*Other 
drug; 
n=135 
(92.5) 
DK/ 
Missin
g; n=2 
(1.3) 
SP; 
n=8 
(5.5) 
*Other 
drug; 
n=138 
(94.5) 
SP; 
n=6 
(4.1) 
*Other 
drug 
n=126 
(86.3) 
DK/ 
Missing 
n=14 
(9.6) 
District 
Morogoro 
(59) 1 (1.7) 
58 
(98.3) 0 
0.08 
1 (1.7) 
58 
(98.3) 
0.09 
1 (1.7) 
56 
(94.9) 2 (3.4) 
0.04 
K/Ulanga 
(87) 8 (9.2) 
77 
(88.5) 2 (2.3) 7 (8.1) 
80 
(91.9) 5 (5.7) 
70 
(80.5) 
12 
(13.8) 
Health 
facility 
type 
Hospitals 
(90) 
9 
(10.0) 
79 
(87.8) 2 (2.2) 
0.11 
8 (8.9) 
82 
(91.1) 
0.07 
6 (6.7) 
73 
(81.1) 
11 
(12.2) 
0.18 
H/Centers 
(22) 0 22 (100) 0 0 22 (100) 0 
21 
(95.5) 1 (4.5) 
Dispensarie
s (34) 0 34 (100) 0 0 34 (100) 0 
32 
(94.1) 2 (5.9) 
HF 
ownership 
Public (79) 4 (5.1) 
75 
(94.9) 0 
0.24 
4 (5.1) 
75 
(94.9) 
0.81 
3 (3.8) 
71 
(89.9) 5 (6.3) 
0.33 
Non-public 
(67) 5 (7.5) 60(89.5) 2 (3.0) 4 (5.9) 
63 
(94.1) 3 (4.5) 
55 
(82.1) 9 (13.4) 
Cadre of 
health 
worker 
Physicians 
(8) 0 8 (100) 0 
0.56 
0 8 (100) 
0.48 
0 8 (100) 0 
0.41 
Cl/ Officers 
(26) 0 26 (100) 0 0 26 (100) 0 
23 
(88.5) 3 (11.5) 
Trained 
nurses (55) 5 (9.1) 
48 
(87.3) 2 (3.6) 5 (9.1) 
50 
(90.9) 5 (9.1) 
43 
(78.2) 7 (12.7) 
Other 
nurses (55) 4 (7.3) 
51 
(92.7) 0 3 (5.5) 
52 
(94.5) 1 (1.8) 
50 
(90.9) 4 (7.3) 
Other 
cadres (2) 0 2 (100) 0 0 2 (100) 0 2 (100) 0 
*Other drugs includes: Chloroquine, Amodiaquine, Artemisinins, Quinine or a combination of these       P-value: Chi squared test 
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Table 4: Personal and/ or family member use of SP for management of uncomplicated malaria in 2002 and 2004. 
Characteri
stic 
variable Category 
Self use N=247(%) –
(2002) 
p-
value 
Self use 
N=81(%) –
(2004) 
p-
valu
e 
Own child/family 
N= 207(%)-(2002) p-value 
Own child/family 
N=84 (%) (2004) 
p-
value 
SP; 
n=135 
(54.7) 
*Other 
drug; 
n=112 
(45.3)   
SP; 
n=49 
(60.5) 
*Other 
drug; 
n=32 
(39.5)   
SP; 
n=124 
(59.9) 
*Other 
drug; 
n=83 
(40.1)   
SP; 
n=37 
(44) 
*Other 
drug; 
n=47 
(55)   
District 
Morogoro 
41 
(56.2) 32 (43.8) 
0.48 
22 
(66.7) 
11 
(33.3) 
0.34 
35 
(47.9) 
26 
(35.6) 
0.41 
12 
(40.0) 
18 
(60.0) 
0.57 
Rufiji 
43 
(50.6) 38 (44.7) - - 
48 
(56.5) 
23 
(27.0) - - 
K/Ulanga 
51 
(53.1) 42 (43.8) 
27 
(56.2) 
21 
(43.8) 
41 
(42.7) 
34 
(35.4) 
25 
(46.3) 
29 
(53.7) 
Health 
facility 
type 
Hospitals 
86 
(50.3) 81 (47.4) 
0.16 
22 
(50.0) 
22 
(50.0) 
0.08 
68 
(39.8) 
67 
(39.2) 
<0.001 
16 
(32.0) 
34 
(68.0) 
0.01 
Health 
Centers 
24 
(53.3) 18 (40.0) 
12 
(66.7) 
6 
(33.3) 
26 
(57.8) 
12 
(26.7) 
6 
(50.0) 6 (50.0) 
Dispensa
ries 
25 
(65.8) 13 (34.2) 
15 
(78.9) 
4 
(21.1) 
30 
(78.9) 4 (10.5) 
15 
(68.2) 7(31.8) 
HF 
ownership 
Public 
99 
(56.3) 72 (40.9) 
0.30 
35 
(71.4) 
14 
(28.6) 
0.01 
100 
(56.8) 52(29.6) 
<0.001 
30 
(58.8) 
21 
(41.2) 
0.001 
Non-
public  
36 
(46.2) 40 (51.3) 
14 
(43.7) 
18 
(56.3) 
24 
(30.8) 
31 
(39.7) 
7 
(21.2) 
26 
(78.8) 
Cadre of 
health 
worker 
Physician
s 3 (50.0) 3 (50.0) 
0.48 
2 
(100) 0 
0.19 
2 
(33.3) 2 (33.3) 
0.01 
0 3 (100) 
0.21 
Clinical 
Officers 
26 
(51.0) 25 (49.0) 
10 
(83.3) 
2 
(16.7) 
21 
(41.2) 
13 
(25.5) 
8 
(66.7) 4 (33.3) 
Trained 
nurses 
34 
(48.6) 34 (48.6) 
18 
(56.3) 
14 
(43.7) 
28 
(40.0) 
29 
(41.4) 
11 
(40.7) 
16 
(59.3) 
Other 
nurses 
69 
(58.5) 45 (38.1) 
19 
(54.3) 
16 
(45.7) 
66 
(55.9) 
38 
(32.2) 
18 
(43.9) 
23 
(56.1) 
Other 
cadres 3 (33.3) 5 (55.6) 0 0 
7 
(77.8) 1 (11.1) 0 1 (100) 
*Other drugs includes: Chloroquine, Amodiaquine, Artemisinins, Quinine or a combination of these 
The multivariate analysis (table 5) shows that, compared to providers at hospitals, 
working at dispensaries and health centers were significant predictors of SP preference 
for older children and adults in the first round; adjusted OR (aOR; 95% confidence 
interval) = 6.3 (1.8-22.2) for dispensaries and aOR = 4.9 (1.7-14.0) for health centers 
(table 5). Poor SP preference was recorded in non-public facilities with respect to 
management of uncomplicated malaria to pregnant women aOR= 0.2 (0.07-0.4) when 
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compared to the public facilities. Non-public facilities had consistently lower odds of SP 
preferences both in a crude and adjusted analysis (table 5). In terms of use, only 
providers at dispensaries had statistically significant higher odds of using SP in the last 
illness episode of a family member than those working in the hospitals aOR= 6.7 (1.9-
23.4). 
Table 5: Health-workers attitude and personal (or/and family) use of SP for management of uncomplicated malaria, 2002 
Chara
cteristi
c 
variabl
e 
Category  Children<5: OR 
(95%CI) 
Older children/ adults: 
OR (95%CI) 
Pregnant women: OR 
(95%CI) Self use: OR (95%CI) 
Own child/family use: 
OR (95%CI) 
(N=254) 
Crude OR 
Adjusted 
OR Crude OR 
Adjusted 
OR Crude OR 
Adjusted 
OR Crude OR 
Adjuste
d OR 
Crude 
OR 
Adjusted 
OR 
Distric
t 
K/Ulanga 
(96) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Morogoro 
(73) 
1.1  
(0.6-2.0) 
1.5‡  
(0.6-3.6) 
1.1  
(0.6-2.1) 
0.9 ‡  
(0.3-2.2) 
0.5  
(0.3-0.9) 
0.9‡  
(0.3-2.1) 
0.9 
 (0.5-1.8) 
1.1‡ 
 (0.5-
2.4) 
0.9  
(0.5-1.8) 
0.7‡ 
 (0.3-1.6) 
Rufiji (85) 
1.1  
(0.6-1.9) 
1.4‡  
(0.7-2.9) 
1.7  
(0.9- 3.3) 
2.0‡  
(0.9-4.4) 
1.4  
(0.8 -2.6) 
2.9‡  
(1.3-6.3) 
0.9  
(0.5-1.7) 
0.9‡  
(0.5- 
1.9) 
1.4 
 (0.7-2.8) 
1.3‡  
(0.6-2.7) 
Health 
facility 
type 
Hospitals 
(93) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Health 
Centers 
(45) 
2.8  
(1.4-5.6) 
2.1 Ɨ 
(0.9-4.7) 
3.1  
(1.3-6.9) 
4.9 Ɨ  
(1.7-14.0) 
3.0  
(1.5-6.1) 
2.1 Ɨ  
(0.9-4.9) 
1.2  
(0.6-2.6) 
1.2 Ɨ  
(0.5-2.6) 
1.7 
(0.8-3.6) 
1.8 Ɨ  
(0.6- 2.7) 
Dispensari
es (38) 
4.1 
(1.9-8.7) 
2.4 Ɨ  
(0.9-6.1) 
4.3 
(1.6-11.7) 
6.3 Ɨ  
(1.8-22.2) 
3.8  
(1.7-8.4) 
2.3 Ɨ  
(0.8-6.6) 
1.5 
 (0.7-3.3) 
1.3 Ɨ  
(0.5-3.4) 
5.4  
(1.8-16.1) 
6.7 Ɨ  
(1.9-23.4) 
HF 
owner
ship 
Public 
(176) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Non-
public (78) 
0.3 
(0.2-0.6) 
0.8 ¥ 
 (0.4-1.7) 
0.6  
(0.3-1.0) 
0.9 ¥  
(0.4-2.1) 
0.1  
(0.09-0.3) 
0.2¥ 
(0.07-0.4) 
0.6 
(0.4-1.1) 
0.7 ¥ 
(0.3-0.5) 
0.6  
(0.3-1.1) 
1.2¥  
(0.5-2.7) 
Cadre 
of 
health 
worker 
Other 
nurses 
(118) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Physician
s (6) - - 
2.0  
(0.2-17.9) 
3.8§  
(0.4-36.4) - - 
0.6  
(0.1-3.2) 
0.8§  
(0.1-4.5) 
0.9  
(0.2-5.4) 
1.3§  
(0.2-8.2) 
Clinical 
Officers 
(51) 
0.7  
(0.3-1.3) 
0.8 §  
(0.4-1.6) 
1.2  
(0.5-2.5) 
1.6§  
(0.7-3.6) 
0.5  
(0.3-1.0) 
0.7§  
(0.3-1.4) 
0.6  
(0.3-1.2) 
0.6§  
(0.3-1.3) 
1.3  
(0.6-2.9) 
1.7§  
(0.8-3.7) 
Trained 
nurses 
(70) 
0.5 
(0.3-0.9) 
0.8§  
(0.4-1.7) 
0.6  
(0.3-1.2) 
1.2§  
(0.6-2.4) 
0.4  
(0.2-0.8) 
1.0§  
(0.5-2.2) 
0.6  
(0.3-1.2) 
0.8§  
(0.4-1.5) 
0.7  
(0.3- 1.2) 
0.9 § 
 (0.5-1.9) 
Other 
cadres (9) 
0.2  
(0.04-1.2) 
0.1§(0.0
3-0.8) 
0.2  
(0.05-0.8) 
0.07§  
(0.02-0.4) 
0.3  
(0.07-1.2) 
0.1§  
(0.02-0.6) 
0.5  
(0.1-1.9) 
0.4§  
(0.1-1.7) 
3.8  
(0.4-31.5) 
3.1§ 
 (0.3-27.1) 
‡Adjusted for type of health facility, health facility ownership and health worker cadre. 
Ɨ Adjusted for district, health facility ownership and health worker cadre 
¥ Adjusted for district, type of health facility and health worker cadre 
§ Adjusted for district, type of health facility and health facility ownership 
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In the second round (table 6), only providers from dispensaries showed higher odds of 
using SP for management of their own [cOR= 5.5 (1.9-15.6)] or family member illness 
episodes [cOR= 4.5 (1.5-13.3)] in un-adjusted analysis, compared to providers from the 
hospitals. As well staff of non-public facilities showed lower odds of SP use that those 
working in the public facilities, in the crude analysis cOR =0.3 (0.1-0.5) for self use and 
0.2 (0.06-0.5) for family member. 
Table 6: Health workers attitude and personal use (or/and family use) of SP for management of uncomplicated malaria, 2004                
Charact
eristic 
variable 
Category  Children<5: OR 
(95%CI) 
Older children/adults: 
OR (95%CI) 
Pregnant women: OR 
(95%CI) Self use: OR (95%CI) 
Own child/family use: 
OR (95%CI) 
n=(146) 
Crude OR 
Adjusted 
OR Crude OR 
Adjusted 
OR 
Crude 
OR 
Adjusted 
OR Crude OR 
Adjuste
d OR Crude OR 
Adjusted 
OR 
District 
Morogoro 
(59) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref 
K/Ulanga 
(87) 
5.8  
(0.7-48.3) 
3.4 ‡  
(0.3-35.2) 
5.1  
(0.7-42.4) 
2.7‡  
(0.2-29.9) 
3.5 (0.4-
31.1) 
2.4‡  
(0.2-30.7) 
1.2  
(0.5-2.2) 
0.5 ‡ 
(0.1-1.8) 
1.2  
(0.5-3.2) 
2.1‡  
(0.5-7.8) 
Health 
facility 
type 
Hospitals 
(90) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref 
H/Centers 
(22) - - - - - - 
1.6 
 (0.6-4.4) 
0.7 Ɨ 
(0.1-3.9) 
2.1  
(0.6-7.6) 
0.8 Ɨ  
(0.1-4.1) 
Dispensari
es (34) - - - - - - 
5.5 
 (1.9-15.6) 
1.2 Ɨ 
(0.2-8.0) 
4.5 
(1.5-13.3) 
3.0 Ɨ  
(0.5-17.6) 
HF 
ownersh
ip 
Public 
(79) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Non-
public (67) 
1.5  
(0.4-5.8) 
0.5¥  
(0.1-2.7) 
1.2  
(0.3-4.9) 
0.4¥ 
(0.08-2.3) 
1.2  
(0.2-6.0) 
0.5¥ 
(0.07-3.5) 
0.3  
(0.1-0.5) 
0.2¥(0.0
5-1.2) 
0.2 (0.06-
0.5) 
0.2¥ 
(0.06-1.1) 
Cadre of 
health 
worker 
Other 
nurses 
(55) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref 
Physician
s (8) - - - - - - 
1.2  
(0.2-5.5) 
2.6§(0.5
-13.5) - - 
Clinical 
Officers 
(26) - - - - - - 
1.9 
 (0.7-5.4) 
1.4§ 
(0.6-3.4) 
0.8  
(0.3-2.3) 
1.3§  
(0.4-4.1) 
Trained 
nurses 
(55) 
1.2  
(0.3-5.0) 
0.8§  
(0.2-3.7) 
1.7  
(0.4-7.6) 
1.0§ 
 (0.2- 5.4) 
5.4 (0.6-
47.8) 
3.6§ (0.3-
34.9) 
1.1  
(0.4-2.8) 
1.8§ 
(0.6-5.4) 
2.5  
(0.6 -9.8) 
3.1§  
(0.4-14.2) 
Other 
cadres (2) - - - - - - - - - - 
‡Adjusted for type of health facility, health facility ownership and health worker cadre. 
Ɨ Adjusted for district, health facility ownership and health worker cadre 
¥ Adjusted for district, type of health facility and health worker cadre 
§ Adjusted for district, type of health facility and health facility ownership 
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7.4 Discussion: 
This study provided an opportunity to assess the influence of health workers’ attitude to 
the usage of new malaria treatment recommendations.  Overall, results showed 
variations in health workers attitudes and practices regarding new treatment 
recommendations in terms of type of health facility, ownership and type of health worker 
at six months post changes and two years later. There was less variation of provider’s 
attitudes and personal use of new recommended antimalarial between districts. 
Dispensaries and health centers showed higher preferences for SP than hospitals. 
Similarly, public facilities reported higher preference for SP than non-public ones. Most 
providers were not comfortable with the use of SP for children below age of 5 and for 
pregnant women. Personal use of SP for their malaria episodes was high in both 
rounds, with some exceptions in the second round. 
The introduction of SP as a first line treatment of uncomplicated malaria in Tanzania 
was not well received (Nsimba SE, 2006). It is therefore not surprising that from the first 
survey (baseline), preference to SP as appropriate treatment for management of 
uncomplicated malaria was low among health workers in the surveyed districts. Their 
dissatisfaction of treatment recommendation could have influenced their perceptions, 
attitudes and practices. This attitude may be based on their daily experiences in the 
clinical management of patients as became evident when we assessed providers’ 
preferences by type of health facility. In many areas especially rural Tanzania, hospitals 
are expected to be receiving referal cases. For malaria, these could mean patients who 
did not respond well to first line treatment at lower level of care, i.e. dispensary or health 
center, hence sent to hospitals for further management including laboratory assessment 
and in-patients’ service. This may explain the significant findings of providers from 
dispensaries and health workers appreciating SP use better than hospitals.  
Many studies have assessed users’ perceptions of new treatments when changes 
occur. Several authors explored community perceptions to malaria treatment and other 
aspects of health services in Tanzania and elsewhere (Tarimo DS et al., 2001; Wakgari 
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D et al., 1999; Okolo SN and Ogbonna C, 2002).  Likewise, most studies of health 
workers’ knowledge, perceptions, attitudes and understanding have been conducted in 
relation to health services and health problems other than malaria (Olowookere SA, 
2009; Ignacio LL and DeArango MV, 1989; Wasunna et al., 2008).  The introduction of 
ACTs in most African countries received considerable attention, with researchers 
evaluating the process of change and performance of health workers on new policies. 
Some of these evaluations were on artemether-lumefantrine in Kenya, Uganda, and 
Zambia as well as on artesunate plus amodiaquine in Ghana (Dodoo ANO, 2009; 
Zurovac et al., 2008c; Zurovac et al., 2007; Zurovac et al., 2008a). These evaluation 
assessed providers’ use of new treatment recommendations for malaria case 
management, with no focus on personal preferences and personal use. 
The difference in providers’ preferences for SP for management of uncomplicated 
malaria may also be related to performance of the health facilities governing 
committees. A fact that public providers were more comfortable with SP than those in 
the non-public sector may be linked to a closer supervision of health management 
teams.  Intrinsically health workers do assess clinical progress of their patients. Results 
in this survey indicate that most providers were skeptical using SP for children under 5, 
and pregnant women; probably because they perceived it too strong for children below 
age of 5 as previous studies from Tanzania reported (Tarimo DS et al., 2001).This 
preference worsened over time suggesting that providers were not satisfied with 
experiences of using SP. This finding is in contrary to what one would expect; that 
providers need time to appreciate, accept and comply with new treatment policies. An 
important lesson here is that, when there is a failing drug in the system, health care 
providers will, without doubt, notice it and may provide initial indication of the drug 
resistance in the population. 
Despite poor attitudes to the new drug for first line management of uncomplicated 
malaria, many providers indicated that they had used SP in their last illness episode of 
malaria. In the first round, it was difficult to assess if SP was used before or after the 
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change, since we did not specify the duration of illness prior the survey, but in the 
second round we gave a time frame; i.e. we inquired for a malaria episode in the past 
three months preceding the survey. Also, we did not seek additional clinical information; 
therefore couldn’t assess if it was correctly used. Interestingly, compared to hospitals, 
providers’ from the dispensaries were more likely to have used SP for their illness 
episode or their family members. This finding was observed in both survey rounds. One 
possible explanation for this observation may be related to a fact that, hospitals are a 
higher level of care, therefore more likely to see referal cases of malaria; i.e. non 
response to first line treatment and/or severe form of the disease. But also, dispensaries 
do not have a wider range of treatment choices and services available, hence more 
likely to follow treatment guidelines presented.  
Also, it is more likely that, knowing this is the only available treatment option for them, 
dispensaries strives to have medications available in stock; hence availability of the 
drugs facilitated it being used by a staff or staff’s family member. This may not be a 
case for higher levels of care, given a wider choice of drugs available. The same may 
apply for public providers, with good health management team supervision, public 
facilities are more likely to abide by the new treatment recommendations, but this 
cannot be said for non-public facilities, hence significantly less use of SP for last malaria 
episodes was observed from non-public providers in this study. SP was available as a 
single dose and its price was not as high as other antimalarials available at the time of 
survey. During time, other antimalarials available in private sector included 
amodiaquine, chloroquine (the outgoing medicine), artemisinin mono-therapy, quinine, 
etc. All of these products require more than a single dose to finish a course of 
treatment, therefore more likely to cost more than SP. A possibility of financial gain for 
using other treatment recommendations than SP cannot be ruled-out in the private 
sector. 
Study limitations: 
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We did not account for the clustering of health facilities in the analysis. This may have 
affected the magnitude of the measured effect. Ideally, this clustering effect should be 
taken into account because there may be similarities between individuals working in the 
same health facility, such that, on average they are more similar to each other than to 
individuals in other health facilities, due to many factors such as training received at 
facility level and experiences acquired through everyday’s practices. However, we 
worked with the assumption of independence between the observations, since we were 
assessing individuals’ attitudes, through their preferences and personal use of treatment 
recommendations. These variables are more likely to be related to personal 
understanding and beliefs. 
However, it is acknowledged that personal preferences can be influenced by many 
factors such as training, work experience and for the case of malaria treatment; 
availability of medicines and appropriate technologies to assist in clinical care of 
patients e.g. diagnostics for malaria confirmation, as well as presence of policy briefs 
and documents for referencing. These factors were not assessed and therefore limit our 
conclusions with regards to the role they play to shape health workers preferences and 
personal use of new treatment recommendations for management of uncomplicated 
malaria in the surveyed area. 
Third, a fact that the criteria used to obtain interviewee was not random, implies that 
results from this evaluation cannot be generalized for all health workers in Tanzania. 
However, we are confident that, this study provided additional information on predictors 
of preferences and practices among health care providers toward SP, which 
complimented previous reports of poor community and provider’s perceptions towards 
SP when it was introduced for management of uncomplicated malaria in Tanzania; as 
well, it provides a clue on what happens to the health system when there is a failing 
drug.  
Although we did not match respondents in the two surveys, the fact that we interviewed 
health workers from the same health facilities, increased our confidence that the 
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differences reported in preferences and practices reflect a general picture for providers 
with similar experiences. 
Fourth, not being able to assess clinical information when assessing practices towards 
recommended treatment through personal/family use, might have led to a biased 
estimation of SP use. It is possible that there were good reasons for not using SP to 
some cases that may be due to, for example, a diagnosis of severe malaria, non-
response to SP or history of hypersensitivity reaction to sulphur- containing medicines.  
Fifth, it is possible that some health workers reported what was considered appropriate 
rather than what they would actually do, or actually did, leading to courtesy bias. 
Furthermore, recalling what happened in terms of treating malaria in the past may have 
been difficult for some participants, introducing a recall bias. These biases could have 
affected measures of effect estimated. In this respect, we limited the recall for up to the 
past three months in the second survey. 
Lastly, the relatively small sample for some sub-groups of explanatory variables e.g. 
physicians; made it difficult to detect associations between some potential risk factors 
and the outcomes studied.  
7.5 Conclusion: 
Following changes in malaria treatment guidelines, health workers in Morogoro Rural, 
Rufiji and K/U districts showed variations in attitude towards new recommendations. 
Health workers generally showed poor attitudes towards the new recommended first 
line treatment, but many used it in their last malaria episode or their dependants’. 
Clinicians did not to totally accept the recommendation after the change, and this 
attitude worsened over time. Poor attitude to and lower use of SP for self-treatment was 
more apparent in hospitals and non-public health facilities. These findings indicate that 
other factors than provider’s attitude may play important role in providers’ practices and 
acceptance of new treatment recommendations. Such things as experience acquired 
through observation of clinical response to treatment, having a range of available 
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treatment choices and patients’ characteristics may have more influence in clinical 
practices.  
The need for close monitoring of implementation of new treatment policies is 
emphasized including assessment of training and sensitization needs for different health 
worker cadres and facility type, particularly early in the change process. Training should 
involve refresher trainings, especially in contents that seem not to be well adhered to. 
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Chapter 8: General Discussion, Conclusions and Limitations 
8.1 General discussion: 
Effective malaria case management requires efficacious antimalarial medicines in place. 
The global move to use ACTs for malaria treatment in early 2000, contributed to a 
tremendous decline in malaria prevalence in many endemic areas (WHO, 2006; WHO, 
2012b). These achievements cannot be attributed to use of ACTs alone, but also scale-
up of other malaria control interventions such as vector control measures as use of 
ITNs, IRS, larviciding, intermittent preventive treatments for vulnerable population 
groups and the increased use of diagnostics for routine care. However, the full potential 
of ACTs to clear malaria infection and halt the disease progression can be realized if the 
medicines are delivered and used as intended, e.g. in the controlled environment. This 
is not possible because medicines need to be used for routine care within the health 
systems using existing channels to procure, deliver, store, distribute and prescribe the 
drugs for patients use; termed “systems effectiveness”.  
The complexity of systems effectiveness is a result of the multi-disciplinarily nature of 
the actors. In the case of malaria control as investigated through INESS platform, health 
system factors played important role in the decay of ACT efficacy (in Rufiji). Major 
losses of systems effectiveness were observed in relation to poor or delayed access to 
care, poor providers compliance to treatment policies which lead into poor patients 
adherence (INESS report to Gates foundation:2011). In the INESS reports, only 37% of 
all fever cases had access to an ACT provider within 24 hours (figure 1, Chapter 8). 
Further decay was due to unavailability of medicines at health facilities, providers’ 
behaviour and patients’ adherence to treatment, resulting to effectiveness of about 18% 
(figure 1, below). Indepth assessment of factors associated with poor providers’ 
compliance during INESS surveys is the primary focus of this work. Here an abstract of 
important findings from the five papers above (chapter 3,4,5,6 and 7) is presented and 
its implication for the control of malaria and other diseases within the context of a similar 
health system structure in the region and elsewhere is discussed; with particular 
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emphasis in service delivery, health workforce, availability of technology and products 
as well as governance. Based on these findings, recommendations are put forward to 
guide appropriate use of resources to maximize systems’ performance for better health 
outcomes.  
Figure 1: Systems effectiveness of ALU in Rufiji Tanzania, 2010-2011. Source: INESS 
report (unpublished data) 
8.2 Quality of services delivered: 
This work demonstrated that having a malaria confirmatory test before treatment, 
significantly reduced over-treatment of malaria (during high transmission season) in one 
area that this policy was implemented (Chapter 3: tables 5 and 6 ; (Masanja et al., 
2012b). Introduction of malaria rapid tests for routine care in Rufiji increased the 
chances of fever patients being seen in a facility with malaria confirmatory capacity 
(chapter 3: table 1). Having the tests in the facility also improved correct testing, i.e. 
testing patients with fever to rule out malaria, complying with testing algorithms provided 
during training of the new policy. Unfortunately, having tests was also associated with 
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higher over-testing, i.e. non febrile patients sent for a malaria confirmatory test, 
indicating poor case selection (chapter 3: table 2). However, the gain achieved by 
prescribers complying with test results, benefits both the patients and the system.  
Improvements in malaria case management following introduction of rapid tests for 
routine use have been reported in other settings as well (D’Acremont V et al., 2011; 
Ishengoma DS et al., 2011) 
 Assessment of the quality of malaria treatment revealed that some patient groups are 
prone to inappropriate dosing of ACT (chapter 4: tables 2 and 3). AL dosing by age for 
older children between 3-12 years of age, showed more than 50% of target group 
received inappropriate AL dosing (p<0.05). Weight based prescriptions provided a 
better indicator for dosing, but were less practiced as evident by the lower proportion of 
patients (33.2%) who had their weight assessed during provider- patient interaction 
(chapter 4: table 1). These findings have important implications for malaria control, as 
sub-therapeutic doses of antimalarial chemicals may lead to resistant strains of the 
parasite and lower the drug’s gametocidal function. In addition, poor providers’ 
behaviour is one precursor of poor patients’ adherence to treatment. If a patient is 
prescribed incorrect or inappropriate dosing, and took the treatment faithfully as 
prescribed, in the end this person did not complete a recommended treatment without 
his/her awareness or intentions of doing so.  
It is further very unfortunate because results in chapter 5 demonstrate that, as malaria 
prevalence declines in population surveys (NBS and Macro ICF, 2011), the burden 
shifts from infants and toddlers to children and young adults. Analysis of data collected 
from 2002-2010 in out-patient settings within the study areas (Rufiji and K/U) shows that 
over the years, children between age of 2-5 years and older children from 5-15 years 
have an increased prevalence of malaria parasitemia at health facilities (chapter 5: table 
2 and figure 2c, 2d); contrary to population based findings to the former. These findings 
bring a public health concern in relation to malaria prevention policies and strategies. 
The respective age group is likely to be school children who are actively involved in 
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outdoor activities. A fact that, the same group is prone to receiving inappropriate dosing 
of ACT when infected (chapter 4) implies that adequate parasite clearance may not be 
achieved, hence a significant morbidity burden and continued malaria transmission in 
the community. 
8.3 Availability of products and technology: 
Products availability is known to have influence on care. Indeed, patients diagnosed 
with RDT in INESS surveys, had higher odds of getting a correct treatment of ACT 
(Chapter 6: table 3 and 4) where as clinical diagnosis of malaria lowered the odds of 
correct treatment (chapter 6: table 3 and 4); and increased the odd of over-treatment 
(chapter 3: table 4 and 6). The frequent stock-out of life saving malaria commodities in 
the study settings threatens quality of care of malaria patients. Innovations like “SMS for 
Life” provide a better means of assessing stock levels of medical products in ones 
administrative area (Barrington et al., 2010). SMS for Life, has further shown to guide 
reallocation of resources in rural health facilities in Kenya in order to reduce the problem 
of stock-outs of medical products (Githinji et al., 2013). This is the current best 
alternative strategy for insuring availability of medical products in health facilities. In the 
Kenya study, up to 73% of stock-out alerts were resolved by district managers through 
redistribution. As a tool to monitor stock levels, too much reliance shouldn’t be put on 
emergency stock replenishing platform. This dependence will lead to expensive 
unscheduled field trips for re-stocking or re-distribution, which has resource implications 
and may divert attention from other prior planned activities. However, the platform can 
be useful to plan for activities during supervision visits, or raise important discussions 
points during planning meetings. 
With regards to improving products availability, the need to reassess the original plan of 
medical products procurement, ordering and distribution act has become more obvious. 
After experience gained in the first 2-3 years of implementing “SMS for Life”, 
implementing partners should now analyze the stocking trends and see how stock 
management can be improved at the facility and national levels. The procedure of 
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products forecasting may need to be revised to take into account real time data 
available through “SMS for Life”. It may be necessary to revise the requisition and 
ordering formulas or use mathematical modeling to account for morbidity patterns, 
population growth (USAID | DELIVER PROJECT, 2011), seasonality, utilization rate, 
changes in weather patterns, availability of diagnostics, resultant epidemics as well as 
other unforeseen factors e.g. increased utilization due to closure of the nearby facility 
for social or administrative reasons, etc. Lately, there have been reports of the national 
medical store department (MSD) delivering products directly from the national level to 
the health facilities. This may be a good initiative to improve availability and stock levels 
of essential medical supplies at the point of care in rural areas.  
8.4 Health workforce: 
An assessment of personnel’s factors affecting provider’s compliance revealed that, 
work experience significantly improved the odds of giving a correct treatment of malaria 
(p=0.02). As well, providers of lower cadres were more likely to comply with treatment 
recommendations (chapter 6: tables 3 and 4); a similar observation to what has been 
reported from neighboring countries (Zurovac et al., 2004; Rowe AK et al., 2003). 
Regular support supervision would be useful to improve compliance in this aspect. In 
chapter 7, this work showed that, providers attitude may have less influence to their 
practices regarding treatment recommendations (Masanja et al., 2012a) than other 
system components; chapter 7: tables 3,4,5 and 6). Such factors as the type of provider 
served and availability of recommended medicines at their respective work areas may 
have more effect in their practices. These findings have practical implications to health 
management teams; that, having the recommended treatment products available in 
health facilities facilitates provider’s compliance. It is possible that, the act of prescribing 
medications that are not in stock frustrates providers, particularly in rural settings where 
this work was carried out, as there aren’t many drug selling outlets and purchasing 
power of the community members is very low. Nevertheless, inadequate health workers 
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performance has been long recognized as widespread problem which required 
multifaceted approaches to address (Rowe AK et al., 2005). 
8.5 Financing and Access to care: 
The poor quality of services may be one of the major factors for poor access to formal 
health care. The proportion of people who had fever and accessed care within 24 or 48 
hour of fever onset, to a recognized ACT provider in INESS survey was very low 
(INESS report to Gates Foundation). Barriers to prompt access to care reported in other 
settings included acceptability, availability and affordability, mentioning a few (Hetzel 
MW et al., 2007; Chuma J et al., 2010). The frequent stock out of medicines in nearby 
health facility discourages prompt attendance to facilities, especially when the problem 
at hand is perceived to be minor, such as fever at its initial onset. The indirect costs of 
medical care, such as transport, food etc, complicates affordability issue. In addition, 
problems with the organization structure of the health system such that a facility can 
stay closed on days when it should have been functional (e.g. due to human resources 
crisis, e.g. because a provider had to travel to district headquarters, humanitarian 
reasons, etc), brings about undesirable consequences. These, including other factors 
described by health financing scientists (Mtei G and Mulligan J, 2007), may  be  among 
the reasons for low enrolment of community health insurance schemes in rural 
Tanzania. 
8.6 Governance: 
On the other hand, problems of providers’ compliance with treatment recommendations 
and availability of medical products would have been significantly improved if district 
health management teams perform supportive supervisions as required. In this work, 
very few health workers reported to have had a supervisory visit within the six months 
preceding the surveys (chapter 5: table 1, 2 and chapter 6: table 2). As a result, we 
couldn’t record any meaningful effect supervision visits have had on quality of care. In 
fact, the role of supervision on improving provider’s performance have led to 
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contradictory findings in the last decade, but seem to, at large, be associated with 
improved health workers performance (Loevinsohn BP et al., 1995; Trap B et al., 2001). 
This finding underscores the need for district health management teams and other 
supervisory bodies to adhere to supervision plans in order to get a common ground for 
discussion of challenges facing health care provision in provider’s working areas at 
different levels of care.  
However, the main hindrances to achieving the required level of supervision activities in 
many resources poor settings are multifaceted and require support from responsible 
leaders as well as investigating cost-effective ways to implement quality supervision 
activities (Rowe AK et al., 2010). Understanding that health policy or health systems 
studies implies broader range of methods (Bennett S et al., 2011); not only limited to 
hypothesis testing and proving causal pathways, etc (Gilson L et al., 2011); an 
assessment of the context where reported providers’ practices occurs was done. This 
lead to an in-depth analysis of stakeholder’s contributions to malaria control efforts in 
the country and realized that the administrative structure of the Tanzanian health 
system leaves room for improvement. The fact that health services are managed by 
different Ministries at different levels of care (figure 2, chapter 8), can be complimentary 
or can lead to contradictory responsibilities between the actors.    
Figure 2: Administrative organization of the Tanzanian health system [adopted from 
the World Bank report: (World-Bank, 2011)  
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8.7 Health services and organization structure: 
Partnership between various Ministries is encouraged because health issues are cross-
cutting and affected by all aspects of life, such as environment, infrastructure, gender, 
education, water and sanitation, etc. For mutual benefits and understanding, a clear, 
transparent and accountable collaboration between actors is needed. For example, 
there are seven divisions (with 6 directorates) working under the Chief Medical Officer 
at the MoHSW (Figure 3, chapter 8 below). 
 The CMO coordinates all health services delivery in the country, including quality 
assurance of services and budgetary allocation of funds to various health services. It is 
worth to remember that, funding matters for the central government (e.g. Ministries) are 
coordinated at the Ministry of Finance and Economic affairs (figure 2 above). Other 
units within the Ministry of health include: Information and communication technology 
which is responsible for e-health, m-health, Tele-health, health management information 
systems, etc; Legal services; Financing & Accounting; Internal Audit; Procurement 
management and Government communication unit (MoHSW-webpage). 
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Figure 3: Directorates under the Chief Medical Officer [summarized from the 
Ministry homepage (MoHSW-webpage)] 
Office of 
the Chief 
Medical 
Officer, 
MoHSW 
Tanzania 
Preventive Services 
(directorate) 
Epidemiology and Disease control  
Reproduction and Child health 
Environmental, hygiene & sanitation 
Health education & Promotion 
Nutritional Services 
Curative Services (directorate) 
Public & Private Health services 
Diagnostic and Technical services 
Traditional & Alternative medicine 
Oral Health 
NCDs, Mental health& Substance abuse 
Human Resources 
development (directorate) 
Health human resources planning 
Allied health services training 
Nursing services training 
Continued Education & Post-graduate 
Social Welfare staff development 
Health Quality Assurance 
(directorate) 
Pharmaceutical Services 
Health Services inspectorate & QA 
Emergency preparedness & response 
Nursing Services 
Social Welfare (Commissioner) 
People with disabilities & elderly 
Family, child welfare & early childhood 
Juvenile Justice services 
Administrative matters and 
Human Resources 
management (directorate) 
Administration 
Human Resources management 
Policy and Planning 
(directorate) 
Policy Section 
Planning Section (& budgetary) 
M&E and Performance reporting 
 
In additional to the Ministry of Health, Ministry of Education and Vocational Training and 
Prime Minister’s Office; health matters are also featured at the President’s Office 
Planning Commission (POPC) under the Social Services Demographic Cluster. The 
cluster deals with monitoring and advisory role in many population services and social 
development issues in the country. 
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Figure 4: Section of the Organization structure of the Planning Commission 
(available at http://www.mipango.go.tz/documents/POPC_orgnization%20structure.pdf 
last accessed on 10th April, 2013) 
 
In all these areas (ministries and POPC), units/sections have specific goals and 
description of their work, which demarcates them from other sections/ units. A simplified 
relationship of country’s administrative health actors is such that, the MoHSW 
supervises formulation of health policy and guidelines, coordinates health services 
provision and monitors quality of services, whereas the local government authorities 
(LGA) under the Prime Minister’s Office (PMO- RALG) delivers these services to people 
and the social services cluster monitors, analyses and advises accordingly. Unless 
there are deliberate measures to coordinate processes and outputs across different 
sections working towards a common goal, every section will be concentrating on what 
they are expected to do, in the usual classical, linearized approach. 
Systems’ thinking requires working in dynamical, inter-connectedness approaches 
between different system components, or actors. Understanding the complex nature of 
systems is the underlying principle of systems thinking approach (Adam T and De 
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Savigny D, 2012). Health problems have multiple, on-going causality and require 
multidisciplinary actions to mitigate them. No single actor can work alone to control, 
eliminate or eradicate a health problem. This is why health systems are categorized as 
complex adaptive systems (CAS) (Pain L and Peters DH, 2011). The effect of 
malfunctioning of one part of the system can result to adverse consequences to the 
other component, or on the system as a whole. A good example as was evident in this 
work is the trickledown effect of poor provider’s compliance to treatment 
recommendations leading to poor patients’ adherence (and probably poor treatment 
outcomes) decreasing systems effectiveness of ACTs.  
8.8 Challenges facing health systems actors 
Scientists have gone further to describe the relationship between health systems 
building blocks and its actors, such that the systems building blocks represent “systems 
hardware” while the interconnectedness and relations between them as “systems 
software” (Sheikh K et al., 2011). Unfortunately, the software part of the health systems 
is often neglected (Bigdeli M et al., 2012). Furthermore, health systems actors, just like 
health systems researchers are too fragmented; based on their expertise, experiences, 
current responsibilities and knowledge. Gilson and colleagues describes this knowledge 
paradigm to be responsible for framing understanding of reality, functions and nature of 
research in relation to health policy and systems (Gilson L et al., 2011). This clash of 
knowledge paradigms may lead into communication barriers that discourage 
interdisciplinary collaborations (Gilson L et al., 2011; Bennett S et al., 2011). In such 
situation, investing in smothering actors’ interactions (the systems software side) may 
prove to be more beneficial. 
On an equal note is the need to foster international partnership and learn from others. 
Although health systems problems occur in local contexts, some expertise may not be 
available locally. The problem of inadequate dosing to older children described in 
chapter 4 can be used to illustrate this point. Tanzania do not manufacture AL (ACT for 
malaria treatment), and therefore cannot modify manufacturers dosing instructions 
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provided to guide clinical use. It is appropriate to conclude that manufacturers’ uses 
internationally recognized profiles with known credible/ confidence intervals to guide 
dosing. This implies that the target population may fall anywhere in these intervals.  In 
this case, a consensus is needed to clarify what patient characteristic (e.g. age vs 
weight) provides a good basis for better clinical outcomes based on the drugs’ 
pharmacokinetics and pharmacodynamics properties. Both age and weight based 
prescriptions have a role in clinical pharmacology particularly in pediatric dosing; age as 
an indicator of maturity e.g. internal organs – for drug metabolism and weight as 
indicator of surface area for drugs’ distribution.  
8.9 Limitations: 
There are several limitations to this work that made it not possible to make reliable 
conclusions on some aspects of care. First; no detailed assessment was made on the 
effect of staff shortages on provider’s compliance. In reality, two facilities that provide 
similar level of health services but with an appreciable gap of total number of health 
workers with the right mix of expertise (e.g. a dispensary with one health worker versus 
that with three staff), may have differing levels of care quality. Our study was not 
structured to assess the implication of this disparity in quality of malaria case 
management. Second; many studies have reported the difference in quality of health 
care services provided between public and private providers (Basu S et al., 2012). Our 
surveys were not powered to assess these differences therefore could not demonstrate 
appreciable findings regarding the influence of providers’ type on quality of care. In fact, 
there were very few private providers in the areas we worked, and in the country as a 
whole. 
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Chapter 9: General Conclusions and Recommendations 
 
9.1 General Conclusions: 
The quality of malaria case management in rural Tanzania needs improvement. Four 
years after the introduction of ACT (AL) for management of uncomplicated malaria, 
provider’s practices are still sub-optimal, stock-out of medical products to facilitate case 
management is rampant, support supervision occur less frequent, correct dosing of ACT 
for uncomplicated malaria is low to some group of patients - especially when 
prescription was age-based, etc. All these challenges affect the quality of malaria case 
management, especially in rural Tanzania. Despite of these deficiencies, this work 
showed that investing in health system does have a positive effect. The policy of 
malaria confirmation prior to treatment seems to improve correct treatment, although the 
strategy is handicapped by stock-out of testing devices. As well work experience had 
positive impact in correct treatment of malaria, but support supervision rarely happens. 
These observations demands integrated efforts to reverse the possible negative 
consequences resulting from poor provider’s compliance. Some of the possible factors 
for this behaviour, as demonstrated here, could be outside the provider’s capacity. 
Issues of stock-outs may, sometimes, need to be dealt at a higher administrative level, 
that is, district, regional or national stakeholders involved in the procurement policy. The 
problem of inadequate dosing may require stakeholder’s involved in health workers 
training to refine existing guidelines and provide recommendations for improvement e.g. 
do refresher trainings, etc. A fact that work-experience improves the odds of correct 
prescription, demands closer support to new employees in their work areas.  
Another complexity may be related to levels of supervision responsibility between the 
various ministries involved in provision of health services (chapter 8: figure 2) and 
implementers. Who is required to provide resources for what kind of supervision 
support, at what level of care, requires more transparency. This is another area to look 
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into deeply and provide practical guidelines. It is possible that the guidelines referred 
here do exist; but they seem not to be complied with very well. If this is the case, then, 
there is a need to fine-tune management procedures and hold responsible actors 
accountable for consequences.  
9.2 Recommendations: 
The complexity of issues demonstrated here speaks to the need to adopt a systems 
thinking approach in the health sector. The problems discussed in this thesis touch a 
small area of health care services in Tanzania, yet highlight challenges and major areas 
of concern. Currently, health systems’ strengthening is on the global health agenda and 
there is adequate will to seize the momentum and act. Several guidelines are now 
available for use by policy makers to analyze and integrate systems components for 
better health system performance (Lavis JN et al., 2012; Bosch-Capblanch X et al., 
2012; Lewin S et al., 2012; Bosch-Capblanch X, 2011). What is needed now to benefit 
from the advances in systems knowledge are the practical methodological steps that 
are context specific to a respective health system. Failure to do this means business will 
continue as usual, and it will take a very long time to see small positive changes in 
health systems’ performance in the developing world. 
Here, three recommendations are put forward to address and progress the health 
systems strengthening agenda, in Tanzania. The aim is not to overhaul the system, but 
rather to provide trouble-shooting mechanisms in areas not working well by 
smoothening interactions between actors and performing technical adjustments 
wherever needed. 
1. First is to improve stewardship in the health sector to ensure health policies are 
implemented effectively. This may require a use of internal “Health Diplomacy” as a 
strategy to employ “systems thinking” for stakeholders’ management of health 
system’s strengthening agenda. This implies, taking time to understand the 
complexity of challenges facing different aspects of care, and finding sensitive, 
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effective ways of harmonization geared towards a common goal. This strategy can 
be very useful if applied at a higher level of administrative hierarchy. Say, in the 
ministry of health having a small team of 2-3 technical staff (with the right mix of 
expertise; e.g. in financing, pharmaceuticals, clinical work, policy analysts, etc) to 
work for systems strengthening, with “systems thinking” approach. Ideally this team 
should work under the CMO in either Quality Assurance or Policy and Planning 
directorates. The main objective of the team should be to analyze challenges in 
different programmes/ units/ sections, and work together for solutions, i.e. 
strengthening the “system software” aspect. When there are conflicting interactions 
between units, the team could act as outsiders to assess the situation and advice 
accordingly. 
A possibility of having this team positioned at the POPC, which is higher ranked than 
within the MoHSW, should be encouraged. It is envisaged that, at POPC, the team 
will have better power to assess and provide useful recommendations taking into 
considerations the existing state of affairs; even at ministerial levels. Ideally this 
organ should connect and be able to work with all actors in health sector, from all 
governmental departments. The assumption for having this team placed at POPC is 
a possibility of getting classified information on resources available and approval to 
divert them to the challenged endeavor. Another advantage of placing this team 
outside the Ministry with a primary responsibility for health matters is to avoid 
animosity among work colleagues. 
2. The second recommendation is based on knowledge creation and training. 
Understanding the nature of complex adaptive systems such as health systems, and 
the possible interactions amongst its components, will help officials make better and 
more informed decisions regarding their actions. This recommendation suggests 
training at two levels; first: is to deal with executives. Here, a programme is advised 
for executive officers and programme officers/ managers. This will provide grounds 
for sharing experiences, learning from one another and working for a common goal 
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between actors within and outside the similar areas of work. Ideally the courses 
could be week-long international or local courses with participants from diverse work 
environment. 
The second part of the training recommendation is a long term strategy that will 
involve introducing health systems block courses to health related trainings. This can 
begin at undergraduate level, e.g., in nursing or medical related trainings, 
management courses; and at postgraduate level, e.g. masters programmes for 
public health and health administration, etc. Already this concept is happening in 
some institutions such as the Swiss TPH, NMAIST (under IHI) is planning a more 
similar course, etc. 
3. A third recommendation is the need for more evidence on health systems 
interventions. Scientists and researchers need to study innovative concepts for 
improving systems performance which address various components of health 
systems in the right mix. One review has raised a concern on lack of evaluations 
which addresses multiple systems building blocks (Adam T et al., 2012). This should 
be regarded as a call to increase evidence for system wide interventions that work. 
In the same manner as the criteria for scientific evidence stands, all forms of 
intervention studies, from randomized control trials (RCTs) to case controls and 
quasi- experimental studies should be undertaken for this course. 
This recommendation does not intend to down-play exploratory, descriptive and 
social science studies, but rather, employ them onboard, to monitor the change of 
paradigm. Descriptive studies will be very useful to highlight the change and 
highlight future directions, where as qualitative studies will provide in-depth 
understanding of the contexts.  
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